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SUMMARY
Conditions have been developed for the successful 
culture, in serum-free medium, of neurone-rich, foetal 
rat spinal cord cells for two purposes. These were, 
firstly, for characterisation of muscle-derived 
neuronotrophic factors and secondly, for analysis of 
monoclonal anti-neuronal antibodies.
Human skeletal muscle extracts were shown to 
increase levels of neurofilament, overall protein and 
choline acetyltransferase activity in the cultured cells 
and also to extend considerably their survival.
A number of monoclonal antibodies with specificity 
for neural tissue antigens have been generated and some 
have been characterised. In particular, an anti­
neurofilament antibody (2F7) has been used routinely 
for identification and assay of cultured neurones, while 
a second antibody (3C4a) appears to recognise a serum- 
inducible neuronal surface glycoprotein.
Conditions have also been developed for the 
successful growth and maintenance of foetal human spinal 
cord neurones in both serum-supplemented and serum-free 
media. These cultures have been used in comparative 
studies.
The rat spinal cord cell cultures have also 
been used in studies of Motor Neurone Disease (MND). 
Binding of MND serum immunoglobulins to the cultures 
has been examined by using immunofluorescence and ELISA 
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INTRODUCTION
11.1 DEVELOPMENT OF NEURAL TISSUE CULTURE SYSTEMS
1.1.1 SELECTION OF APPROPRIATE SYSTEM
Harrison (1908, 1910) initiated the study of neural 
tissue in culture with explants of frog spinal cord 
suspended in clotted lymph. He was successful in 
answering the question as to the origin of the "long 
fibres" of the nervous system by observing the outgrowth 
of nerve axons from cell bodies into the surrounding 
lymph clot. He also noted that the growing tip of the 
axon was expanded to form the appropriately named "growth 
cone", previously described by Cajal (1890) in sections 
of the developing chick nervous system (see Letourneau, 
1983) .
The range of neural tissue culture systems has 
since expanded (rev. Nelson, 1975) to include organ 
culture, explants, dissociated tissue and neuronal cell 
lines.
Organ culture involves culture of whole isolated 
spinal cord usually from frog or chick (Katz & Miledi, 
1963) .
Explants have been prepared from isolated chick 
or mammalian sensory and autonomic ganglia (Sobkowicz 
et a l ., 1973), from sections of spinal cord (Peterson 
et a l ., 1965) and from brain (Pomerat & Costero, 1956; 
Hild, 1966) .
Dissociated tissue cultures normally involve a 
single cell suspension produced by a combination of 
enzymic and mechanical procedures. Dissociated cells
2are plated out at specific densities (rev. Ransom &
Barker, 1981) . Re-aggregation of some of the cells may 
occur spontaneously, or this may be actively encouraged 
(Seeds & Vatter, 1971). For some purposes, however, 
re-aggregation of the cells is undesirable and various 
attempts have been made to reduce it, usually by modifying 
the substratum (Section 1.1.5).
Dissociated neural cultures provide maximum 
accessibility for morphological examination. Their large 
surface area allows for efficient exchange of nutrients 
and waste with the media. In addition, potential neurotoxic 
or neurotrophic substances included in the media are 
in rapid, direct contact with the cells.
Dissociated spinal cord cell culture was initially 
developed by using embryonic chick as the source 
(Fischbach, 1972). The neurons had a survival time of 
only a few days in culture. With foetal mice as the 
tissue source (Peacock et al ., 1973? Ransom et al., 1977), 
longer term cultures of 3 to 8 weeks duration were 
reported. A vital factor was the age "in utero" of the 
foetuses which would only yield "good, healthy cultures" 
between days 12-14.
Dissociated foetal rat spinal cord cultures (Digby 
et a l ., 1985) are prepared in a similar manner to those 
of mouse, with day 15 foetuses yielding the best cultures 
irrespective of which medium or substratum is used 
(Section 2 .3.1. 6) .
Neuronal cell lines (see Nelson, 1977, for review) 
have been derived either from spontaneously arising 
tumours of the nervous system (eg. the C-1300 mouse •
3neuroblastoma which arose in 1940 and was carried by 
serial passage in mice until adapted to tissue culture 
by Augusti-Tocco & Sato (1969) or by chemical induction 
(eg. Schubert & Jacob, 1970) . Their properties have 
been extensively studied (eg. Prasad et a l ., 1973; 1975; 
1976) including their ability to form functional synapses 
with primary muscle cell cultures (Nelson, 1977).
Each type of system described above has its 
own advantages and disadvantages and these are summarised 
in Table 1 (p. 4; from Nelson, 1975) . Survival time of 
the culture may be an important factor in the choice 
of an appropriate system, and hence this has been added 
to Nelson's original table.
Table 1 Properties of tissue culture systems (from Nelson, 1975).
Scale graded between minimum (0) and maximum (++++) degrees.
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51.1.2 CULTURE OF HUMAN NEURAL TISSUE
Early attempts at the culture of human neural 
tissue were restricted to explants. Peterson et a l . (1965),
for example, successfully grew a spinal cord explant 
from a 6 week old human embryo. Explants were not 
successful when prepared from 12-16 week foetuses.
The first report of the successful culture of 
dissociated human neurones was by Scott (1971), who 
used dorsal root ganglia (DRG), from 10-16 week foetuses,
grown in serum supplemented medium (SSM) containing .......
a high potassium ion (K+) concentration. The neurones 
remained viable for up to 11 weeks. Proliferation of 
the connective tissue cells was observed to be much 
slower than in the comparable chick system. Kennedy et 
a l ., (1980) and Dickson et a l . (1982) produced and
characterised cell cultures grown from dissociated DRG 
and brain, from 15-20 week old human foetuses, by using 
standard methods for animal cell culture, and with the 
aid of cell-type specific markers (Section 1.2.8).
Only very recently have successful cultures of 
dissociated foetal human spinal cord been reported (Kato 
et a l ., 1985; Kim et al., 1986). These have both been 
produced from very young human foetuses (approx. 8 weeks 
"in utero"), and have been cultured in serum supplemented 
medium.
Cultures of human spinal cord neurones are required 
in order to repeat and extend studies already performed 
using animal material. In particular, studies on growth 
factors and disease processes are of interest. Touzeau
and Kato (1986) have shown that three key enzymic activities
6are unaffected by growth in media supplemented with 
heat-inactivated (HI) serum from patients with Motor 
Neurone Disease (MND) (see also Section 1.3.5(iv)).
71.1.3 MEDIA REQUIREMENTS
The earliest culture media were biological fluids, 
such as lymph, embryonic extract, plasma or serum. 
Development of synthetic media began with salt solutions 
which were supplemented with the various biological 
fluids. Explants and cell dissociates were usually grown 
embedded in a supporting structure, such as a plasma 
or fibrinogen clot.
A number of cell lines were isolated which were 
able to grow directly on the surface of the glass vessel. 
One example, isolated by Scherer et al . (1953) , from
a human uterine carcinoma (strain HeLa) was found by 
Eagle (1955) to proliferate in a medium consisting of 
a mixture of thirteen amino acids and seven vitamins, 
together with cofactors, carbohydrate and salts. He 
was further able to establish the concentration of each 
constituent required for maximal growth. A-small serum 
supplement of approximately 0.25% was, nevertheless, 
found to be essential for growth and survival.
Several other media were formulated in the 1950's 
to allow for the optimum growth of different cell lines 
and primary cultures. The Dulbecco-Vogt modification 
of Eagle's medium (DMEM) is richer in glucose than Eagle's 
minimum essential medium (MEM, BME). For culture of 
neural tissue, this concentration (4.5g per litre) is 
usually raised still further (to approximately 6g per 
litre) by supplementation in individual laboratories 
(Digby et al, 1985) . These media contain bicarbonate 
which acts as a buffer when exposed to 5-10% CC>2 in
8an "open-culture" incubator. Alternatively HEPES buffer 
may be used in some systems. Sodium phenol red gives 
a direct visual indication of the pH of the media.
To date, the majority of cultures have been grown 
in one of the above mentioned media, usually supplemented 
with approximately 10% animal sera (foetal calf or horse).
A nutritionally complete medium containing, in 
addition, eight trace elements was formulated by Ham 
(1965). This medium, F12, was used to great effect by 
Hutchings and Sato (1978) to define the contribution of 
serum to the growth of the HeLa cell line. They showed 
that the serum component of the medium could be replaced 
by the hormones insulin, transferrin and hydrocortisone 
plus epidermal growth factor (EGF, see Haigler, 1983, for 
review) and fibroblast growth factor (FGF, Gospodarowicz, 
1975) .
These requirements were found to differ from cell 
line to cell line, and in 1979 Bottenstein and Sato 
defined a specific serum-free supplemented media for 
the growth of a neuroblastoma cell line.
The next year they published the first report 
of the maintenance of post-mitotic primary neurons (chick 
DRG sensory neurons) in a serum-free modified medium 
(Bottenstein et al ., 1980). Synthetic basal medium was 
supplemented with insulin, transferrin, progesterone, 
putresceine and selenium (N1 supplement). They also 
found that nerve growth factor, NGF (see Bradshaw & Young, 
1976, for review) was essential and had to be added to 
both serum-free and control serum-supplemented medium. An 
initial period of 48 hours in serum-supplemented media
was allowed for the adequate attachment of the cells to 
the collagen substrate.
The ability of primary neurones to grow in serum-free 
chemically defined media has several advantages. In 
the absence of serum, the non-neuronal cells present 
fail to multiply and may eventually die off (Bottenstein 
et al ., 1980; Bottenstein, 1983). This means that the 
cultures are effectively "neurone-enriched" and the 
neurones can achieve their full developmental potential.
The interfering or masking chemical interplay between 
the neurones and glial cells is reduced, allowing the 
biochemical parameters and responses of the neurones 
themselves to be more accurately assessed.
An alternative "in-culture" method of reducing 
non-neuronal growth in serum-supplemented media is to 
add mitotic inhibitors (cytosine arabinoside, uridine, 
fluorodeoxyuridine etc.) to the media at appropriate 
times (eg.Godfrey et al., 1975).Although these drugs cannot 
affect the division of the post-mitotic neurones, there 
is some evidence that they have other undesirable non­
specific cytotoxic or biochemical modulatory activities 
(Kato et al ., 1985), and their use is thus best avoided.
Scott and Fisher (1970) demonstrated a 10 fold 
increase in neurone survival in cultures of dissociated 
chick DRG when the K+ ion concentration was raised from 
6.8mM to 40.8mM (with reduction in NaCl to maintain 
the correct osmolarity). Scott (1971) also reported 
the optimum K+ concentration for culture of human 
dissociated spinal ganglia to be 20.8mM.
Bennett and White (1979) showed enhanced survival of
10
parasympathetic neurones from chick ciliary ganglia (CG) 
when the K+ concentration was raised to 25mM without 
compensatory changes in NaCl. The effect is assumed 
to result from depolarisation induced by the high K+ 
concentration which mimics the normal in vivo innervation 
of the neurones.
These studies have led to the suggestion that 
dissociated neural tissue should be routinely cultured 
in high K+ concentration media. This has been employed 
by Kato et a l . (1985), who recorded a twofold increase
in choline acetyltransferase (ChAT) activity when human 
foetal spinal cord cells were grown in 23.6mM potassium 
chloride (KC1) instead of the usual concentration of 
5.4mM.
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1.1.4 PURIFICATION OF NEURONES FROM HETEROGENOUS CELL
POPULATIONS
Early attempts to purify neurones for culture 
from mixed cell populations exploited the differential 
adhesiveness of the cells for material surfaces. Thus, 
freshly dissociated cells are plated out and left until 
the non-neuronal cells have attached. Gentle agitation 
can then be applied to selectively detach the neurones 
for re-plating (McCarthy & Partlow, 1976; Adler et a l . , 
1979) .
Neurones can also be partially purified prior 
to initial seeding by virtue of their characteristic 
buoyant densities in low "g" velocity sedimentation 
(Berg & Fischbach, 1977) or density gradient centrifugation 
(Schnaar & Schaffner, 1981). The "large cell fractions" 
(LCF's) thus obtained from spinal cord dissociates show 
increased ChAT activity and will only survive in culture 
if they are plated onto a highly adhesive substratum 
in the presence of muscle cells, or muscle-cell conditioned 
medium. They develop a primarily motor neuron-like 
morphology.
It is also possible to purify neurones by virtue 
of their unique cell surface features. For example, 
chick embryo sympathetic ganglion neurones possess high 
numbers of receptors for a-bungarotoxin (a-BgT). Dvorak 
et al. (1978) , used an a-BgT affinity column and succeeded 
in attaining a purification of 9-10 fold with the final 
cell suspension being greater than 95% neurones. The 
cells were viable and electrically active when grown in
12
culture (with NGF and serum included in the medium) .
Immunoglobulins purified from antisera, or monoclonal 
antibodies specific to neuronal cell surface antigens can 
also be used as ligands in immunoaffinity columns to 
effect the purification of neurones (Au & Varon, 1979;
Varon & Manthorpe, 1980).
In an alternative approach, antisera or monoclonal 
antibodies specific for non-neuronal cell- surface antigens 
can be used to destroy unwanted cells selectively through 
complement-mediated lysis (Varon et a l ., 1979; Brockes 
et a l ., 1979).
In yet other approaches, motor neurones have been 
purified 4.8 fold from adult mouse spinal cord (Eagleson 
& Bennett, 1983). The neuronal cell bodies were labelled 
by the retrograde transport in vivo of True Blue fluorescent 
dye and horse-radish peroxidase (HRP). Following 
dissociation of the spinal cord cells, they were sorted 
by a Coulter counter on the basis of both cell size 
and True Blue fluorescence. Forty percent (40%) of the 
"large, fluorescent cell fraction" in subsequent culture 
were labelled by developing the HRP reaction after 2 
hours. However, only 38% of these cells were still viable 
after a mere 24 hours in culture (the longest period 
studied). Plating the cells out in skeletal muscle-cell 
conditioned medium increased the viability of the labelled 
cells to 70% after 24 hours in culture.
The retrograde labelling technique for motor neurones 
has also been applied to foetal rats by Smith et al .(1986) , 
who kept 14 day beheaded rat embryos in organ culture 
for up to 6 hours following the intra-limb injection of
wheat germ agglutinin conjugated to the fluorescent 
marker Lucifer Yellow Vinylsulfone. Ventral spinal cord 
cultures were then prepared from the embryos and the 
labelled neurones were examined in vitro. Pre-culture 
purification based on fluorescence activated cell sorting 
is, in principle, possible but was not attempted.
To date, there is no specific immunological cell- 
surface marker for motor neurones. This undoubtedly 
holds the promise of being the best tool for their eventual 
purification to homogeneity.
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1.1.5 ATTACHMENT OF CELLS AND OUTGROWTH OF NEURITES
ON VARIOUS SUBSTRATA '
Nerve tissue was originally grown embedded in a plasma 
or fibrinogen clot, contained in a glass chamber. Nowadays, 
it is invariably grown in purpose-made plastic ware or 
on glass coverslips or slides contained therein. A number 
of additional treatments to such surfaces have been 
proclaimed beneficial to nerve cell attachment and neurite 
outgrowth (see Grinnell,1983, for review).
Popular and efficient factors are those likely 
to occur naturally in the extracellular matrix, especially 
collagen (Iversen, 1981) and fibronectin (Steele &
Hoffman, 1986) .
Synthetic, polycationic substances such as Poly 
Ornithine (PORN) and Poly-(D/L)-lysine are also commonly 
used (Collins, 1978; Varon et al., 1979; Bennett & Nurcombe, 
1979; Bennett et al■, 1980; Smith & Appel, 1983). In 
addition to improving attachment, these synthetic factors 
also appear to reduce the proliferation of glia and 
fibroblasts (Varon, 1977). Because of their property 
of prompting rapid neural cell adhesion, they are also 
moderately successful in reducing spontaneous aggregation 
following initial seeding and thus provide cultures 
with an improved monolayer-like morphology (Adler et 
a l ., 1979). Worthy of a mention in this context is the 
observation of Thierey et al . (1977), that antibodies
to the neural cell adhesion molecule, N-CAM(Brackenbury 
et a l ., 1977) inhibit nerve cell aggregation. Unfortunately 
the presence of anti-N-CAM antibodies in tissue culture
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has been observed to interfere with the normal pattern 
of retinal cell growth and development (Rutishauser 
et a l ., 1978, reviewed by Rutishauser, 1984).
Pre-treatment of surfaces with serum-supplemented 
media has also proved to be beneficial, whether or not 
the material surface has been coated with one of the 
other factors (eg. collagen). This effect was originally 
thought to arise from direct adsorption of fibronectin 
from the serum component. However, at the serum 
concentrations normally used (10-20%), it is serum albumin 
which is adsorbed onto the material surface and this 
has been shown to inhibit the. attachment of certain 
cell types (Grinnell & Feld, 1982).
It can be seen that there may be a multiple sandwich 
layer of adhesive factors and cells between the material 
surface and the neurones themselves. The neurones 
presumably attach to some factor/s via specific cell 
surface receptors, and the identity of this factor/s 
is of paramount importance and interest, with considerable 
implications both in vitro and in vivo. Liesi et a l ■ (1984)
and Calof and Reichardt (1985) have clearly shown that 
laminin adsorbed onto culture surfaces is the essential 
component for nerve cell attachment and neurite outgrowth. 
Laminin is currently receiving much attention in the 
field of growth cone advancement during embryogenesis 
and nerve axon regeneration (reviewed by Davis et a l .,
1985). For instance, it is well known that, in contrast 
to the PNS, nerve axons will not regenerate in the CNS 
following section. CNS neurones will, however, regenerate
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in the frog and goldfish. This was originally thought 
to result from an intrinsic property of mammalian CNS 
neurones, but it now appears that it is the microenvironment 
which determines whether or not neurite growth will 
occur (Carbonetto, 1984). Thus, both mammalian CNS and 
PNS neurones will send axons through living or dead 
explants of peripheral (sciatic) nerve in tissue culture, 
but neither will penetrate explants of central (optic) 
nerve trunk (Schwab & Thoenen, 1985). There is evidence 
that laminin is only transiently produced by astrocytes 
during the embryonic establishment of non-regenerating 
CNS systems eg. chick optic nerve (Cohen et al.,
1987), and that astrocytes only continue to produce 
laminin in mature regenerating systems (Smith et al.,
1986). Schwann cells, however, appear to always produce 
laminin (Longo et al., 1984; Bunge & Bunge, 1983).
There also appear to be non-permissive factors 
in the CNS. If glial cells are established first in 
culture and neurones added later (7 days), they will 
not grow over oligodendrocytes and "windows" are seen 
(Schwab&-Caroni, 1987) .It has been determined that myelin 
is the non-permissive factor and that elastase abolishes 
this effect, thus indicating a protein component. On 
sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE), two regions of non-permissive proteins 
have been identified in the region of 30-35KDa and 250KDa.
Neurite outgrowth and regeneration therefore appears 
to depend on the presence of permissive substrates 
(esp. laminin) and the absence of non-permissive substrates.
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In addition, specific soluble neuronotrophic and neurono­
tropic factors may be involved (Section 1.1.7).
In a heterogeneous cell population, such as that 
obtained from dissociation of embryonic rat spinal cord, 
fibroblasts and glial cells are present. Fibroblasts 
have been shown to secrete fibronectin directly onto 
material surfaces (Grinnell & Feld, 19820 . Glial cells 
produce laminin. It may therefore be unneccessary to 
pre-treat material surfaces for this type of culture; 
a possibility which has been explored in the present 
thesis.
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1.1.6 POLYPEPTIDE GROWTH FACTORS (PGFs)
James and Bradshaw (1984) have published an excellent 
review on this subject. Briefly, there is now a long 
list of PGFs which have been recognised, some of which 
are completely characterised eg. epidermal growth factor 
(EGF) (reviewed by Haigler et al., 1983), platelet-derived 
growth factor (PDGF)(Antoniades et a l ., 1979; reviewed 
by Westermark et al., 1983), glial growth factor (GGF)
(Lemke & Brockes, 1983) and fibroblast-derived growth 
factor, FDGF(Dicker et a l ., 1981).
As a general rule PGFs are polypeptides which 
are produced by one cell type and have certain stimulatory 
actions, usually on neighbouring cells (paracrine) or 
even on themselves (autocrine). The effects are usually 
to stimulate mitogenesis in dividing cell types, to 
produce an increase in cell size (hypertrophy) or to 
extend cell survival.
The trophic effect of nerve on muscle has long 
been recognised. As a result of denervation of adult 
muscle there is a decrease in the resting membrane 
potential, development of extrajunctional acetylcholine 
sensitivity, loss of endplate cholinesterase, and muscle 
atrophy and degeneration. The original concept that 
muscle activity alone could regulate these processes, is 
no longer accepted (reviewed by Oppenheim, 1985). Podleski 
et al. (1978) added rat spinal cord explants or CNS
homogenates to a cloned rat muscle cell line and found 
a large increase in the density and numbers of acetylcholine 
receptors. Markelonis and Oh (1979) extended these studies
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to show that a protein of molecular weight 84KDa extracted 
from chicken sciatic nerve had trophic effects on primary 
cultures of chick muscle cells. The rate and degree 
of morphological maturation and the level of protein 
synthesis in the cells was enhanced. Muscle fibres were 
also reported to survive for longer in the presence 
of this extracted protein. They further went on to identify 
and name the glycoprotein responsible "sciatin" and 
to show that it also had effects on the number and density 
of acetylcholine receptors (Markelonis et al., 1982a).
It appears that "sciatin" is closely related to transferrin, 
another growth-regulating protein (Markelonis et al.,
1982b) .
Fontaine et al. (1986) also have identified a
peptide in spinal cord motoneurones, encoded by the 
calcitonin gene and hence named calcitonin gene-related 
peptide (CGRP), which increases the number of acetylcholine 
receptors in primary cultures of chick embryo myotubes.
It is likely that at least one of the factors 
identified is a true polypeptide growth factor in that 
it has long-term effects on the growth and survival 
of muscle cells. Other factors, which have more limited 
and shorter term effects, especially on receptor function 
etc. will probably best be classified along with other 
similarly acting peptides termed collectively the 
"Neuropeptides" (Bloom, 1979).
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1.1.7 SPECIFIC NEURONO TROPHIC FACTORS
As mentioned previously (Section 1.1.5) there is 
a group of factors which promote neurone attachment 
to the substratum and/or have neurite-outgrowth promoting 
activity (NOPA). There is also a group of soluble factors 
which have marked effects on neuronal growth, development, 
differentiation and survival (reviews, Varon & Bunge, 1978; 
Varon & Adler, 1981; Barde et al., 1983).
The earliest of these to be recognised was a 
protein, originally isolated from snake venom, which 
specifically promoted the growth of sensory and sympathetic 
nerve cells both in tissue culture and in the living 
chick embryo (Cohen, 1959) .
The mouse sub-maxcillary gland was found to be 
a rich source of this nerve-growth promoting protein 
(Cohen, 1960) which was subsequently purified 100 fold 
with a 10-20% yield. An antiserum was prepared to this 
fraction and daily subcutaneous injections were given 
to newborn or adult mice. This resulted in a rapid and 
extensive destruction of the sympathetic chain ganglia 
(Levi-Montalcini & Booker, 1960). In newborn mammals, 
daily injection of the antiserum for a period of 8 days 
resulted in the disappearance of up to 99% of the 
sympathetic nerve cells. This phenomenom was termed 
"immunosympathectomy11.
The protein itself was named nerve growth factor 
(NGF) although this term is misleading as some groups 
of neurones are unaffected by the factor or its antiserum 
(notably the somatic motor neurones).
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Since then, many aspects of NGF have been extensively 
studied and periodically reviewed (Levi-Montalcini & 
Angeletti, 1968? Mobley et al ., 1977; Greene & Shooter,
1980; Thoenen & Barde, 1980; Harper & Thoenen, 1980), 
Briefly, the "active" component of NGF (beta or 2.5S NGF) 
is a dimer of two identical polypeptide chains. Each 
chain is composed of 118 amino acids, with a molecular 
weight of 13,259 Da. There are three intra-chain disulphide 
bridges. Sequence analysis has shown close analogy with 
insulin and even more so with proinsulin, thus indicating 
a common evolutionary precursor. In the submaxcillary 
gland jSNGF occurs in a complex (7S NGF) with two other 
subunits (gamma and alpha). It is widely distributed 
and is found particularly in target tissues for sympathetic 
and sensory neurones. Traces also occur in blood (reviewed 
by Purves, 1986). In vitro, NGF has been shown to have 
many effects on the metabolism of these neurones. It 
stimulates anabolic processes such as uridine uptake, 
synthesis of RNA and protein, lipid, and glucose uptake 
and metabolism. Administration of NGF to cultured superior 
cervical ganglia (SCG) of neonatal rat produced a five 
fold increase in tyrosine hydroxylase and dopamine — 
hydroxylase levels; activity which resulted in increased 
noradrenaline synthesis (see Thoenen & Barde, 1980) .
NGF administration also increases neurite outgrowth 
and neuronal survival, although Burnham et a l . (1972)
did show that NGF could be replaced to some extent by 
an increase in the proportion of non-neuronal ganglionic 
cells. Lazarus et a l . (1976) also showed that sympathetic
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neurones could subsequently survive without NGF supplements, 
if they received it for the first 5-7 weeks in culture.
More specifically, McGuire et a l . (1978) demonstrated
that NGF was capable of stimulating the incorporation 
of radiolabelled fucose or glucosamine into a cell surface 
glycoprotein of the rat pheochromocytoma PC12 cell line.
This glycoprotein was accordingly dubbed NGF-inducible 
large external (NILE) glycoprotein, and was shown to 
be immunologically distinct from the large external 
transformation-sensitive (LETS) glycoprotein of Hynes 
(1976), although it may be identical to part of the LI 
antigen (Sajovic et a l ., 1986). Remarkably the 
morphological effect of the NGF on the cell line is 
that the cells stop dividing, extend long microtubule- 
containing processes and acquire electrical excitability 
and increased sensitivity to acetylcholine. They appear 
to have been "converted" to sympathetic neuron-like 
cells.
The site and mechanism of action of NGF is not 
totally clear, although it has been demonstrated that 
it is endocytosed by a receptor mediated process and 
transported retrogradely to the neuronal soma (Stoeckel 
& Thoenen, 1975) . Some of its effects may be more locally 
controlled via second messengers (Varon & Bunge, 1978).
In contrast to the PNS, catecholaminergic neurones 
in the CNS do not respond to NGF (Gnahn et a l ., 1983;
Hefti et a l ., 1985). In particular, ChAT activity in 
the corpus striatum of neonatal rats is increased two 
fold by direct intracerebroventricular injection of
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NGF (30pg every 2 days) (Mobley et a l ., 1985).
Furthermore, Fischer et al . (1987) have experimented
with continuous intracerebral infusion of NGF (over 
four weeks) into aged rats with behavioural impairment 
resulting from cholinergic neuron atrophy. They report 
that this treatment resulted in the "amelioration of 
cholinergic neuron atrophy and spatial memory impairment". 
The implications from this and other data, as also 
mentioned by Korsching (1986), is that it is possible 
that Alzheimer's disease may be the result of an impairment 
in a retrograde trophic support system for the cholinergic 
neurones involved.
Some of the above data are consistent with the 
concept of Varon & Adler (1981) that NGF may "control 
the quantity of neurotransmitter produced regardless 
of its choice". It indicates the involvement of other 
"specifying" factors.
By analogy with NGF it has long been suspected 
that there are other trophic molecules responsible for 
the maintenance of neuronal populations unaffected by 
NGF itself (eg. spinal motor neurones). Research in 
this field has been slow, because of the lack of a 
recognised rich source of the factor/s.
Hamburger (1975) reported that during normal 
development of the chick embryo there is a loss of 
approximately 40% of the neurones from the lateral motor 
column (LMC). This loss occurs between days 6.5 and 9.5 
which is also the time that the motor nerve axons are 
forming connections with target skeletal muscle. Hollyday
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and Hamburger (1976) further showed that the loss of 
neurones could be increased by removal of a limb bud 
or buds from the developing chick embryo, or decreased 
by grafting on an additional leg. This was an early 
indication that motor neurones must make connections 
with their peripheral targets in order to survive.
One suggestion as to the mechanism involved was 
that the nerve fibers competed for a limited supply 
of a trophic agent supplied by the muscle cells. Once 
a connection was made and the trophic agent sequestered, 
then subsequent attempts at innervation by other nerve 
fibers would be unsuccessful. Support for such a situation, 
by analogy, comes from sympathetic neurones, death of 
which, caused by axotomy (Banks & Walters, 1977) or 
vinblastine administration (Johnson, 1978) can be 
prevented by the exogenous administration of NGF. NGF 
can also reduce naturally-occurring nerve cell death 
in the chick spinal cord autonomic visceral motor columns 
by more than 60% (Oppenheim et a l ., 1982).
Giller et a l . (1973) reported "the first
demonstration that postsynaptic cells may specifically 
increase the pre-synaptic cell enzyme activity responsible 
for the neurotransmitter used at that junction". Using 
foetal mouse spinal cord and skeletal muscle, they showed 
an approximate 10 fold increase in ChAT activity when 
the cells were cultured together rather than separately. 
Their data "suggested that the increased ChAT activity 
was due to a trophic effect of muscle on spinal cord 
neurones".
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They went on to show that the active factor could 
be transmitted in the medium from cultured muscle 
cells when applied to cultured nerve cells (Giller et 
al., 1977).
Parallel studies (White & Bennett, 1978; Bennett & 
Nurcombe, 1979) with cholinergic ciliary ganglion (CG) 
neurones demonstrated increased initial survival of 
the neurones when cultured with skeletal myotubes or 
in muscle cell conditioned media.
Nurse and O'Lague (1975) demonstrated that 
sympathetic neurones from the newborn rat superior cervical 
ganglion (SCG) were capable of developing functional 
cholinergic synapses with skeletal myotubes in culture.
This was surprising as the neurones in vivo are destined 
to be noradrenergic.
Patterson and Chun (1977) suggested that autonomic 
neurones are capable of being either adrenergic or 
cholinergic. They showed a 25 fold depression in 
catecholamine production linked with a 40 fold increase 
in acetylcholine synthesis when SCG neurones were cultured 
in skeletal muscle cell conditioned media. Neuronal 
survival and overall growth was apparently unaffected.
Ross et al. (1977) examined this finding with
SCG explants of various ages and came to the conclusion 
that the ability of the adrenergic neurones to develop 
cholinergic characteristics "reaches a maximum at 
approximately the second postnatal day: beyond the third 
postnatal week this shift does not occur".
In the last ten years there has been a veritable
26
explosion in the testing of conditioned media and tissue 
extracts on neuronal culture systems. The conditioned 
media are prepared from a variety of different cell 
lines and primary cultures including glial, striated 
muscle, smooth muscle, liver, lung etc. from several 
different species. Likewise, extracts of various tissues 
from foetal, postnatal and normal or denervated adult 
animals are prepared. They are tested for potential 
neuronotrophic activity on various neuronal cultures 
eg. autonomic, sensory or somatic motor neurones.
The activities studied are:
(a) ability to improve attachment of neurones to the 
substratum (assessed after a few hours in culture 
by counting adherent cells),
(b) ability to promote initial neuronal survival (assessed 
after several hours or up to a few days in culture by 
counting viable cells),
(c) ability to promote neurite outgrowth from cells 
or explants in culture (assessed after the first 
few hours/days in culture by counting the number 
of neurites and/or measuring their length, or by 
assaying neurofilament protein levels),
(d) ability to stimulate specific neurotransmitter synthesis 
(usually assessed by assaying neurotransmitter 
production in terms of the levels of the synthesising 
enzyme eg. Acetylcholine production by ChAT activity).
The ability of conditioned media or tissue extracts 
to promote long term maintenance of neurones in culture 
has not been generally assessed, because of the
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unsuitability of most culture systems for this purpose 
(reviewed by Appel, 1984). Thus, most culture systems 
have serum included in the medium which undoubtedly 
contains directly or indirectly acting (eg. via glial 
cell mediation) maintenance factors. The inclusion of 
serum in the medium may also affect the other parameters 
studied, which could account for the considerable 
variation in levels of stimulation reported.
Table 2 (p 28) is a compilation of reports 
associated with neuronotrophic activity of conditioned 
media and tissue extracts (reviews are not included) .
It appears that there may be three types of 
'‘cholinergic activity". Firstly, an "instructive" activity 
which is capable of specifying the differentiated fate 
of some autonomic neurones (reviewed by Fukada, 1985) 
and may or may not be subserved by the same molecule 
which promotes the second activity, namely the increased 
levels of choline acetyltransferase (ChAT) and hence 
acetylcholine synthesis. The third activity involves 
the selective survival of cholinergic neurones in a 
heterogeneous cell population, which may be subserved 
by yet another molecular species.
The cholinergic activities appear to be connected 
with any tissue which itself receives a cholinergic 
innervation in vivo. The ChAT "level stimulating" activity 
may also be found in some other tissues eg. liver, serum. 
The activities are usually associated with glycoproteins 
of varying molecular weights eg. 14-17KDa (Smith et 
al., 1985)), 21KDa (Weber et a l ., 1985), 22KDa (Fukada,
Table 2 Cumulated reports of neuronotrophic activities associated with co-culture, conditioned 
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1985) , 40-45KDa (Nishi & Berg, 1981), 55-65KDa (Smith 
et a l ., 1985) .
The neurite outgrowth promoting activities (NOPA) or 
"morphologic" activities, are apparently associated 
with two species. One is of high molecular weight and 
attaches to the substratum (probably laminin) and is 
only found in conditioned media (rev. Barde et a l .,
1983). The other is of lower molecular weight eg. 35KDa 
(Smith et al ., 1985), 40KDa (Henderson et a l ., 1981), 
and remains in solution to directly stimulate the cell 
bodies to put forth growth cones. Glial cells also produce 
a soluble neurite outgrowth promoting factor of 43KDa 
which is believed to operate via its protease inhibitory 
activity (Monard, 1985) .
Survival of neurones may also be promoted by 
other molecules, or any of the above. There may be multiple 
sources available for different stages in development 
ie. serum ---> glial ---> target tissue in that order.
The apparent multiple factors are in marked contrast 
to NGF which serves many functions in the sensory and 
sympathetic nervous system (reviewed by Yanker & Shooter,
1982) .
Smith et al. (1986) have, however, demonstrated
more restricted and selective effects of their muscle- 
derived neuronotrophic factors. Using cultures of foetal 
rat ventral spinal cord in which the motorneurones 
had been specifically labelled by retrograde transport 
of wheat germ aggluti nin conjugated to the fluorescent 
marker Lucifer Yellow vinylsulfone, they were able to
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show increased survival, neurite outgrowth and acetylcholine 
synthesis in the labelled neurones when grown in medium 
containing muscle extract. Their data of selective effects 
of partially purified factors is based on the identification 
of cholinergic neurones by a monoclonal antibody to 
choline acetyltransferase. They claim that this identifies 
motorneurones because "cholinergic cells other than
motorneurones in the ventral cord.............. are rare
at the stage of rat development from which the cultures 
were prepared". On this basis they have shown that their 
55KDa neutral glycoprotein specifically stimulates 
acetylcholine synthesis and neurite outgrowth of 
motorneurones, but has no effect on their initial survival, 
which appears to be increased by a 1200-1500Da peptide 
(which also has a stimulatory effect on acetylcholine 
synthesis). The 33-35KDa "morphologic factor" is not 
specific for motorneurones, but stimulates neurite 
outgrowth in other neurones as well, while having no 
effect on acetylcholine synthesis.
The question of long term maintenance of motor­
neurones is not addressed in the above study. Data in 
this respect would help to complete the picture on 
motor neurone-specific trophic factors and shed light 
on the question as to whether they rely for their continued 
survival, in the adult animal, on a regular supply of 
a single factor which also maintains cholinergic activity. 
Such a factor might be secreted in larger quantities 
following denervation so as to stimulate terminal or 
collateral sprouting and hence re-innervation (Pestronk 
& Drachman, 1984).
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A fascinating recent development has occurred 
in connection with the 5 6KDa neuronotrophic factor of 
Gurney et al (1984a; 1984b).
This factor is also mentioned in the context 
of Motor Neurone Disease (MND) (Section 1.3.5V).
It was reported to be released by denervated 
or immobilised skeletal muscle and to induce neuronal 
sprouting in vivo. The finding of antibodies directed 
against this protein in the serum of patients with MND 
was, however, insubstantiated (Hauser et a l ., 1986; 
Ingvar-Maeder et al ., 1986; Gurney et al., 1986a).
Subsequently, Gurney et a l . (1986a; 1986b)
identified the same factor in mouse salivary gland.
Upon purification and testing on cultured chick neurones 
it did not show any neurite-outgrowth promoting activity 
(as might have been expected from the previous data), 
but instead was active in supporting the survival of 
a sub-population of spinal and sensory (but not autonomic) 
neurones. They also identified the factor as a "lymphokine 
product of lectin-stimulated T cells which induces 
immunoglobulin secretion by cultured human peripheral 
blood mononuclear cells". On this basis the factor was 
named Neuroleukin. Neuroleukin is reported to be present 
in skeletal muscle> brain >> heart, kidney, testes > 
liver and salivary gland (in that order of relative 
content^.
It has been proven, through amino acid sequence 
analysis comparison, that the factor termed "Neuroleukin" 
by Gurney et a l .(1986a) is in fact the enzyme 
glucophosphoisomerase (GPI)(Faik et a l ., 1988; Chaput
et a l ., 1988; Gurney, 1988). This extraordinary finding 
has yet to be fully explained, although it is possible 
that the enzyme does act as a neuronotrophic factor• 
through combination with a neuronal surface receptor.
A 19-amino acid synthetic peptide has been produced 
which is part of the gpl20 envelope glycoprotein of 
the human immunodeficiency virus (HIV-1) and also 
Neuroleukin. It has been shown to block the action of 
Neuroleukin (Ho et al., 1987) and might therefore help 
to explain the neuropathology sometimes associated with 
the acquired immunodeficiency syndrome (AIDS).
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1.2 IDENTIFICATION AND ASSAY OF THE DIFFERENT CELL TYPES 
PRESENT IN NEURAL TISSUE CULTURE
1.2.1 MAJOR CELL TYPES PRESENT IN THE VERTEBRATE
NERVOUS SYSTEM
The vertebrate nervous system is a complex 
organisation of many different cell types which perform 
highly specialised functions. Whenever neural tissue 
is used as the source for culture, these cell types 
will be present to different extents and in varying 
degrees of organisation according to the system chosen 
(Section 1.1.1).
In dissociated cell culture it has been demonstrated 
that the various cell types present re-organise themselves 
into functional arrangements which are similar, if not 
identical, to those present in the intact tissue (Nelson, 
1975 for review).
The three main types of cells likely to be present 
in neural tissue culture are neurones, glial cells and 
connective tissue cells.
Neurones can be divided into many classes and 
sub-classes eg. somatic motor, visceral motor, sensory, 
inter-neurones. An important point is whether a neurone 
can be classified as "central" or "peripheral". A true 
central neurone is one whose cell body, axon and terminal 
occur within the CNS eg. an upper motor neurone (UMN).
A neurpne whose cell body is located within the CNS 
is also classified as "central", although its axon may 
leave the CNS and terminate in the periphery eg. a lower
motor neurone (LMN). In embyogenesis both of the above 
neurones are derived from the neural tube. Neurones 
of the peripheral .nervous system (PNS), however, are 
generated from the neural crest and possibly also the 
placodes (Cohen & Selvendran , 1981). They include the 
autonomic neurones of the superior cervical ganglia 
(SCG) and the sensory neurones of the dorsal root ganglia 
(DRG).
Glial cells can also be divided into several classes 
and sub-classes.
Oligodendrocytes are the cells primarily responsible 
for myelination in the CNS, Schwann cells are their 
equivalent in the PNS (Raff et al., 1978).
Astrocytes provide physical and chemical support for 
the neurones of the CNS. The protoplasmic (TYPE I) 
astrocytes occur mainly in white matter, whereas the 
fibrous (TYPE II) astrocytes occur mainly in grey matter 
where they are closely associated with neurone cell 
bodies and axons, sending end feet to impinge upon them. 
They also send end feet to blood vessels and act as 
intermediates between blood and neurones, thus contributing 
to the "blood-brain barrier" (reviewed by Abbott, 1986; 
Janzer&Raff, 1987 ) • In particular, there is good 
evidence that astrocytes are responsible for controlling 
the neuronal extracellular K+ and Cl concentration 
through specific uptake processes, thus playing a role 
in the ion-flux events which accompany nerve-impulse 
transmission (reviewed by Abbott, 1986) .
Recent evidence (Raff et al., 1983; Miller & Raff,
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1984) suggests that type II astrocytes are developmentally 
more closely related to oligodendrocytes than they are 
to type I astrocytes - both type II astrocytes arid 
oligodendrocytes have a common precursor cell (the 0-2A 
progenitor).
The microglial cells are phagocytic scavengers 
which are now thought to originate from outside the 
nervous system. They are derived from circulating blood 
monocytes during embryogenesis and migrate into the 
CNS as an "amoeboid" form which eventually become static 
and extend processes. They can resume their phagocytic 
activity during any period of neural injury. However, 
if the damage is severe, then there may also be re-invasion 
of the CNS by the monocyte macrophages (reviewed by 
Ling, 1981?' Perry & Gordon, 1988).
The connective tissue cells are termed fibroblasts 
and are of mesenchymal origin, deriving from the meningeal 
capsule of the nervous tissue (Schachner , 1982arb,c).
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1.2.2 MORPHOLOGY OF CELLS IN NEURAL TISSUE CULTURE
It is sometimes possible to distinguish the various 
cell types purely by morphology. Thus, neurones are 
likely to be seen as large cell bodies with extensive 
neuritic trees and long axons. Astrocytes (especially 
Type II) are named according to their characteristic 
star-shaped appearance.
It is, however, impossible to distinguish between 
protoplasmic (Type I) astrocytes and fibroblasts based 
on purely morphological criteria. Both appear as large, 
flat cells with a large oval nucleus.
Oligodendroglia, which have extensive branched 
processes, may be confused for fibrous (Type II) astrocytes. 
Furthermore, some astrocytes tend to look remarkably 
like neurones, as some sub-classes have a long axon-like 
process (Bergmann glia).
It is also becoming clear that some cell types 
may appear identical, and yet represent different 
sub-classes which are categorised by surface antigenic 
differences (Section 1.2.8(ii)).
Amoeboid microglial cells are relatively easy 
to distinguish as they have no processes, an off-set 
nucleus, and highly vacuolated cytoplasm.
In view of the difficulties attending unambiguous 
identification of the various cell types, the search 
for specific markers has been long and continues unabated. 
The various methods used are reviewed in the forthcoming 
sections.
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1.2.3 HISTOCHEMICAL TECHNIQUES FOR DISTINGUISHING THE
MAJOR CELL TYPES IN NEURAL TISSUE
The main existing methods were reviewed by Humason 
in 1967. They include a modification of the original 
Bielschowsky method for silver impregnation of nerve 
fibres and neurofibrils which appear to be brownish-black. 
There are many other variations on the silver impregnation 
theme, including the Golgi Rapid Method which specifically 
stains nerve cells and processes deep black, while the 
background remains light yellow. A further method is 
that of Sevier and Munger (1965) which is suitable for 
paraffin-embedded sections. The specificity of such 
methods has, however, always been poor.
Perhaps the most successful and recent silver 
staining method was reported by Howard and Barnes (19 79), 
who developed a modification of the Del Rio-Hortega 
silver carbonate method for the demonstration of central 
nervous system elements, and claimed that "neurones, 
oligodendroglia, astrocytes and microglia can be 
differentiated on the basis of their nuclear staining 
properties". The gold chloride sublimate method of Ramon 
y Cajal is reputed to be specific for astrocytes which 
are stained black, in contrast to nerve cells which 
are pale red (Humason, 1967). The pyridine-silver method 
of the same author, stains nerve cells and neurofibrils 
and can distinguish between myelinated and non-myelinated 
fibres.
Other methods, such as Luxol Fast Blue S and that 
of Ora (Humason, 1967) rely on the staining of myelin.
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Howard and Barnes (1979) stated that methods such 
as Luxol Fast Blue S, periodic acid Schiff and aldehyde 
fuchsin had only met with "some success" in their hands.
The doorway has always been open for better, more 
specific techniques than these early ones.
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1.2.4 HISTOCHEMICAL TECHNIQUES FOR THE LOCALISATION OF
SPECIFIC NEUROTRANSMITTERS AND ASSOCIATED ENZYMES
An alternative histochemical approach is to stain 
substances which are likely to be specific to particular 
groups of cells. In particular, Falck and Owman (1965) 
developed a fluorescent histochemical technique for 
the cellular localisation of biogenic amines. The technique 
relies upon the fact that certain monoamines can be 
converted to fluorescent products by treatment with 
paraformaldehyde gas, provided that they are enclosed 
in a dry protein layer. Noradrenaline,5-hydroxytryptamine 
and dopamine are all amenable to this treatment, and 
when converted to their 3,4-dihydro compounds and subjected 
to ultra-violet illumination, produce fluorescence of 
characteristic wavelength. This method has been widely 
used to demonstrate noradrenergic, serotoninergic and 
dopaminergic neurones in sections of the nervous system 
(eg. Kerkut et al ., 1967).
In the absence of an equivalent technique for 
acetylcholine itself, attention has been directed towards 
the enzymes responsible for its synthesis and degradation. 
Staining for cholinesterase is not particularly useful 
in that the enzyme is not restricted to cholinergic 
neurone (Gombos & Aunis, 1982). Such staining has found 
its main application in the demonstration of motor end 
plates or of areas of general cholinergic activity (Koelle 
& Friedenwald, 1949; Karnovsky & Roots, 1964). The 
acetylcholine-synthesising enzyme, choline acetyltransferase, 
on the other hand, is generally accepted to be localised
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within cholinergic neurones(Gombos & Aunis, 1982). A 
histochemical procedure for its determination was reported 
by Burt (1970). This method relies upon the precipitation 
of lead mercaptide by free Coenzyme A, generated in 
the synthesis of acetylcholine. The specificity of the 
technique was severely criticised by Hebb et al.(1970) 
and Kasa et a l .(1970) who suggested that positive results 
depend in part upon the activity of other enzymes which
liberate free Coenzyme A. They put forward an improved
. * . -3version of the technique which includes 10 M
di-isopropylfluoro-phosphate (DFP). This reduces by 
90% the non-specific hydrolysis of Acetyl-CoA, without 
affecting the activity of choline acetyltransferase(ChAT).
A modified method was used by Kim (1971) to 
demonstrate ChAT activity in chick spinal cord explants.
In place of DFP, Kim used another specific inhibitor 
of acetylcholinesterase (BW 284 C51) to prevent the 
non-specific hydrolysis of Acetyl-CoA. He reported ChAT 
activity mainly in large motor neurones. The reaction 
was always negative if Acetyl-CoA and choline chloride 
were omitted.
In a critical analysis of the technique, Burt 
and Silver (1973) came to the conclusion that, even 
with all reasonable precautions, a maximum of 73% of 
the enzyme activity associated with the deposition of 
reaction product could be related to acetylcholine synthesis 
and hence ChAT activity. They discounted another compound, 
chloroacetylcholine (ClACh), used by Kasa et a l . (1970)
as not being 'Effective as an inhibitor".
In view of the lack of specificity of the above 
technique, it has now largely been discarded and superceded 
by an immunohistochemical approach (Section 1.2.8(D).
Few other enzymes of neurotransmitter metabolism 
have been used in histochemical localisation. Detection 
has usually been with specific antisera or monoclonal 
antibodies (Section 1.2.8(D), although detection of 
GABA transaminase, relies on its reduction of a tetrazolium 
salt. This method has been used to localise the enzyme 
activity in nuclei of rat and rabbit brain stem and 
spinal cord, and in rat cerebellar cortex (Gombos &
Aunis, 1982).
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1.2.5 RADIOLABELLED NEUROTRANSMITTERS AND PRECURSORS
FOR THE IDENTIFICATION OF NEURAL ELEMENTS
A widely used method for the demonstration and 
localisation of specific neuronal tracts and cell types 
in neural tissue is through the use of radiolabelled 
neurotransmitters and/or their precursors. The neural 
tissue/culture under study is incubated with the labelled 
compound and the binding/uptake of the compound can 
then be demonstrated visually through the technique 
of autoradiography. Suitable controls (eg. in the presence 
of unlabelled compound) are performed to analyse the 
specificity of the binding/uptake.
Examples of the use of this technique include 
the demonstration of GABAergic neurones in dissociated 
cultures of human foetal spinal cord through the uptake 
of radiolabelled GABA (Touzeau & Kato, 1986; Kato et 
al ., 1987). Apparently 60% of the neurones present were 
labelled by this method when the autoradiograms were 
subsequently developed and examined. As glial cells 
also take up GABA (for its catabolism) a specific inhibitor 
of non-neuronal GABA uptake had to be used, namely ft — 
alanine. Another control was the inclusion of aminocyclo- 
hexane carboxylic acid (ACHC), which specifically blocks 
neuronal GABA uptake.
Thyrotropin-releasing hormone receptors have now 
been extensively mapped in the CNS through the technique 
of radio-ligand binding and autoradiography (Pazos 
et al., 1985; Manaker et a l ., 1985a; Manaker et a l .,
1985b). These studies have demonstrated high concentrations
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of receptors in spinal cord so confirming the presence 
of TRH neuronal systems previously detected by 
immunohistochemical means (sections 1.3.5(iii) and 1.2.8(D).
An elegant technique which illustrates the versatility 
of autoradiography was published by Cuello et a l ., in 
1980. They were able to label a monoclonal antibody 
to substance P directly and internally by growing the 
hybridoma cell line in radioactive medium. The combined 
use of this radiolabelled monoclonal antibody and a 
conventional antibody, raised in a different species, 
to enkephalin, was successful in revealing the coexistence 
of two neuropeptides in nerve terminals of the substantia 
gelatinosa. The monoclonal antibody was detected by 
autoradiography and the conventional antibody by peroxidase 
staining.
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1.2. 6 ASSAY OF SPECIFIC ENZYMES IN NEURAL TISSUE
In addition to the "direct visualisation" histo- 
chemical techniques for localising enzymes within neural 
tissue, there is also a need for assays of specific 
enzymes within the tissue (or culture) as a whole. This 
provides little indication as to the specific localisation 
of cells within a heterogeneous population, but is used 
to demonstrate the presence of cell-type specific enzymes 
and to assess levels of activity which may be related 
to the proportions of cells present.
The colorimetric method for the determination 
of acetylcholinesterase activity (Ellman et a l ., 1961) 
is still used as an indicator of the presence and activity 
of cholinergic cells (Digby et a l ., 1985).
A radiochemical method for the determination of 
ChAT activity (Fonnum, 1969; Fonnum, 1975), or one of 
its many subsequent modifications (eg. Berg & Fischbach , 
1978) is, however, usually chosen to assay cholinergic 
activity, and hence the presence of cholinergic neurones 
in heterogeneous nerve cell preparations.
A number of enzymes are present to a much higher 
extent in glial cells than in neurones (eg. carbonic 
anhydrase, glutamine synthetase) and assays of these 
enzymes can be employed as "glial markers" (reviewed 
by Schousboe, 1982).
Three forms (aa,0f7/Y7) of the glycolytic enzyme, 
enolase, are found in the nervous system. Thecvttform 
has been shown to be localised to glial cells, whereas 
the y y  form is confined strictly to neurones (Scarna
58
et a l . , 1982; Steinberg et a l ., 1983).
A sandwich enzymoimmunoassay has been successfully 
used to assess levels of the neurone-specific enolase 
(NSE) and hence to give an index of neuronal damage 
following experimental lesions of rat brain and also 
of lesions, following coma, in man (Scarna et al , 1982*^
Steinberg et a l ., 1984).
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1.2.7 TOXINS AS SPECIFIC MARKERS OF NEURAL ELEMENTS
The first satisfactory marker specific for neurones 
was tetanus toxin. Mirsky and co-workers (19 78) were 
able to demonstrate, by autoradiography and 
immunofluorescence, complete specificity of the toxin 
for cultured neurones from many different regions of 
the nervous system (brain, spinal cord, dorsal root 
ganglia etc.) of mouse, rat and chick. Subsequently,
Raff et a l . (1983) have claimed that Type II astrocytes
also bind tetanus toxin. This emphasises the need for 
dual labelling in attempts to identify cell types 
unambiguously (eg. the additional use of anti-neurofilament 
antibody for the identification of neurones - see Table 
4, p 70). The receptors for tetanus toxin have, until 
recently, been assumed to comprise solely the gangliosides, 
GDlb and GTlb . The binding studies which demonstrated 
this were, however, all carried out at non-physiological 
pH and salt concentration and now Critchley et a l . (1986)
have shown that "under more physiological conditions 
of salt and pH, the interaction of tetanus toxin with 
gangliosides is very weak and the membrane receptors 
for the toxin are protease-sensitive". They suggest 
that other membrane constituents such as sialoglycoproteins 
may be the true receptors for the toxin.
The cholera toxin B-subunit has been shown to 
recognise and specifically bind to the oligosaccharide 
chain of ganglioside, GM1. Doherty and Walsh (1987) 
have shown further that in dissociated dorsal root ganglion 
cells (from embryonic chick), the toxin binding appears
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to be specifically to neurones. It would appear, however, 
that both GM1 and cholera toxin binding is more widespread 
in other culture systems or neural tissue (see Table 4, 
p 70) . which limits its usefulness as a specific neuronal 
marker.
It is possible that other toxins may be specific 
to neuronal sub-types. Botulinum toxin, for example, 
appears to be specific for cholinergic nerve terminals, 
if not for motor neurone terminals (Dolly et a l ., 1984).
Poliomyelitis virus is neurotropic and may bind 
specifically to motor neurones (Miller et a l ., 1980).
Young and Snyder (19 73) provided evidence that 
strychnine binds to the putative glycine receptor of 
spinal cord synaptic membrane. Glycine is a major inhibitory 
transmitter within the spinal cord and the convulsions 
and muscular hyperactivity characteristic of strychnine 
poisoning would be consistent with its role as an 
antagonist. Strychnine affinity columns have been used 
to purify the glycine receptors. Further experimental 
data indicate that strychnine binding may be at an 
allosteric site, distinct from glycine binding, possibly 
the chloride ionophore (Pfeiffer & Betz, 1981).
Following the use of fluorescent-labelled anti­
strychnine antibodies, it has been claimed (Bhattacharyya 
& Bhattacharyya, 1981; Srinivasan et a l ., 1983) that 
strychnine binding sites are restricted to spinal motor 
neurones. If this is indeed the case, then strychnine 
would constitue the only known direct marker for motor 
neurones to date.
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1.2.8 ANTIBODIES FOR IMMUNOHISTOCHEMICAL LOCALISATION
OF NEURAL ELEMENTS 
1.2.8(i) ANTIBODIES RECOGNISING INTRACELLULAR ANTIGENS
Prime candidates for the production of marker 
antibodies are the proteins of the cell cytoskeleton 
(rev. Kalhins & Connolly, 1981; Cooper, 1986). The 
cytoskeleton comprises three groups of filaments: the 
microfilaments, intermediate filaments and microtubules 
(macrofilaments). The microfilaments and microtubules 
occur in most cell types and are composed of the proteins 
actin and tubulin respectively.
The intermediate (7-llnm) filaments are, however, 
largely composed of different protein subunits depending 
on cell type (summarised in Table 3, p 62). The presence 
of one type of intermediate filament protein in a cell 
does not, hbwever, neccessarily exclude the presence 
of another. A particular example, as demonstrated by 
Shaw and Weber (1983) , is the presence of vimentin in 
cells which are also positive for glial fibrillary acidic 
protein (GFAP).
Many polyclonal and monoclonal antibodies have 
been produced to intermediate filament proteins as cell- 
type specific markers or as probes to study their structure 
and function (Anderton et al ., 1980; Wood & Anderton,
1981; Yen & Fields, 1981; Debus et a l ., 1982; Shaw &
Weber, 1982; Lee et a l ., 1982; Eng, 1982; Goldstein 
et al ., 1983; Sternberger & Sternberger, 1983; Trojanowski 
et al ., 1986; Lee et a l ., 1986). Well characterised 
monoclonal antibodies to all the intermediate filament
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Table 3 "Cell-type specific" intermediate filaments of the 
cytoskeleton
















*Note Oligodendrocytes have no intermediate filaments- 
only microtubules
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proteins are now commercially available.
Other prime intracellular candidates for specific 
antibody generation are neurotransmitter synthesising 
enzymes. In particular ChAT has received considerable 
attention. Early attempts to purify the enzyme, to raise 
monospecific antisera and apply the antibodies to staining 
techniques gave many problems (Malthe-Sorenssen et al., 
1973; Eng et a l ., 1974; McGeer et al ., 1974; Ryan and 
McClure, 1979; Peng et al., 1980) and the results were 
severely criticised (rev. Kasa, 1986; rev. Cuello & 
Sofroniew , 1984).
Several groups have now reported the production 
and immunohistochemical use of monoclonal antibodies 
to ChAT (Levey et a l ., 1981; Eckenstein & Thoenen, 1982; 
Crawford et al., 1982;Nagai et al., 1983; Levey et a l .,
1983) . In particular Barber et al. (1984) have published
an elegant study of.ChAT localisation, by a monoclonal 
antibody, in the rat spinal cord. The immunoreaction 
product was deposited in cell bodies, dendrites, axons 
and axon terminals, thus allowing comprehensive 
visualisation of entire cholinergic neurones and systems. 
The main findings were that ChAT-positive neurones are 
not restricted to the somatic motor neurones of the 
ventral horn and the pre-ganglionic autonomic neurones 
in sympathetic and parasympathetic spinal segments. 
Previously unknown ChAT-positive neurones were also 
identified in dorsal horn, central grey matter and in 
the intermediate spinal gray region. It was accordingly 
concluded that " cholinergic elements in the spinal 
cord are considerably more numerous and widespread than
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was previously thought".
In a developmental study performed by the same 
workers (Phelps et al ., 1984) it was shown that ChAT- 
positive cells in the intermediate region (named "partition" 
cells) are the most intensely stained and show 
immunoreactivity "earlier than any other putative 
cholinergic cells in spinal cord, including motoneurones".
These new findings must therefore bring into serious 
question the use of ChAT as a specific marker for motor 
neurones, especially in developing systems (including 
tissue culture).
Other enzymes of neurotransmitter metabolism which 
have been probed in the nervous system by immunohisto- 
chemical means include dopamine jft-hydroxylase, tyrosine 
hydroxylase, dopa-decarboxylase, phenyl-ethanolamine- 
n-methyltransferase, (for the localisation of monoaminergic 
neurones) and glutamate decarboxylase (to map the neuronal 
pathways of the amino acid neurotransmitter gamma-amino- 
butyric acid (reviewed by Gombos & Aunis, 1982).
Antisera and monoclonal antibodies have also been 
produced to small neurotransmitter molecules by coupling 
them with a large immunogenic molecule (eg. BSA). Monoclonal 
antibody to serotonin was produced by Consolazione et 
al. (1981), and Geffard et al. (1984) have reported the
first demonstration of highly specific and sensitive 
(polyclonal) antibodies against dopamine.
The neuropeptides are mostly highly immunogenic 
and many, including enkephalin and substance P have 
been localised to specific neuronal pathways by
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immunohistochemical methods (Bloom, 1981) . Worthy of 
a special mention in this respect is Thyrotropin-releasing 
hormone (TRH). TRH was isolated originally from 
hypothalamic tissue and was shown to stimulate the release 
of thyrotropin (TSH) from the anterior pituitary, both 
in vivo and in vitro (see Redding & Schally, 1969).
Antibody to TRH was first prepared by Bassiri and Utiger 
(1972). TRH is only a tripeptide (1-pyroglutamyl-L- 
histidyl-L-prolineamide) and hence only weakly immunogenic. 
It was ,therefore, coupled to BSA prior to immunisation, 
which yielded highly specific and sensitive antisera.
Hflkfelt et al . (1975) performed an immunohisto­
chemical analysis of the distribution of TRH in the 
CNS and found that it was widespread, with TRH-staining 
fibers present even in rat spinal cord anterior horn.
Sharif and Burt (1983), have demonstrated high affinity
3
binding sites for [ H]-TRH (or one of its analogues) 
in spinal cord.
The physiological role of TRH in .the CNS (especially 
spinal cord) is reviewed in a later Section (1.3.5(iii)).
Acetylcholine, unfortunately, is not suitable 
for chemical conjugation in the same way as other small 
neurotransmitter molecules. To overcome this problem,
Geffard et al . (1985a) synthesised acetylcholine-like
conjugates from choline, glutaric anhydride and polypeptides 
in a manner such that the structure of acetylcholine 
was conserved. The antibodies produced were found to 
be highly specific for acetylcholine and were applied 
for the first time to immunocytochemical staining in
the locust brain (Geffa-rd et al., 1985b). The wider 
application of this tool should greatly enhance our 
knowledge and understanding of cholinergic systems and 
acetylcholine subcellular localisation.
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1- 2.8(ii) ANTIBODIES RECOGNISING CELL-SURFACE ANTIGENS
Intracellular markers suffer from the disadvantage 
that the cells must be either disrupted, or fixed and 
permeabilised to allow access of the reagents (eg. 
monoclonal antibodies). The cells are therefore killed 
in the process. It is much more satisfactory to have 
a marker which will recognise a surface feature of a 
cell without causing it any damage. Such markers can 
also be used for the purification or selective depletion 
of specific cell types as previously mentioned (Section 
1.1.4), and to demonstrate the variable expression of 
surface antigens on the same cell type during different 
stages of differentiation (Leibowitz & Hughes, 1983).
Cell surface antigens were first identified with 
adsorbed polyclonal antisera. A forerunner in this field 
was the Thy-1 antigen which was initially thought to 
be present only on thymocytes and thymus-derived 
lymphocytes. It was subsequently found, however, also 
to be present on fibroblasts. Moreover, after prolonged 
culture of nervous tissue, some astrocytes and neurones 
also become Thy-1+ . Oligodendrocytes, on the other hand, 
never express the Thy-1 antigen (reviewed by Schachner, 
1982). A monoclonal antibody to Thy-1 antigen has been 
reported to stain not only the surface of a fibroblast 
cell line, but also vimentin of the intermediate filaments 
(Dulbecco et a l ., 1981).
The example of Thy-1, and of several subsequently- 
discovered antigens, emphasise the need for caution 
in describing a marker as "cell-type specific". It is
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good practice to employ a series of markers so that 
cross reference can be made to categorise the cell types. 
There are now in existence many antisera, monoclonal 
antibodies and other markers which recognise cell-surface 
antigens in nervous tissue (Table 4, p 70) For example, 
Type I astrocytes are usually classified and identified 
as being GFAP+ , , Type II astrocytes as GFAP+ ,
A2B,- , neurones as Tetanus toxin ,neurofllament protein , 
(but GFAP” ) etc.
Athough there are a few reports of monoclonal 
antibodies which can distinguish between sub-populations 
of neurones from the CNS and PNS (Vnlliamy et al., 1981; 
Cohen & Selvendran, 1981; Hirsch et a l ., 1983), there 
is still no definitive marker to distinguish motor 
neurones from other neurones and glia. This can, at 
present, only be achieved by the retrograde transport 
of a marker (usually horse-radish peroxidase) from the 
site of injection (skeletal muscle) to the cell bodies 
in the ventral horn (Neuhuber & Niederle, 1980). When 
applied to culture techniques it is necessary to kill 
the cells to develop the reaction after a few days in 
culture (Bennett et al ., 1980). Alternatively, Smith 
et al . (1986) have used wheatgerm agglutinin coupled
to Lucifer Yellow vinylsulfone in their foetal rat system. 
Unfortunately, this is only reliable for a few days 
after subsequent culture as the fluorescence diminishes.
A good example of a cell-surface marker which 
appears to be limited to a particular class of neurones 
is seen in the CHOL-1 antigen (Jones et a l ., 1981).
The antiserum, raised to small synaptosomes prepared
from the purely cholinergic electric organ of the electric 
fish, Torpedo marmorata, appears to recognise cholinergic 
nerve terminals specifically. Recent evidence produced 
by Ferretti and Barroni (1986) suggests that the two 
gangliosides GTlb and GQ bear antigenic determinants 
specific for cholinergic neurones.
The diversity and immunogenicity of the gangliosides 
(reviewed by Ledeen, 1985) is perhaps the best hope 
for the identification of sub-sets of neurones. Kim 
et a l . (1986) go as far as to suggest that "each neural
cell type may contain a specific and characteristic 
set of gangliosides".
Table 4 Markers for Neural Tissue Components
(unless otherwise stated, markers are all antisera and/or monoclonal antibodies- 
see list of abbreviations, p v i )
Markers Antigen Surface or 
intracellular
Cellular specificities References
/3-S100 protein IC astrocytes Cicero et al.,1970 
Aono et al.,1988
GFAP glial fibrillary 
acidic protein 
5 lKDa








S schwann cells Brockes et al., 
1977
GC galactocerebroside S oligodendrocytes Raff et al., 1978
7-enolase enzyme IC neurones Schmechel et al., 
1978
Scarna et al.,1982













S neurones & sub-population 
type II astrocytes
Mirsky et al.,1978 
Raff et al.,1983 









S neurones,type II astrocytes 
oligodendrocytes (neurone 
specific in mouse retina)
Eisenbarth et a 1., 
1979
Raff et al. 19 79
*D2 polypeptide
139KDa








S CNS neurones Cohen & Selvendran 
1981
RT97 neurofilament 
protein 200 & 
160KDa
IC neurones Wood & Anderton, 









IC cholinergic neurones Levey et al.,1981 
see also Section 
1.2.8 (i)






S astrocytes, ependymal cells 
mtiller celIs,meningeal cel Is
Bartlett et al., 1981
NS-1 lipid S oligodendrocytes Schachner,1982b
NS-2 polypeptides
84 & 120KDa & lipid
S glioblastoma Schachner, 1982b
NS-4 polypeptides 
145 & 200KDa
S neurones>>glia Schachner,19 82b
*BSP-2 glycoprotein 
180,140 & 120KDa
S neural cells Rougon et al.,1982
BSP-3 glycoprotein 48KDa S astrocytes> >neurones Hirn et al.,1982
F-10-44-2 glycoprotein 90KDa S white matter (glia?) McKenzie et al.,1982
continued
Table 4 (continued)





S cholinergic neurones Richardsonetal., 198 2 




S neurones Choung et al.,1982 
Rutishauser,1984
SSEA-1 glycolipid S astrocytes 80-90% Lagenaur et al. ,19 82
°NILE glycoprotein
200-230KDa
S neurones Salton et al.,1983 
Sajovic et al. ,1986
F3-87-8 glycoprotein 
130, lOOKDa
S CNS specific Lakin et al., 1983
MI/NI S astrocytes(80%)(human) Dickson et al.,1983
308 S astrocytes(80%)(human) Dickson et al.,1983







S neurones(cerebellar) Rathjen & Schachner 
1984
MRC OX-2 glycoprotein,41KDa S neurones (cerebellar) Webb & Barclay,198 4
continued
Table 4 (continued)





glycolipid S sensory neurones (sub-set) Dodd et al.,1984
224-58 glycolipid S Schwann cells -Guerci et al.,1986 
Goujet-Zalc et al., 
1986
F480 S microglia (non-motile) Austyn & Gordon,1981 
Perry & Gordon,1988
C138 microtubules IC neurones (brain, sub­
population)
Hirsch et ai.,1983
Fibronectin S fibroblasts Raff et al., 1979
MBP
myelin basic 
protein S myelinated fibre tracts Jen Chou et al., 1986













Doherty & Walsh, 
1987
GQ ganglioside S neurones(80-90%)astrocytes 
10-20%)(human)
Kim et al.,19 86
continued
Table 4 (continued)
Markers Antigen Surface or 
Intracellular
Cellular specificities Reference
GM4 ganglioside S astrocytes(80-90%)oligo­
dendrocytes , schwann cells 
(50%)(human)
Kim et al.,1986
GD3 ganglioside S astrocytes(5-10%)oligo­
dendrocytes (human)
Kim et al.,1986
Ml IC astrocytes(sub-population) Schachner,1982
Cl IC astrocytes(sub-population) Schachner,19 8 2
NG2 S astrocytes, neurons see Kim et al.,1986
SI S astrocytes, neurons see Kim et al.,1986
RB01
RB02
S oligodendrocytes see Kim et al.,1986
*I and ^ indicate probable identical antigen (underlined)
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1.3 INVESTIGATION OF MOTOR NEURONE DISEASE
1.3.1 INTRODUCTION
Neural tissue culture systems have been applied 
to many general studies of growth, development and 
differentiation, as already reviewed in the first two 
sections of this introduction.
In addition, dissociated neural tissue cultures 
are readily adapted to electrophysiological study. The 
mature cultures, usually in 35mm dishes, are mounted 
on the stage of an inverted phase contrast microscope 
modified to maintain temperature at 37°C. The bathing 
medium is either the culture medium, or a balanced salt 
solution at pH7.4. The morphologically identified neurones 
are large enough to be readily impaled with microelectrodes 
for intra-cellular readings. Drugs and other 
pharmacologically active substances can be applied in 
the vicinity of the neurone under study by iontophoresis. 
Studies of this nature have established resting membrane 
potentials, demonstrated the electrical excitability 
of neurones compared to glial cells and shown "normal" 
neurone-neurone synaptic interactions (rev. Nelson,
1975; Peacock et a l ., 1973? Ransom et a l ., 1977).
The responses of spinal neurones in culture to 
many drugs and biochemicals (including amino acids) 
have been recorded and in some cases a classification 
based on these data is possible eg. neurones from DRG 
will only respond to gamma aminobutyric acid (GABA), 
while spinal cord neurones will respond to most amino
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acids (rev. Ransom & Barker, 1981).
Essentially, neurones in mature dissociated culture 
appear to behave in a similar manner to those in less 
disrupted systems previously studied (ie. in vivo, or 
organ culture).
The electrophysiology and pharmacology of neurone- 
muscle synapses in tissue culture has also been extensively 
studied with the use of combined cultures of neurones 
and muscle cells. Normally, a stable culture of myotubes 
is established first and neurones are added subsequently 
(Fischbach, 1972; rev. Nelson, 1975; Puro & Yeh, 1983).
Of particular interest in the field of neurone- 
muscle synaptogenesis in culture was the observation 
by Nurse and O'Lague (1975) that dissociated sympathetic 
SCG neurones from neonatal rats would form functional 
cholinergic synapses with rat myotubes in culture, a -  
Bungarotoxin blocked synaptic transmission from neurone 
to myotube, but not from neurone to neurone, thus 
indicating that the neuronal nicotinic ACh receptor 
might not be identical with the muscle nicotinic ACh 
receptor. Their data suggest the exercise of extreme 
caution in the classification of neurones which innervate 
skeletal muscle in culture.
Ransom and Barker (1981) summarised their review 
on the subject of the properties of mammalian central 
neurones in cell culture by suggesting that due to the 
"rich background information that has accumulated about 
the general properties of different (neural) culture 
systems", that they should be employed in a "more selective,
problem-solving" capacity in future. They envisaged 
that "a researcher will employ neural cultures when 
it is apparent that he can exploit certain of their 
unique features to answer his question most expeditiously" 
The use of neural cultures as a "problem-solving" 
model system has been clearly recognised by workers 
interested in the pathogenesis and aetiology of Motor 
Neurone Disease (MND).
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1.3.2 CLASSIFICATION OF MOTOR NEURONE DISEASE
Motor Neurone Disease is a collective term for a 
group of diseases characterised by initial degeneration 
of somatic a-motor neurone tracts, followed by muscular 
atrophy (assumed to result from the inability of the 
dead neurones to supply essential trophic factors to 
their target skeletal muscle - Section 1.1.6). There 
is, at present, no generally accepted cause for the 
degeneration of the neurones themselves.
The variations of the disease are classified (with 
much apparent ambiguity) according to the relative 
involvement of upper motor neurones and lower motor 
neurones and depending on the "segmental level" of the 
CNS at which the neurones are primarily affected.
The term Amyotrophic Lateral Sclerosis (ALS) is 
sometimes used interchangeably with MND (especially 
in the USA). It refers to the "hardening" of the spinal 
cord (produced by glial scar tissue) observed at the 
post-mortem investigation of a victim of MND (Rowland,
1984) .
Clifford-Rose (1983) prefers to restrict the term 
ALS to those cases in which upper motor neurone signs 
predominate. Where lower motor neurone signs predominate, 
he uses the term progressive muscular atrophy (PMA).
If the lower motor neurones of the lower cranial nerves 
are affected then swallowing, speech and facial muscles 
malfunction and this is termed chronic (progressive) 
bulbar palsy. Destruction of the upper motor neurones 
supplying the facial, tongue and throat muscles (following
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a stroke for example), gives rise to similar symptoms 
in a condition termed pseudo-bulbar palsy.
In view of the confusion over terminology, the 
term MND will be used hereafter to cover all the variations 
of the disease. From the biochemist's point of view 
it is the term which best describes the central dysfunction 
ie. the death of motor neurones.
Not all somatic Of-motor neurones are affected.
In MND those supplying the eye muscles and the sphincter 
muscles of the bladder and anus are spared (Rowland,
1984) . It is generally accepted also that the autonomic 
and sensory neurones are unaffected, except perhaps 
in some protracted cases (Steiner et al ., 1984). Likewise, 
other neurones in the brain are unaffected and the intellect 
is unimpaired, although rare cases may be accompanied 
by dementia (Wilkstrom e t a l ., 1982).
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1.3.3 STRUCTURAL AND ULTRASTRUCTURAL PATHOLOGICAL CHANGES
IN AFFECTED MOTOR NEURONES
At the structural level there is denervation, 
abnormal end-plates and some axonal sprouting in affected 
skeletal muscle (Bjornskov et al ., 1984). The affected, 
but surviving, cell bodies appear shrunken and nuclear 
changes are common (Yates, 1977). A unique finding in 
MND is the occurence of amorphous material containing 
silicon which is deposited around, or embeds the endoplasmic 
reticulum and some cytoplasm. They are electron-dense 
and called intracytoplasmic inclusions (or Bunina bodies). 
Their significance, if any, is unclear (ORhmotb et a l .,
1980) .
The so-called typical central chromatolysis seen 
after axotomy is considered to be rare in MND. However, 
this has been reported to be abundant in one case of 
only 10 months duration (Hirano & Inoue, 1980).
This response to axotomy is a relatively short lived 
reaction and probably does occur in the early stages 
of MND, but would not be seen in cases of longer 
progression (Sobue et al ., 1983). The "signal" for 
chromatolysis is considered to result from the absence 
of a factor normally supplied by the periphery (Cragg,
1970).
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1.3.4 INCIDENCE AND EPIDEMIOLOGY OF MOTOR NEURONE DISEASE
The incidence of the disease worldwide is 1-2 
per 100,000. Males are affected more commonly than females 
(approximately 2:1). The mean age of onset is 66 years 
with an average duration of 3 years. Up to 10% of the 
cases are familial, the remainder are termed "sporadic", 
although they may occur in occasional clusters (eg.
Melmed and Krieger, 1982).
Some studies (reviewed by Kurtzke, 1982) have 
shown an increased incidence of the disease associated 
with previous trauma to the limbs, or in occupations 
where heavy labour is involved (especially pneumatic 
drilling and farming). Buckley et al.(1983) have reported 
that in England and Wales (1959-1979) the greatest 
occupational excess of MND sufferers was in the leather 
industry. Whether this was associated with the labour 
involved, a chemical toxin used in the process (such 
as a dye substance) or some other factor, is unknown.
The disease used to occur at a much higher frequency 
(50x in 1954) in certain islands of the western pacific: 
notably Guam, West New Guinea and the Kii peninsula 
of Japan (Nemo et al., 1974; Hoffman et al., 1981; Garruto 
et a l ., 1981; Yanagihara et a l ., 198 3). This "Guamanian" 
form of MND used to account for up to 20% of all deaths 
in the regions affected. The onset of the disease was 
earlier than the sporadic form and was commonly accompanied 
by Parkinsonian-Dementia (PD). There is a major pathological 
difference between the "Guamanian" and "sporadic" forms 
of MND. On post-mortem examination of "Guamanian" disease 
victims it is found that affected upper and lower motor
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neurones have "neurofibrillary tangles" ie. the normal 
structure of the axonal cytoskeleton appears to have 
been disturbed, resulting in abnormal accumulation and 
morphology of the axonal filaments (Garruto and Yase,
1986) . Interestingly, this is also seen in the brains 
of those patients who have died with Alzheimers disease 
(see Appel, 1981), but only rarely in cases of "sporadic" 
MND.
Garruto et al. (19 85) have reported that the 
incidence of MND and P-D on Guam and the other islands 
has declined steadily until it is now only slightly 
higher than the sporadic incidence. This remarkable 
occurence seems to be linked with the increasing 
"civilisation" of the islanders, and strongly suggests 
the reduction in an environmentally available "trigger" 
for the disease.
In their most recent review of the data, Garruto 
and Yase (1986) rule out several possibilities for the 
source of the neurotoxic agent, such as the ingestion 
of a cyanogenetic glycoside (cycadin) present in the 
locally distributed cycad nut. They concentrated on 
the mineral composition of the local soil and drinking 
water. These are both unusually low in calcium and 
magnesium and relatively rich in aluminium and iron 
in all three foci. Moreover, patients show deposition 
of calcium and aluminium in affected neurones, and 
disturbances in calcium and vitamin D metabolism. Garruto 
and Yase (1986) concluded that-"The accumulating 
epidemiological, genetic and environmental evidence,
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as well as the experimental results increasingly support 
the hypothesis that a basic defect in mineral metabolism 
and secondary hyperparathyroidism, provoked by chronic 
nutritional deficiencies of calcium and magnesium, led 
to increased intestinal absorption of toxic metals and 
deposition of calcium, aluminium and other metals in 
neurones of patients with ALS and P-D".
That elemental deposition can lead to the production 
of neurofibrillary tangles has been confirmed experimentally 
in animals with aluminium intoxication (Selkoe et al.,
1979). It seems likely that the accumulation of neur- 
fibrillary tangles interferes with the normal functioning 
of the nerve cells, leading to their death (Section 
4.1.6 ).
Deary and Powell (1986) have, however, suggested 
that care should be excercised in the interpretation 
of the mineral spectra obtained from the postsynaptic 
densities prepared from the brains of Guamanian ALS 
patients (and fr.om those with Alzheimers disease and 
Parkinsonian-dementia). They have shown nearly identical 
spectra from the cerebral cortex of human foetuses, 
and suggest that the mineral deposition may be secondary 
- a result of the concentration of neuronal elements.
Most recently (Spencer et a l ., 1987), attention 
has returned to the ingestion of the seed of the plant 
Cycas circinalis 1. as the potential source of 
environmentally available neurotoxin. Macaque monkeys 
were fed long term with jg-N-methylamino-L-alanine (L-BMAA), 
which is present in the cycad nut. The animals developed
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"corticomotoneuronal dysfunction, parkinsonian features 
and behavioural anomalies, with chromatolytic and 
degenerative changes of motor neurons in cerebral cortex 
and spinal cord". The cycad plant is now only rarely 
used as a food source in Guam, and this is consistent 
with the observed decline in incidence of Motor Neurone 
Disease and Parkinsonian-dementia on the island (Garruto 
et a l ., 1985). There is also a precedent for these findings 
in that it is accepted that human lathyrism (an upper- 
motor neurone degenerative disease) results from excessive 
ingestion of the chickling pea Lathyrus sativus. This 
species contains the accutely neurotoxic amino acid 
jft-N-oxalylamino-L-alanine (BOAA), which may manifest 
its activity through its role as a potent glutamate 
receptor agonist (Spencer et al ., 1984). In view of 
these findings it may well be that Guamanian MND-PD 
will be referred' to as "cycadism".
The above data are consistent with the "excitotoxin" 
concept of Olney (see Coyle, 1982) who proposed that 
acidic amino acids, which have potent neuroexcitatory 
effects, cause neuronal degeneration by excessively 
depolarising neurones via. specific receptors responsive 
to these amino acids.
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1.3.5 MAIN HYPOTHESES OF THE AETIOLOGY AND PATHOGENESIS
OF SPORADIC MND
In sporadic MND, neurofibrillary tangles are rarely 
seen. Many possible causes of the disease have been 
cited and examined experimentally.
A major problem is that many demonstrated 
abnormalities can be interpreted as secondary effects 
rather than primary causes. In particular, there are 
many reports of impairment in neurotransmission, and 
alterations in levels of neurotransmitters and/or their 
synthesising enzymes and receptors in MND (Denys and 
Norris, 1979; Hayashi et al., 1981? Festoff and Fernandez, 
1981; Belenduik et a l ., 1981; Gillberg et a l ., 1982? 
Whitehouse et a l ., 1983; Manaker et a l ., 1985? Gillberg 
and Aquilonius, 1985).These are, most probably, all 
secondary features related to the loss of neurones and 
denervation in MND. Anticholinesterase drugs may 
occasionally relieve muscle fatiguability, but' they 
do not result in long term clinical improvement (see 
Fowler, 1984).
Other MND-related abnormalities, which are likely 
to be secondary in nature, include increased amino acid 
levels in motor cortex (Yoshino et a l ., 1979), elevated 
CSF protein (Guiloff et a l ., 1980), abnormal carbohydrate 
metabolism (Saffer et al ., 1977) and abnormal calcium 
metabolism (Mallette et a l ., 1977).
Some of the possible primary causes of MND that 
have recently received serious attention will be 
discussed in detail below.
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1.3.5(ii Persistent or Previous Viral Infection
One hypothesis, now sharply declining in popularity, 
is that MND is caused by persistent or previous neurotropic 
viral infection (Matthews et a l ., 1977 ? Pertschuk et 
al ., 1977; Kott et al ., 1979? Weiner et a l . , 1980; Miller 
et a l ., 1981). It is stil 1 accepted however, that there 
is an elevated risk of developing MND following early 
infection with polio virus. Nevertheless, this has now 
been eliminated from the population and yet sporadic 
MND continues unabated.
There has recently been a small upsurge in the 
belief that at least some cases of MND may be the result 
of viral infection (reviewed by Rowland, 1987) . For 
example, the human immunodeficiency virus (HIV) responsible 
for the acquired immunodeficiency syndrome (AIDS) can 
penetrate spinal cord and peripheral nerves and a young 
patient has been seen with both AIDS and typical ALS.
1.3.5(ii) Deficient Repair of DNA Damage
Another hypothesis which remains to be proved 
or disproved is that MND results from abnormalities 
in neuronal DNA and its function. In particular, there 
may be a deficiency in its repair mechanisms (Davidson 
and Hartmann, 1981; Bradley & Krasin, 1982? Unger et 
al., 1985). This hypothesis does not explain the specificity 
for motor neurones.
1.3.5(iii) Deficiency of Thyrotropin Releasing Hormone
As reviewed earlier (section 1.2.5, 1.2.8(D),
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Thyrotropin-releasing hormone is widespread in the CNS.
The accumulating evidence suggests that it acts as a 
neuropeptide with modulatory activity on other 
neurotransmitter systems. The cholinergic system has 
been specifically implicated in this respect, as it 
has been shown that TRH potentiates the excitatory 
actions of cholinergic agents on neurones (see Pazos 
et a l ., 1985). This activity could well explain the 
transient improvement seen in patients with ALS who 
were infused with TRH (Engel et al ., 1983a).
Reduced levels of TRH in the cerebrospinal fluid 
of patients with MND (Engel et al., 1983b) and lower 
concentrations of TRH receptors in brain tissue (Mitsuma 
et a l ., 1986) and the spinal cord (Manaker et al., 1985a) 
have been reported, but these may well be secondary 
phenomena.
In view of the clinical improvement seen by Engel 
et a l . (1983), however, a number of other trials have 
been undertaken with TRH (Imoto et al ., 1984) or one 
of its longer acting analogues (eg. Guiloff et a l .,
1987) . This therapeutic approach may prove useful in 
boosting the performance of surviving neurones, but 
it seems unlikely to be effective in halting the progressive 
course of neuronal degeneration. A longer term 
neuronotrophic activity has, however, been proposed 
for TRH, largely through its reported activity to boost 
ChAT activity and stimulate neurite outgrowth in cultured 
rat ventral spinal cord (Schmidt-Achert et a l ., 1984).
It has also been reported to reverse the neuronal damage
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caused by the substance P antagonist, spantide, and 
to stimulate myelin lipid synthesis in chick neural 
cultures (see Griffiths, 1986).
Recently, Court et al. (1987) reported an increase
in the level of thyrotropin releasing hormone in the 
wobbler mouse (Section 1.3.6), but no changes in three 
patients with motor neurone disease.
1.3.5(iv) Autoantibodies or other Toxic Blood Borne 
Factors
This hypothesis is perhaps one of the most 
amenable to testing with neural tissue culture as.a 
model system. It concerns the possibility that there 
may be present in the body fluids of patients with MND 
a component of exogeneous or endogeneous origin which 
is specifically toxic to motor neurones.
A key finding in this respect was the report by 
Wolfgram and Myers (1973) that 70% of diluted sera from 
patients with MND are toxic to the anterior horn cells 
of the neonatal mouse spinal cord in tissue culture, 
as assessed by morphological criteria. Sera from other 
neurodegenerative diseases, and controls, were reportedly 
inactive in this respect. The toxic factor was non- 
dialysable and hence presumed to be protein in nature.
The toxic factor was also proclaimed to be different 
from that previously reported by Bornstein and Appel 
(1965) and Field and Hughes (1965). The latter was found 
to be present in 60% of ALS serum and to cause 
dymelination of cultured mouse cerebellar cells. This
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factor had been shown to be antibody in nature. Its 
presence in a high proportion of ALS sera is almost 
certainly a secondary occurrence as there is secondary 
demyelination in MND.
The original finding of Wolfgram and Myers could 
not, however, be repeated by Horwich et a l . (1974) "using
the same technique as the previous investigator". Neither 
could it be confirmed by Liveson et a l . (1975) using
organotypic nerve and muscle tissue cultures, or by 
Ecob et a l . (1984). Nevertheless, Roisen et a l . (1982a,b)
reported the demonstration of an "unique, highly specific, 
non-dialysable, heat labile, apparently complement- 
independent antineuronal factor in the sera of about 
75% of all ALS patients". The factor was "neither rapid 
or long acting"; it required considerable time (5-6 days) 
to act". The culture system used was like that used 
by Wolfgram and Myers: explanted neonatal mouse spinal 
cord sections, and the cytotoxic activity was reported 
to be ineffective when tested on embryonic neurones.
More recently, Maher et a l . (1987) have also confirmed
the finding of some cytotoxic activity of ALS sera for 
cultured spinal neurones.
Askanas et a l . (1981) tested CSF from patients
with MND and other neuromuscular disorders on explants 
of embryonic rat spinal cord. They saw no alteration 
in morphology of the cultures, neither was the level 
of neurone specific enolase (NSE) affected.
Touzeau . and Kato have investigated the effects 
of ALS serum incorporated in the media of dissociated
91
neuronal cultures from both the ciliary ganglia of chick 
embryo's (1983) and human foetal spinal cord (1985).
They found no differences in neuronal survival, ChAT 
activity, glutamic acid decarboxylase (GAD) activity 
and lactate dehydrogenase (LDH) activity after lengthy 
periods in culture, when compared to neurones grown 
in control sera. It is important to note, however, that 
unlike previous studies, the sera were heat inactivated 
before inclusion in the media. This would destroy the 
effectiveness of a complement-dependent cytotoxic antibody, 
or of other heat-sensitive, directly acting neuro-cytotoxic 
proteins (eg. enzymes).
Ronnevi et a l . (1984), and Conradi and Ronnevi
(1987) have recently described an antibody mediated 
destruction of normal erythrocytes when incubated with 
serum from patients with MND, when compared to controls. 
Other neurological disease (OND) sera have much lower 
levels of this cytotoxic activity. The relationship 
of this phenomenom, if any, to neurone damage is unclear.
Digby et al . (1985) , using an alternative approach,
showed significantly increased binding of serum 
immunoglobulins from MND patients to live, mature cultures 
of embryonic rat spinal cord cells when compared to 
control and OND sera.
The possibility that MND may have an immune system 
involvement has also been studied in other approaches. 
Tissue typing studies have shown increased frequencies 
of HLA types A3 and B12 (Antel et al., 1979; Antel et 
al., 1982), A2 and A28 (Behan et al., 1976) and BW35
92
(Kott et a l ., 1976) in MND. Other work, however, gave 
no evidence of differences in frequency from controls 
(Pedersen et a l ., 1977) and one study showed a decrease 
in HLA-A9 (Bartfeld et al ., 1982).
The concentrations of immunoglobulins and complement 
factors in the sera of ALS patients are generally reported 
to be normal (Whitaker et a l ., 1973? Tavolato et al .,
1975; rev. Antel et al., 1979). The occasional report 
of elevated levels of immunoglobulins eg. in Guamanian 
MND (Hoffman et a l ., 1981) is put down to secondary 
infections rather than to a specific anti-viral or 
autoimmune response.
Plasmapheresis with or without immunosuppression 
has had no effect on the course of the disease (Silani 
et al ., 1980; Keleman et al., 1983). There is no 
inflammation or lymphocytic infiltration of neural tissue 
in the disease (Tavolato et a l ., 1975).
A few studies have detected immune complexes in 
neural biopsy tissue and sera of MND patients (Norris, 
1979? Oldstone, 1976; Noronha et a l ., 1978). Others 
have reported negative findings (Barron et al ., 1978?
Antel et a l ., 1979? Rissanen, 1978). It is, once again, 
most likely that positive findings in this respect are 
a consequence of the disease rather than its cause.
The possibility of immune cellular abnormalities 
in MND patients have also been studied with mixed success. 
Kott et a l . (1976), Behan (1979), Hoffman et a l . (1978)
all reported depressed or negative skin tests to common 
antigens. The in vitro lymphocyte proliferative response
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to non-specific mitogens has been reported to be both 
normal (rev. Antel et al., 1979) and abnormally low 
(Hoffman et a l ., 1978; Behan et al., 1979; Digby et 
al., 1985; Aspin et a l . , 1986).
Nemo et al. (1974) found no difference in the
response of lymphocytes from Guamanian ALS patients 
to specific brain antigens compared to controls. With 
lymphocytes separated from the blood of patients with 
sporadic MND, Aspin et al. (1986) showed a proliferative
response to rat spinal cord cell membranes in 4 out 
of 14 cases as compared to 0 (from 9) in controls.
Bartfeld et a l . (1985) found no significant changes 
in the percentages of immunoregulatory and activated 
T cells in ALS patients.
The significance of the increased binding of the 
serum immunoglobulins from MND patients to rat spinal 
cord cells in culture (Digby et al ., 1985) and other 
positive immune system findings (Aspin et al., 1986) 
is discussed (Section 4.L6i) with reference to additional 
data on this subject presented in the Results section 
(S ection 3.1.10 ) .
The hypothesis that immune system dysfunction 
is a causative and/or contributory factor in MND overlaps 
to some extent with other theories. One of these, the 
"viral theory" has already been mentioned (Section 
1.3.5(i)). It is also possible that viral antigens induce 
antibodies which cross-react with some of the host's 
antigens. In this context, Fujinami et a l . (1983) used
monoclonal antibodies to demonstrate common antigenic
determinants on measles virus phosphoprotein, herpes
simplex virus protein, and a human intermediate filament 
(probably vimentin). This "molecular mimickry" may be 
of significance in the appearance of so-called auto­
antibodies during virus infection, although whether 
or not they are themselves involved in the disease process 
is unclear.
Another potential variation of autoimmune disorder 
may be associated with paraproteinaemia. It has been 
found that around 5-7% of cases in a large group of 
patients with MND had monoclonal immunoglobulin production 
Moreover, it was demonstrated that in at least two example 
the immunoglobulin produced was directed against neuronal 
elements, the antigen being gangliosidic in nature (Freddo 
et a l ., 1987; reviewed by Rowland, 1987). The disease 
in these individuals is restricted to the lower motor 
neurones and hence is similar to the rare form of MND 
( 5% of cases called pure progressive muscular atrophy 
(PMA). The site of autoimmune attack may well be at 
the exposed periphery ie. synaptic connections. Upper 
motor neurones are presumably unaffected because of 
their so-called "immunological privilege" (see Lampson,
1987) .
1.3.5(v) Deficiency of Specific Neuronotrophic Factors
Involvement of the immune system has also been 
implicated in the next hypothesis of the aetiology 
and pathogenesis of MND. If, as has been suggested by 
much data (reviewed in Section 1.1.7), mature motor 
neurones rely upon a continuous supply of a specific
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trophic factor from their target cells, then a deficit 
in this factor would result in premature death of mQtor 
neurones. It has already been shown that inactivation 
or destruction of NGF by a specific antisera has devastating 
effects on the viability of sympathetic and sensory 
neurones in the developing chick (Cohen, 1960) and that 
NGF is essential to support mature sensory neurones 
(Johnson & Yip, 1985). Hence, by analogy, it has been 
proposed that, if antibodies to the equivalent 
neuronotrophic factor(s) were present in adult humans, 
this would lead to death of motor neurones.
Gurney et a l . (1984a; 1984b) mimicked denervation
in mouse gluteus maximus muscle by the administration 
of botulinum toxin which blocks acetylcholine release 
from motor nerve terminals. They found that the terminal 
and collateral sprouting that this elicits was reduced 
when the muscle was treated with sera from 9 out of 19 
sporadic ALS patients and 2 of 6 with familial ALS, 
but not with control or OND sera. Furthermore, on immunoblot 
analysis, the ALS sera recognised a 56KDa protein secreted 
by denervated rat diaphragm muscle. An antiserum raised 
against this protein also suppressed terminal axonal 
sprouting in the mouse botulinum-treated gluteus maximus 
muscle. Unfortunately, these dramatic findings could 
not be confirmed in similar studies by Hauser et al .
(1986) and Ingvar-Maeder et al. (1986). Nor were Donaghy
and Duchen (1986) able to demonstrate the inhibition 
of experimentally induced sprouting with sera from patients 
with MND and associated paraproteinaemia.
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In immunoblot studies, Jehanli et a l . (1986), reported
more common binding of serum immunoglobulins from patients 
with MND to the three neurofilament polypeptides (Mr 200,
150 and 70KDa) prepared from rat spinal cord. Antibodies 
to the 150KDachain predominated. Brown et al. (1987)
failed to show any consistent differences in immunoblot 
studies with sera from patients with MND or controls 
directed against spinal cord homogenates. They did, 
however, report that staining to 52KDa and 70KDa proteins 
was more common. The implication, from immunohistochemical 
evidence, was that the 70KDa antigen may have been the 
low molecular weight neurofilament polypeptide. The 
52KDa antigen is very close to the molecular weight 
of glial fibrillary acidic protein (51KDa). Antibodies 
directed towards cytoskeletal elements are unlikely to 
be significant in the aetiology of MND.
In connection with the above reports, data have 
recently been published (Henderson et a l ., 1987) which 
demonstrate inhibition of neurite-outgrowth promoting 
activity by muscle extracts (15 out of 20) from patients 
with spinal muscular atrophy (SMA). This is an inherited 
disorder of early onset in which only the lower motor 
neurones degenerate, making it similar to "pure" progressive 
muscular atrophy (PMA), the rarest form of motor neurone 
disease (Section 1.3.2). The inhibition of neurite outgrowth 
from dissociated chick spinal neurones is apparently 
specific to that evoked by neonatal chick skeletal muscle 
extract. There is no effect on the neurite outgrowth 
promoting activity of embryonic chick skeletal muscle
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extract. The inhibition is maximal at l-10|jg/ml of SMA 
extract. Above this dose, the human muscle extract itself 
begins to show neurite-outgrowth promoting activity.
There was no inhibitory activity in an equal number 
of age matched pathologic or morphologically normal 
controls.
The above results raise the possibility that there 
may be inhibitors of motor neurone growth factors present 
in muscle from patients with SMA. The nature of these 
factors and their significance is not clear.
All of the above reports have concentrated on 
one aspect of neuronotrophic activity only; namely neurite 
outgrowth promoting activity. It has been shown that 
this activity can reside in a different molecule from 
the cholinergic stimulatory activity (Smith et a l .,
1985). It is not clear whether the survival promoting 
activity of some conditioned media or tissue extracts 
is associated with a separate molecule, or either or 
both of the others. It may be a case of degree ie. a 
minimal amount of a neuronotrophic factor maintains 
cell survival, while larger quantities have stimulatory 
activities. The demonstration of inhibitors (or destroyers) 
of a motor neurone survival factor would have the greatest 
implications in Motor Neurone Disease.
There are many other antecedent events which could 
lead to the reception by the motor neurone soma of an 
inadequate supply of life-sustaining trophic factors.
It is possible that there may be antibodies to the 
receptor for the trophic factor(s) on the motor neurone
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terminal membrane. Hence, even if a normal supply of 
trophic factor(s) were available for the muscle fibre, 
its uptake might be blocked, or the receptors destroyed, 
thus resulting in insufficient factor reaching the soma 
via fast retrograde axonal transport.
Alternatively, the muscle fibres may just stop 
synthesising or secreting the factor for some unknown 
reason.
A third possibility is that the retrograde transport 
of the factor may be interrupted. This is a distinct 
possibility in Guamanian MND where neurofibrillary changes 
are seen (Garruto & Yase, 1986) .
Using the technique of video-enhanced differential 
interference contrast optics and computer analysis (see 
Schnapp & Reese, 1986), Breuer et al . (1986) have revealed
abnormalities of fast retrograde axonal .transport in 
excisicnalbiopsies of motor nerve from patients with 
advanced sporadic MND. The retrograde organelle traffic 
density was reduced by 68.4% compared to controls, with 
a combined reduction in the speed of their movement. 
Anterograde transport was essentially normal, as were 
the ultrastructural features of the axons. A reduction 
of this nature could result in an insufficient supply 
of trophic factor(s) to the soma and lead to cell death.
Appel (1981) extended the "trophic factor" hypothesis 
of the aetiology of MND to include Parkinsons disease 
and Alzheimers disease. These are neurodegenerative 
diseases similar to MND, in which specific sets of neurones 
are affected, usually in later life. In the "unifying 
hypothesis" proposed, these diseases would all be due
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to the lack of a specific neuronotrophic factor for 
each set of neurones. This notion has been picked up 
recently by Korsching (1986) who speculates that Alzheimers 
dementia may be due to the abnormal synthesis or utilisation 
of a trophic molecule (perhaps NGF) by the magnocellular 
cholinergic neurones affected in the disease.
It seems likely, as suggested again recently by 
Rowland (1987), that there is no single causative factor 
in Motor Neurone Diseases, but they can be triggered 
by many different antecedent events. The specificity 
of the disease does, however, point to the induction 
of a common biochemical disorder which results in the 
death of the neurones. An attractive possibility for 
this mechanism would be through interference with a 
specific motor neurone survival factor. Positive immune 
system findings, defective DNA repair, decreases in 
receptors, neurotransmitters and enzymes etc. would 
all follow as secondary and, perhaps, amplifying effects. 
Muscular atrophy in turn would follow due to the failure 
of the dead nerve cells to supply a trophic factor to 
the muscle (Section 1.1.6).
A particular attraction in the study of motor 
neuronotrophic factors is that this might lead to a 
rational therapeutic approach in Motor Neurone Disease.
Even if the triggering events were not identifiable 
or preventable, or the common biochemical disorder is 
not the induced deficiency of a motor neurone survival 
factor, it is still possible that exogeneous administration 
of such a factor could slow or halt the progress of
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the disease and even stimulate or allow for some peripheral 
re-innervation to occur. There is a precedent for this 
in that NGF has been shown to rescue neurones otherwise 
doomed to die through axotomy or colchicine administration 
(Section 1.1.7) .
1.3.5(vi) Environmentally Available Neurotoxins
It has long been suspected that exposure to 
heavy metals (especially lead and mercury) may be antecedent 
events in some cases of MND (reviewed by Yanagihara,
1982). Accumulating evidence now strongly suggests that 
at least some cases of sporadic MND may result from 
exposure to specific neurotoxins available in the 
environment. In particular, the recent evidence concerning 
the involvement of a plant neurotoxin in Guamanian MND-PD 
(Spencer et a l ., 1987) is persuasive in the light of 
the link between an upper motor neurone, disease (lathyrism) 
and consumption of another plant neurotoxin (Spencer 
et a l ., 1984). In addition, the example of MPTP (1,2,5,6- 
methylphenyltetrahydropyridine) which induces Parkinsons 
disease in animals and humans (reviewed by Langston,
1985) demonstrates that neurotoxicity specific to a 
limited set of neurones (dopaminergic nigrostriatal 
neurones) is possible. The active neurotoxic compound 
is, in fact, MPP+ which is produced from MPTP in the 
body through the actions of the enzyme monoamine oxidase 
(MAO). MAO inhibitors have been found to be protective 
against the induction of Parkinsonism produced through 
MPTP administration. In addition, there is a lower incidence
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of Parkinsonism in patients taking MAO inhibitors regularly 
to alleviate depression (Langston, 1985? Snyder & D'amato,1986).
MPP+ was apparently used in the 1960s as a herbicide, 
especially in an agricultural area of Quebec. There 
is a higher incidence of Parkinsonism in this area, 
especially among farmers (Horizon,1987 ). Interestingly, 
there is also a higher incidence of MND among farmers 
(Buckley et al ., 1983) and it is possible that this 
is caused by exposure to a selective neurotoxin present 
in agrochemicals, rather than heavy labour as was originally 
supposed.
It is possible that a single exposure to a neurotoxin 
anytime during the patients lifespan would be enough 
to induce neurodegenerative disease symptoms in later 
life. In the case of Parkinsonism, symptoms only develop 
when greater than 80% of the dopaminergic neurones have 
degenerated. Neurotoxic reduction of the number of 
neurones from, say, 80% to 50% would therefore not induce 
Parkinsonism until ageing and other general neurotoxic 
stimuli had further reduced the levels to 20% (see 
Langston, 1985).
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1.3.6 ANIMAL MODELS AND THERAPEUTIC APPROACHES
There are two well-known animal models of motor 
neurone disease: hereditary motor neurone disease in 
the so-called "wobbler" mouse (Harris, 1975) and hereditary 
canine spinal muscular atrophy (Cork et a l ., 1980).
Apart from basic morphological and physiological studies, 
few experiments have bee reported using these animals.
In 1983, however, Lange et al., performed a therapeutic 
trial on wobbler mice in which gangliosides (previously 
reported to enhance neuronal regeneration and sprouting) 
and thymosin (reportedly effective in induction and 
maintenance of immune function) were administered long 
term. There was no improvement in either group.
Clinical trials have also been carried out with 
ALS patients being given daily injections of gangliosides 
over several months (Bradley et a l ., 1984; Harrington 
et al ., 1984). No significant improvement was reported 
in either case.
It has recently been claimed that a syndrome similar 
to progressive muscular atrophy has been induced in 
guinea pigs through the repeated immunisation of highly 
purified swine spinal motor neurones (Engelhardt & Joo,
1986). The observed destruction of lower motor neurones 
in the guinea pigs appeared to be immunologically mediated 
and suggests common antigenic determinants with swine 
motor neurones. The site of induced cross-reactive 
autoimmune attack may have been at the periphery (ie. 
synapses) or, perhaps, through retrograde transport 
to the perikaryon (see Rowland, 1987). This animal model
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may prove to be a useful tool to test therapeutic approaches 
to MND, although it may only be applicable to those 
rare cases of pure progressive muscular atrophy, and 
even then, only if they themselves are produced through 
an immunological mechanism.
Experimental Amyotrophic Lateral Sclerosis can 
also be induced in the guinea pig through chronic vitamin 
C withdrawal (den Hortog Jager, 1985). This can be 
prevented by administration of n-acetylcysteine and 
dithiothreitol. In clinical trials, de Jong et a l . (1987)
reported stabilisation in 26 out of 42 MND patients 
receiving these drugs for 6 months. Ktlther and Struppler 
(1987), however, could find no such improvement in patients 
given n-acetylcysteine alone.
other attempts at therapy have largely centred around 
the administration of anticholinesterase drugs (Section 1.3.5) 
and Thyrotropin Releasing Hormone (Section 1.3.5(iii).
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AIMS OF THE PROJECT
1. To investigate additional factors required for the 
improved growth and survival of spinal cord cell cultures 
grown in serum free medium (SFM).
2. (i) To develop a protocol for the successful growth 
of human foetal spinal neurones in culture with the 
emphasis on maintenance in serum free medium (SFM).
(ii) To use the human cultures in comparative studies 
with rat cultures (with respect to growth, development 
and disease processes).
3. To carry out further studies into Motor Neurone 
Disease of particular relevance to the autoimmune/ 
neurocytotoxic factor hypotheses through the investigation 
of serum immunoglobulin binding to spinal cord cell 
cultures.
4. The production of an anti-neurofilament monoclonal 
antibody for the routine identification of cholinergic 
neurones in spinal cord cell cultures.
5. The production of an anti-choline acetyltransferase 
monoclonal antibody for the identification of cholinergic 
neurones in spinal cord cell cultures.
6. The production of (potentially novel) anti-neuronal 
cell surface monoclonal antibodies for
i) identification of neurones in culture
ii) purification of neurones from heterogeneous cell 
populations and/or selective depletion from spinal
cord cell cultures through complement-mediated destruction
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6. iii) study of novel neuronal cell surface antigens 
(eg. during development of cultures.
7. The production of other monoclonal antibodies, 
with cell-type specificities, for the further 




Standard plastic tissue culture treated dishes, 
multiwell trays and flasks were obtained either from 
Flow laboratories (Irvine, Scotland, U.K.) or GIBCO 
BRL (Paisley, Scotland, U.K.) . Culture medium (DMEM
and RPMI 1640), supplements (glutamine and penicillin- 
streptomycin) and Foetal Calf Serum (FCS) were also 
from either of the above two suppliers. Batch tested 
Donor Horse Serum (DHS) was obtained from Northumbria 
Biologicals Ltd. (Cramlington,Northumberland, U.K.). 
Accessory tissue culture items (Petri-dishes, pipettes 
and tubes) were ordered from Walter Sarstedt Ltd. (Beaumont 
Legs, Leicester, U.K.), Sterilin Products Ltd. (Teddington, 
Middlesex, U.K.) or Atom Medical Supplies (Hove, Sussex, 
U.K.).
Glass coverslips (13mm dia.) were obtained through 
BDH Chemicals Ltd. (Poole, Dorset, U.K.) and PTFE-coated 
multitest slides (10 well x 8mm dia.) were from Flow 
Laboratories (Irvine, Scotland, U.K.).
All general chemicals were from BDH Chemicals 
Ltd (Poole, Dorset, U.K.) or Fisons (Crawley, Sussex,
U.K.). Biochemicals and immunochemicals were from Sigma 
Chemical Company (Poole, Dorset, U.K.) unless otherwise 
stated.
14 3[ C] or [ H] Acetylcoenzyme-A was obtained 
from Amersham International (Amersham, U.K.) at a specific 
activity of l-5Ci/mmole.
Nitrocellulose paper was from Millipore (Bedford, 
U.K.) or Sartorius (Belmont, Surrey, U.K.).
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Filters for sterilisation of heat-sensitive 
liquids (0.22pm) were obtained through Sera Lab Ltd. 
(Crawley, Sussex, U.K.).
Pregnant Wistar rats were bred and supplied 
by the animal house, Bath University (Bath, Avon, U.K.).
Foetal and adult human tissue was collected 
from local hospitals in Bath and Bristol, with the approval 
of the Ethical Committees.
Tetanus toxoid was a generous gift from Dr.
Jonathan Lamb of University College Hospital, London,
U.K. The tetanus toxin anti-sera was prepared in the 
department by Dr. J. Nickless.
The X-63 8Ag mouse myeloma cell line was originally 
purchased from Flow Laboratories (Irvine, Scotland,
U.K.) .
Guinea pig complement was from Miles laboratories 
(High Wycombe, Buckinghamshire, U.K.) or Sera Lab Ltd. 
(Crawley, Sussex, U.K.).
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2.2 MEDIA AND SOLUTIONS
The compositions of important media and solutions 
are listed below.
PUCKS BALANCED SALT SOLUTION (Ca* + and Mg + + free) pH7.3
NaCl 137mM GLUCOSE 33mM
KC1 5.4mM SUCROSE 44mM
Na^HPO. 0.16mM HEPES lOmM2 4
KHoP 0 . 0.22mM2 4
SERUM SUPPLEMENTED MEDIUM (SSM) pH7.4
The basic medium was Dulbecco's Modification of Eagles 
Medium (DMEM) containing sodium bicarbonate (0.85g/l) 
and glucose (4.5g/l) to which the following were added:
Foetal Calf Serum (FCS) 10%




SERUM FREE MEDIUM (SFM) pH7.4
The basic medium was DMEM, as above, to which the 
following were added:
INSULIN 0.2pg/ml PROGESTERONE 2x10
i 00 3
BIOTIN lyg/ml SODIUM SELENITE 3x10
S
001
THYROXINE 3|jg/ml PUTRESCEIN 1x10 ”4m
TRANSFERRIN 5|jg/ml HYDROCORTISONE 5x10 -7m
PEN/STREP lOOU/ml GLUTAMINE 2mM
GLUCOSE 1.5g/l
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HEPES BUFFERED EAGLES MEDIUM (H-EAGLES) pH7.4
The basic medium was Eagles Minimum Essential Medium 






The basic medium was RPMI 1640 containing sodium 
bicarbonate (2g/l) to which the following were added:









HYPOXANTHINE, THYMIDINE (HT) 0.ImM
16 pM
FREEZING MIXTURE
MYOCLONE FOETAL CALF SERUM (MY-FCS) 50%
DIMETHYL SULPHOXIDE (DMSO) 20%
CLONING MEDIUM (NO HAT OR HT) 30%
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2.3 METHODS
2.3.1 CULTURED SPINAL CORD CELLS
2.3.1.1 STERILE TECHNIQUE
Tissue culture materials were either obtained 
sterile, or sterilised in a bench-top autoclave at 121°C, 
20psi for 20 min. Media and solutions were also either 
purchased sterile, or sterilised by autoclaving as above. 
Heat sensitive solutions were sterilised by passage 
through a 0.22pm filter. Culture media were usually 
supplemented with antibiotics to reduce further the 
risk of infection.
All "open" culture procedures were performed in 
a sterile air-flow hood (Microflow Pathfinder, M.D.H.).
The cultures were stored in ventilated dishes 
or bottles in a clean LEEC MKII Automatic CO^ incubator 
at 37°C. The atmosphere supplied was 5% CC^ in air.
Equipment which had come into contact with human 
material was post-sterilised by autoclaving or immersion 
in 1% sodium thiosulphate solution before disposal.
Waste human material was soaked in 1% sodium thiosulphate 
before being sealed in plastic bags and deep frozen 
at -20°C for eventual transport to a recognised human 
waste disposal incinerator at the Royal United Hospital, 
Bath, Avon.
2.3.1.2 PREPARATION OF PLASTIC AND GLASSWARE FOR TISSUE 
CULTURE
Plastic ware was supplied specially processed
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for tissue culture and required no further treatment 
before use unless they were treated with collagen (Section
2.3.1.3 and 2. 3.1.4).
Glass coverslips were boiled in 0.1M sodium hydroxide 
and rinsed extensively in running tap water and distilled 
water. They were then dried at 60°C before enclosure 
in a glass bottle for autoclave sterilisation.
Glass PTFE coated multitest slides were individually 
washed in warm 3% Decon solution with gentle rubbing.
They were then rinsed sequentially in running tap water, 
distilled water, and double-distilled water, followed 
by drying at 60°C. They were individually wrapped in 
aluminium foil and tape before sterilisation in the 
autoclave.
2.3.1.3 EXTRACTION OF RAT TAIL COLLAGEN
The skin was completely removed from a single 
rat tail and the tendons were stripped from the bones 
with strong forceps, rinsed in water and transferred 
to 1:1000 glacial acetic acid (100ml) in water. This 
was stirred for 24h at 4°C and the insoluble material 
was sedimented by centrifugation in a MSE 18 high speed 
centrifuge at 2,5000 r.p.m. (500xg) for 2h at room 
temperature.
A protein assay was performed, on a small aliquot 
of the supernatant, by the method of Lowry et a l . (1951)
and the remainder was stored at 4°C.
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2.3.1.4 COATING AND PHOTOPOLYMERISATION OF COLLAGEN
Riboflavin sodium monophosphate solution (0.05% 
w/v) was prepared in double distilled water, filter 
sterilised, and stored in the dark at 4°C for up to 
6 months.
This solution was added to collagen in the ratio 
lml to 4mg (approx. 4ml) and the mixture was quickly 
applied to culture surfaces at lOpl per cm2 in low 
level illumination in the culture hood, and evenly spread 
with a sterilised L-shaped glass rod. The surfaces were 
exposed to bright fluorescent light for 30 min to induce 
polymerisation (Masurovsky & Peterson, 1973).
Collagen-coated culture-ware was stored in the 
incubator at 37°C for up to 1 week prior to use. Before 
a cell suspension was added, the collagen was rinsed 
slowly 3 times with sterile water to leach out the 
residual yellow-coloured riboflavin and to re-hydrate 
the collagen itself.
2.3.1.5 PRODUCTION OF A SINGLE CELL SUSPENSION FROM
FOETAL RAT SPINAL CORD
This was performed according to the method already 
established in the department (Digby et al., 1985).
A 15 day pregnant rat was killed by stunning and 
cervical dislocation. The fur and skin were sterilised 
with 70% ethanol before transferal to the culture hood.
The uterus was dissected out and the foetuses liberated 
into sterile phosphate buffered saline in a petri dish.
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The spinal cords were dissected free from surrounding 
tissue under a binocular microscope and transferred 
to Puck's Ca++ and Mg++-free balanced salt solution 
( 3ml ) (see p 106) for composition). They were then minced 
with iridectomy scissors and transferred to a screw-top 
tube (12ml). DNAase I (lmg/ml in Pucks solution; 250pl) 
was then added, followed by Trypsin III (5mg/ml in 
Pucks solution; 250|jl).
After an incubation period of 30 min at 37°C, 
the spinal cord fragments were washed in serum supplemented 
media (SSM)( p 106) for composition) gently centrifuged 
at 1500rpm (200g) for 5 min in an MSE Centaur bench 
centrifuge. The supernatant was discarded and fresh 
SSM (3ml) was added. The fragments were dissociated by 
gentle passage up and down a plastic pasteur pipette 
(trituration). This was repeated two or three times 
until all fragments were dispersed. The total volume 
(ml) of medium used was equivalent to the number of 
spinal cords used.
A viable cell count was performed on a small aliquot 
of the cell suspension (50jj 1) mixed with an equal volume 
of 1.5% Trypan blue dye. The number of cells was 5±0.5 
million per spinal cord. The number of spinal cords 
was usually between 10 and 15.
The cells were seeded onto culture surfaces in 
an appropriate volume of SSM at 100,000 per cm2. Other 
seeding densities were also tested on bare glass culture 
surfaces (up to 200,000 per cm2).
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2.3.1.6 BASIC PROCEDURE FOR CULTURE OF FOETAL RAT SPINAL 
CORD CELLS
The cultures were kept in a LEEC incubator at 
37°C in an atmosphere of 5% CO2 in air. The cells initially - 
attach to the culture surfaces in small aggregates.
Over the first three days these aggregates become 
connected with numerous processes. The culture surface 
between the aggregates becomes covered with a monolayer 
of predominantly large, flat fibroblast-like cells.
On day 3 the SSM was replaced by serum-free medium (SFM)
(see p 106 for composition), which was replenished every 
3 days. Under these conditions the cell aggregates 
remained viable (ie. phase-bright and attached to the 
culture surface with high levels of enzyme activities) 
for approximately 3 weeks (Digby et a l ., 1985).
2.3.1.7 PRODUCTION OF TISSUE EXTRACTS FOR ADDITION TO 
CULTURE MEDIA
Skeletal muscle was dissected free from the 
limbs of 8-14 week-old suction terminated human foetuses 
and 12-20 week prostaglandin induced aborted foetuses.
Hearts and livers were removed from the larger foetuses. 
Adult human skeletal muscle w a s ■dissected free from 
fat and connective tissue.
All tissues were then treated in the same manner.
They were washed twice with gentle squeezing in cold 
phosphate buffered saline and then homogenised at 10%
(w/v) in fresh PBS using an Ultra-turrax homogeniser.
113
The homogenate was then centrifuged at 100,000g (35,000 
rpm) for 60 min at 4°C in a Beckman L5-50b Ultracentrifuge. 
The supernatants were filter sterilised and then stored 
frozen in aliquots at -20°C. Small samples were retained 
for protein assay.
On defrosting the extracts, a brown precipitate 
often forms which can be removed by centrifugation at 
4,000rpm( 2,600g) before addition of the supernatants 
to media over the range 0-200|jg of extract per ml.
2.3.1.8 MORPHOLOGICAL EXAMINATION AND PHOTOGRAPHIC RECORDING 
OF CULTURES
The cultures were routinely examined on a Carl 
Zeiss "Jena" inverted phase contrast binocular microscope 
under tungsten lamp illumination. Live or fixed cultures 
were frequently processed by an immunofluorescence method 
and these were examined on a Zeiss Standard 18 microscope 
fitted with an epi-fluorescence condenser equipped with 
HBO 50W super-pressure mercury lamp for UV excitation. 
Cultures grown on multitest slides or glass coverslips 
could be examined under both low (xlOO) and high (x400) 
power magnification, while cultures grown in plastic 
culture dishes could be examined under low power only, 
if the dishes were inverted.
The cultures could be photographed by attachment 
of an Olympus OM 2R camera back to the trinocular head.
The camera was loaded with Kodak ASA 400 black and white 
film for prints or Fuji ASA 400 colour reversal film 
for slides. Under tungsten lamp illumination best results
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were obtained with a l/30s exposure (low power) or 
*5S exposure (high power) . Under UV illumination an 
exposure of 10-15s was found suitable depending on the 
strength of the fluorescence observed.
Black and white films were processed using Kodak 
D76 (negatives) and D163 (prints)developers according 
to manufacturer's instructions. Colour reversal film 
was returned to the manufacturer for processing.
2.3.1.9 ASSAY OF TOTAL PROTEIN IN CULTURES
The homogenised culture samples for protein 
assay contained 0.5% Triton X-100 non-ionic detergent.
It was therefore necessary to use a modified Lowry protein 
assay for detergent extracts (Markwell et a l ., 1978) 
in which SDS is included to prevent precipitates being 
formed in the reaction tubes and cuvettes.
Standard curves were constructed over the range
0-100|jg protein by using bovine serum albumin (BSA) 
as the standard. A standard solution of BSA in 
'homogenisation buffer" (potassium hydrogen phosphate 
0.05M. di-sodium hydrogen phosphate 0.05M, sodium chloride 
0.2M, EDTA ImM and 0.5% v/v Triton X-100) (2mg/ml; 10-50pl) 
were pipetted into individual plastic tubes (3ml) in 
duplicate. The volume was adjusted (to 50pl) with buffer 
where necessary. Two tubes contained buffer (50pi 1) only 
as blank controls.
Solution A contained 2% sodium carbonate, 0.4% 
sodium hydroxide, 0.16% potassium sodium tartrate and 
1% sodium dodecyl sulphate (all w/v in distilled water).
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Solution B was 4% copper sulphate heptahydrate (w/v) 
in distilled water. Just prior to the assay, these two 
solutions were mixed in the proportion 100:1 respectively, 
and the resulting solution (C) (1ml) was added to each
of the test tubes containing protein, with gentle mixing. 
After an incubation period of 10 min at room temperature, 
Folin and Ciocalteau's phenol reagent (lOOpl), diluted 
50% with distilled water, was added to each tube with 
further mixing. The blue colouration which developed 
was read after 45 min in a Cecil CE 212 spectrophotometer 
at a wavelength setting of 750nm.
The optical density readings were plotted against 
the protein content of the samples. The standard curves 
were repeated several times on different days to ensure 
their reliability.
In order to assess the total protein present 
in spinal cord cell cultures it was first necessary 
to harvest and homogenise the cells. The test cultures 
were usually grown in 4 x 15mm dia. multi-well culture 
dishes. The medium was removed and the cultures were 
washed carefully twice with phosphate buffered saline 
pH7.4. The drained cultures could then be stored at 
-20°C/-80°C for simultaneous future assay (eg. for 
time-course studies).
Preliminary experiments indicated that a' suitable 
volume in which to pool and homogenise a single 4-well 
dish culture was 300|j 1. This was achieved with 2 x 150|jl 
aliquots transferred sequentially around the 4 wells.
The cells were scraped from the culture surfaces into
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the buffer using a metal spatula wrapped with PTFE tape 
to prevent cell adhesion.
The cells in buffer were transferred to a ground 
glass mini-homogeniser (Jencons,Ltd.,Beds., UK.) and 
disrupted by hand. It was found that with all cultures 
that a 10-50pl sample of this homogenate, when substituted 
for the BSA solution in the standard curve procedure, 
would give an optical density which fell in the appropriate 
linear range. It was then a simple procedure to calculate 
the total protein content of the homogenate.
The protein content of the cultures is usually 
expressed as pg per 15mm dia. well. Volumes were suitably 
adjusted when 35mm dish cultures were used.
2.3.1.10 ASSAY OF CHOLINE ACETYLTRANSFERASE ACTIVITY 
IN THE CULTURES
Choline acetyltransferase (ChAT) activity was 
measured by a modified procedure based on the method 
described by Fonnum (1969).
The radioactively labelled Acety1-Coenzyme A 
was diluted in homogenisation buffer to a concentration 
of 2mM and a specific activity of lOpCi/p mole. Aliquots 
(lOOpl) of this solution were stored at -20°C.
On the day of the assay, the following were 
added to one of the radioactively labelled Acetyl-CoA 
aliquots to give the reaction mixture: BSA (50mg/ml; 
lOOpl) , homogenisation buffer (600pl) , 12.5mM choline 
chloride (lOOpl) and l.OmM neostigmine bromide (lOOpl).
This was sufficient for up to 50 micro assays. The reaction
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mixture was dispensed into Eppendorf tubes (20|jl/tube) .
A single assay consisted of 4 tubes: duplicates contained 
either reaction mixture alone or reaction mixture plus 
10M formic acid (20pi 1) as a reaction inhibitor. This 
was repeated according to the number of culture dishes 
which were to be assayed.
The assays were performed at the same time as 
the protein assays and hence aliquots of the same cell 
homogenates were added to the reaction tubes.
The reaction catalysed by ChAT is:
3 14 ChAT 3 14
[ H] [ C]-Acetyl-CoA+choline   [ H] [ C]-AcetyIcholine+CoA
Preliminary experiments ascertained that production 
of radiolabelled acetylcholine is linear if 10|jl aliquots 
of the homogenates were used and the tubes incubated 
for 10 min at 37°C. (NOT SHOWN ) . At the end of this 
period, the duplicate tubes which had not previously 
received formic acid had 20pl added to terminate the 
reaction.
To each reaction tube was then added freshly 
prepared sodium tetraphenylboron solution (15mg/ml in 
2-Heptanone; 300jj 1) . The tubes were stoppered and then 
shaken vigorously to mix the water and organic phases.
The freshly synthesised acetylcholine was selectively 
extracted by ion-pairing with the sodium tetraphenylboron. 
The tubes were then centrifuged in an MSE microcentaur 
microfuge on high speed for 5 min. Aliquots (150jj 1) 
of the organic phase were removed from each tube and 
transferred to scintillation vials containing Optiphase- 
safe scintillant (5ml). The samples were counted for
1-2 min in a Packard Tricarb liquid scintillation
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spectrophotometer.
A value for the rate of labelled acetylcholine
production is obtained by the following equation:
SPECIFIC CPM (ie. CPM NO FORMIC-CPM WITH FORMIC X 2 X 
EXTRACTION FACTOR X 30
COUNTING EFFICIENCY X 2.2 X 106 X SPECIFIC ACTIVITY AcCoA
(pCi/pinole) x 10 min
‘ 3 14
= [ H] OR [ C] Acetylcholine formed |jmoles/min/culture dish
NOTES
(a) The specific cpm is multiplied by two as only half of 
the organic phase is counted.
(b) The extraction of labelled acetylcholine by sodium 
tetraphenylboron in heptanohe was shown by Fonnum 
(1969) to be approximately 95-98%. As comparative, 
rather than strictly absolute values were required, 
the extraction factor was therefore assumed to be 
100% (ie. 1 in the equation).
(c) As a 10pl aliquot was used, the values are multiplied 
by 30 to give the total activity in the 300[j 1 of 
homogenate from one 4-well dish.
g
(d) 2.2 x 10 is the standard cpm per pCi.
(e) The specific activity of the diluted labelled 
AcetylCoA was 10pCi/|jmole.
(f) The figure was divided by the number of minutes 
incubation (10) to arrive at a final result of 
labelled acetylcholine production in pmoles/min/ 
culture well.
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The result could also be related to the protein 
assay obtained for the same dish to give the specific 
activity in pmoles/min/mg protein.
2.3.1.11 ASSAY OF SPECIFIC NEUROFILAMENT PROTEIN LEVELS 
IN CULTURES
The method was based on that reported by Doherty 
et a l . (1984).
4-well culture dishes (frozen or fresh) were 
twice rinsed carefully with phosphate buffered saline 
and then fixed with 5% glacial acetic acid (0.5ml) in 
70% ethanol at -20°C for 15 min. They were then rinsed 
with a buffered salt solution containing phenol red 
as pH indicator, until neutrality was re-established.
An initial incubation was performed with 5% 
animal serum (FCS, DHS, NRS or NGS were tested) in phosphate 
buffered saline. This solution (1ml) was added to each 
well and left at room temperature for 60 min. This blocks 
non-specific protein binding sites on the cultures and 
dishes, and also Fc receptor binding sites.
After this incubation, the blocking solution 
was replaced in two of the wells with the monclonal 
anti-neurofilament antibody supernatant (RPMI 1640 medium 
+ 10% FCS + secreted monoclonal antibody). The other 
two wells in each dish received media which had not 
been exposed to antibody secreting hybridoma cells ("normal 
medium") to act as non-specific second antibody binding 
controls. The incubation period was 3h at room temperature.
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The cultures were next washed three times with 
normal medium over a time period of 20-30 min. The second 
antibody (goat anti-mouse IgG-peroxidase conjugate) 
diluted 1:500 in normal medium was then dispensed at 
0.5ml per well. It was left at room temperature for 
2/3 h.
Following a final extensive wash period with 
phosphate buffered saline, the wells were filled with 
freshly made substrate solution (0.4ml) containing 
tetramethylbenzidine (lOmg/ml in dimethylsulphoxide,
DMSO; 0.1ml) and 30% hydrogen peroxide solution (1.5p1) 
in 0.1M sodium acetate buffer pH6.0 (10ml).
After 15-30 min at room temperature, the now 
blue-coloured substrate/product solution (0.1ml) was 
transferred to a 96 well microtitre plate containing 
2M sulphuric acid (25p1) per well. This both stops the 
reaction and converts the blue product to a yellow colour. 
The optical densities were read at 450nm on a Dynatech 
minireader II. The results are proportional to the amount 
of neurofilament protein in the cultures.
2.3.1.12 PROCEDURE FOR THE DEMONSTRATION OF
ACETYLCHOLINESTERASE ACTIVITY IN THE CULTURES
This was based on the "direct-colouring" 
thiocholine method of Karnovsky and Roots (IS 64) for 
teased or sectioned tissue.
Acetylthiocholine iodide (5mg) was dissolved 
in 0.1M sodium hydrogen maleate buffer pH6.0 (6.5ml).
To this was added in sequence with mixing: 0.1M sodium
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citrate (0.5ml), 30mM copper sulphate (1ml), distilled 
water (1ml) and 5mM potassium ferricyanide (1ml). The 
acetylcholinesterase inhibitor ImM neostigmine bromide 
(lml) was replaced for the water in the incubation medium 
as the control.
Cultures were washed and either used live or 
fixed with 5% acetic acid in 70% ethanol, or 4% 
paraformaldehyde in PBS. A suitable volume of test or 
control incubation medium was then applied and left 
for several hours at 37°C before examination on the 
Zeiss microscope.
2.3.1.13 IDENTIFICATION OF NEURONS IN THE CULTURES THROUGH
TETANUS TOXIN BINDING
Live cultures grown on coverslips or 10-well 
multitest slides were incubated first with 5% SSM. This, 
and all subsequent incubations were for lh at room 
temperature. The blocking solution was replaced with 
tetanus toxin diluted (to lOpg/ml) in 5% SSM. After 
careful washing in 5% SSM, the cultures were incubated 
with rabbit tetanus toxin antisera (1:100 in 5% SSM). 
Further washing was followed by incubation with anti-rabbit 
Ig-FITC conjugate diluted 1:100 in 5% SSM. There was 
a final wash (x2/3) in PBS before the cultures were 





Balb/c mice were immunised with three different 
neural tissue preparations.
(a) Foetal rat spinal cord cell cultures were set up
in 35mm dia. dishes and grown in SSM/SFM until day 15-18 
to provide a source rich in neurones. Ten of these mature 
cultures were washed carefully with PBS and the cells 
were harvested by scraping into PBS (final vol. 0.5ml).
The cells were injected into the peritoneal cavity of 
a 4-5 week old male Balb/c mouse without further addition 
or processing. An identical booster was given 3-4 weeks 
later.
(b) Preparations rich in synaptic membrane fragments 
were prepared from both cultured rat spinal cord cells 
and adult rat spinal cord tissue by the method of Young 
and Snyder,(1973). The tissue (10% w/v) was homogenised
in 5mM Tris buffer, pH7.6, containing 50pM calcium chloride 
and 0.32M sucrose. The homogenate was centrifuged for 
10 min at 1,000 g (4,000rpm). The supernatant was retained 
and the "nuclear" pellet was re-suspended and re-centrifuged 
as above. The two supernatants were pooled and centrifuged 
at 17,000 g (14,000 rpm) for 20 min at 4°C in a MSE 
18 high speed centrifuge. The crude mitochondrial pellet 
thus obtained was "shocked" three times with 5mM Tris 
buffer pH7.6 (20 volumes) at 4°C. The suspension was 
re-centrifuged at 9,000 g (9,500 rpm) for 20 min to 
pellet the cytoskeletal proteins. Finally, the supernatant
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was centrifuged at 48,000 g (26,000 rpm) for 20 min at 
4°C in a Beckman L5-50b ultracentrifuge to produce the 
synaptic membrane pellet (P3) which was re-suspended 
in a minimal volume of PBS, assayed for protein, and 
stored frozen at -20°C. The defrosted preparation (lOOfjg) 
was emulsified in Freund's complete adjuvant (0.25ml) 
and injected intraperitoneally into a young male Balb/c 
mouse. A booster injection was given some 3/4 weeks 
later with the'1 preparation this time emulsified in Freund's 
incomplete adjuvant.
(c) A commercial preparation of choline acetyltransferase 
extracted from bovine brain was dissolved in PBS at 
a concentration of 0.5mg/ml. This solution (0.25ml) 
was mixed and emulsified with the same volume of Freund's 
complete adjuvant. This was then injected into young 
male Balb/c mice. After 3/4 weeks the procedure was 
repeated, this time with Freund's incomplete adjuvant.
2.3.2.2 MYELOMA CELL LINE CULTURE
During the period of immunisation, the X-63 8Ag 
myeloma cell line was continuously grown and sub-cultured. 
Until one week prior to the fusion procedure, the medium 
used, "cloning medium" (see pl07 for composition) contained 
0.13mM 8-Azaguanine to prevent the cells from spontaneously 
reverting to an aminopterin-insensitive form. This was 
later omitted. The cells were also occasionally tested 
for their sensitivity to aminopterin.
Care was taken to ensure that the cells were
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healthy and growing in "log-phase". Their density was
g
kept at around 0.5 x 10 cells per ml by regular sub­
culture (usually every 2/3 days).
2.3.2.3 PROVISION OF A MACROPHAGE FEEDER CELL LAYER
Balb/c mice were killed by cervical dislocation 
and their fur and skin was sterilised by immersion in 
70% ethanol. The skin was dissected back to expose the 
peritoneum. Sterile PBS (5ml) was then injected into 
the peritoneal cavity of each mouse. The abdomen of 
each mouse was massaged to suspend the peritoneal 
macrophages into the PBS which was then withdrawn by 
pipette through a hole cut in the peritoneum. Samples 
heavily contaminated with blood were discarded.
The macrophage suspensions were irradiated for 
approximately 4 min (2,000 rads), and then pelleted 
by centrifugation in an MSE centaur at 1500 rpm (200 g ) , 
at room temperature. The supernatant was discarded and 
the cells were resuspended in a small volume of normal 
cloning medium. A cell count was performed and the 
macrophages were then diluted to a suitable volume and 
seeded out into plastic culture ware at approximately 
20,000 per cm2. The macrophages were prepared the day 
before a fusion experiment and seeded out into 5 x 96 well 
flat-bottomed dishes in cloning media (50jjl/well) containing 
hypoxanthine, aminopterin and thymidine (HAT supplement)
(see p 107 for concentrations).
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2.3.2.4 FUSION PROCEDURE AND SUBSEQUENT GROWTH OF
HYBRIDOMAS
The fusion procedure was usually performed 5 
days after the second injection of antigen into the 
mouse. In most cases, the serum of the mouse was tested 
for a positive reaction to the antigen/s 2 days prior 
to the fusion procedure.
On the day of the fusion procedure, polyethylene 
glycol (PEG, Merck 4,000) (4.5g) was added to PBS, pH7.4
(5.5ml), in a McCartney bottle. This was autoclaved 
and agitated while still hot to fully dissolve and disperse 
the PEG. A test on the resulting solution (when at room 
temperature) shows a pH of around 6.8. This is close 
to the lower peak for maximum fusion efficiency (K.Thompson, 
personal communication) and was therefore used unadjusted.
It was kept at 37°C until needed.
The immunised mouse was killed by cervical 
dislocation, and sterilised. The spleen was dissected 
out and placed in a 90mm Petri dish. The cells were 
washed out with PBS (10ml) injected repeatedly into 
the spleen sac with gentle squeezing. The cells were 
then transferred to a sterile tube (12ml) and futher 
dispersed by gentle trituration. The contents were 
allowed to stand for a few minutes to allow any remaining 
lumps to settle. The cell suspension was then transferred 
to a sterile glass centrifuge tube (50ml).
The myeloma cells were then harvested. At a
g
density of approximately 0.5 x 10 per m l , 2 x 50ml 
"T" flasks containing 15ml cell suspension each were
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required to furnish 15 million cells. These were added 
to the spleen cell suspension to give an approximate 
ratio of 1 myeloma cell to 6/7 spleen cells.
The mixed cell suspension was centrifuged at 
1500 rpm (200 g) for 10 min in a bench centrifuge. The 
supernatant was discarded and the warm PEG/PBS solution 
(lml) was added dropwise over 60 sec to the pellet with 
constant agitation to prevent "clumping". This was 
immediately followed by warm PBS (lml) added in the 
same manner. Further warm PBS was slowly added to make 
the total volume up to 20ml. The cells were then once 
again centrifuged and resuspended in warm normal cloning 
medium (20ml). This was dispensed into 2 x 50ml "T" 
flasks and incubated at 37°C overnight to allow for 
the completion of the cell fusion process. The next 
morning, the cells were pooled, centrifuged and resuspended 
in cloning medium (100ml) containing HAT supplement.
The cell suspension was dispensed into the five macrophage- 
conditioned 96 well plates at 200|j 1 per well. The plates 
were incubated at 37°C (10% CC>2 in air) for 5 days.
Any infected plates, after 1 or 2 days, were discarded.
The medium was replenished at day 5 by withdrawal 
of medium (150 j j1) and replacement with fresh cloning 
medium + HAT (175|jl). Inspection of the plates at this 
time usually revealed considerable cell death with 
debris accumulating around the circumference of the 
wells and "clearing" apparent in the centre.
After a further five days in the incubator, 
the medium was similarly replenished, except that cloning
medium + HT supplement was used. Inspection of the plates
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at this time (10 days) revealed considerable "clearing" 
of the wells. Occasionally there was some contamination 
from large, flat, fibroblast-like cells presumably derived 
from the capsule of the spleen sac. In extreme cases 
these cells would overgrow the cultures, resulting in 
their having to be discarded.
At day 15 the plates were again fed with cloning 
medium + HT supplement and re-examined. At this time 
some wells already contained large, visually obvious 
colonies of hybridoma cells. It is possible that some 
wells may contain up to 30 colonies derived from individual 
fusion events (K.Thompson, personal communication).
The cells multiplied rapidly, and it was necessary to 
commence the staggered assay procedures when the colonies 
reached 50% confluency. The medium now required changing 
at least every two days.
2.3.2.5 SCREENING ASSAYS FOR SPECIFIC ANTIBODY PRODUCTION
BY HYBRIDOMAS
2 . 3 . 2 . 5 (i) INDIRECT IMMUNOFLUORESCENCE ASSAY
The main objective with the mouse immunised 
with whole rat spinal cord cell cultures was to produce 
a monoclonal antibody which specifically recognised 
neurofilament protein. Preliminary tests with a donated 
anti-neurofilament antibody (RT97 John Wood, Beckenham) 
showed that the main cell clusters and processes (neurons) 
were strongly and specifically stained by the following 
procedure:-
Rat spinal cord cell cultures were set up on
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13mm dia. coverslips or 10-well multitest slides and 
grown as previously described(Section 23JLQ until day 
15-18. The cultures were then carefully washed with 
PBS and fixed by immersion for 15 min in 5% glacial 
acetic acid in 70% ethanol. They were then rinsed until 
neutral by repeated immersion in a balanced salt solution 
containing phenol red as indicator. The cultures were 
next covered with a layer of 5% animal serum (usually 
NRS) in balanced salt solution (BSS)(13mm dia. coverslips- 
250(j 1; 8mm slide wells -50|j1), and left for lh at room 
temperature to block non-specific binding sites. This 
was then replaced with the monoclonal antibody suitably 
diluted in 5%NRS/BSS (or the test hybridoma supernatant 
undiluted). The cultures were allowed to stand for lh 
at room temperature. Controls were incubated with 5%NRS/BSS 
alone. Excess antibody was washed away by dipping the 
cultures in a large volume of 5%NRS/BSS and the cultures 
were covered with the appropriate volume of second antibody 
conjugated to fluorescein isothiocyanate diluted 1:100 
in 5%NRS/BSS. A mixture of anti-mouse IgG and IgM or 
an anti-mouse polyvalent Ig (IgG, IgM + IgA) was used 
unless otherwise stated. The incubation was carried 
out in the dark for lh at room temperature. Finally 
the cells were washed by dipping several times in BSS 
or PBS and mounted using glycerol in PBS (3:1) before 
examination on the Zeiss fluorescence-equipped microscope.
A positive result was judged and graded with reference 




This was the screening method used in the 
fusions where the mice had been immunised with commercial 
bovine ChAT. It was based on that reported by Hawkes 
et a l . (1982).
Nitrocellulose paper was marked out into 4mm 
squares and cut into strips. The strips were washed 
in distilled water and then dried at room temperature.
A solution (lmg/ml) of the bovine ChAT antigen in PBS 
was spotted onto the centre of each square ( 1p1) and 
allowed to dry for 30 min at room temperature. Control 
squares were spotted with BSA (lmg/ml in PBS).
The strips were washed in Tris-buffered saline,
TBS (50mM Tris-hydrochloride, 200mM sodium chloride 
pH7.4) and, while still wet, cut up into their component 
4mm squares and placed in the wells of 96 well microtitre 
plates. The unoccupied protein binding sites were then 
blocked by addition of 1% casein and 5% animal serum 
in TBS to each well (250pl) . This was left for 30 min 
at room temperature with gentle agitation. The blocking 
solution was then replaced by the test supernatant or 
diluted antisera (150p1) and gently agitated for 3h 
at room temperature or overnight at 4°C. Controls received 
fresh blocking solution only.
The wells were next aspirated and filled with 
blocking solution several times over a period of 30 
min to thoroughly wash the papers. The second antibody 
was then applied (anti-mouse IgG/M - peroxidase conjugate 
diluted 1:500 in blocking solution; 150p1) and left
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for 2 h at room temperature. This was then removed and 
the filters thoroughly washed, as before, with TBS.
The enzyme substrate solution was prepared fresh 
by the addition of 0.4% 3-amino-9-ethylcarbazole ( A EC) 
in dimethyl formamide (0.5ml) and 30% hydrogen peroxide 
(10(j 1) to 50mM sodium acetate solution, pH5.0 (9.5ml).
This solution (100^1) was added to each well and gently 
agitated.
A positive result was indicated by the development 
of an insoluble brown product spot in the exact location 
of the original antigen spot. This was usually clearly 
visible within 30 min of substrate application. Colour 
development was terminated by several washes in distilled 
water and the nitrocellulose piece dried between filter 
papers.
2.3.2.6 CLONING OF HYBRIDOMA CELL LINES
The hybridomas growing in the wells which had 
given positive results in the screening procedures were 
immediately transferred to larger wells (15/16mm dia.) 
which had been pre-conditioned with fresh macrophages.
The medium volume was increased to approximately lml 
with normal cloning medium (ie. HT could now be omitted). 
Two cloning techniques were used:-
2 . 3 . 2.6 (i) CLONING BY LIMITING DILUTION
The cells in a selected well were counted 
for viability and serially diluted in fresh, normal 
cloning medium until their theoretical concentration
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was either 5, 10 or 50 cells per ml. Each one of these 
dilutions was distributed (200p1/wel1) over freshly 
macrophage-conditioned 96-well plates. Two plates were 
used for the 5 cell/ml dilution to give a theoretical 
192 wells each containing a single hybridoma cell. Only 
one plate was used for each of the other two dilutions 
to give a theoretical 2 and 5 cell/well distribution.
The plates were incubated under normal conditions.
2.3.2.6 (ii) CLONING BY MICROMANIPULATION
A reverse stage, inverted phase contrast 
microscope (Microtec, Micro Instruments Ltd., Oxford,
UK) was placed in an open culture hood. The specially 
designed and constructed micromanipulating device was 
fitted with a sterile glass pasteur pipette which had 
ben drawn out to a fine point in a bunsen flame. A length 
of plastic tube attached to the pasteur served as a 
flexible mouthpiece.
Some cells from a selected well were diluted 
with normal medium in a 50mm dia. Petri dish, such that 
only a few at a time were in the field of view when 
observed under the microscope (HP x 200).
A small reservoir was taken up into the pasteur 
pipette to negate the tendency for capillary attraction. 
The tip of the pasteur pipette was then carefully brought 
into close contact with an individual cell which was 
taken up by gentle suction and transferred to a well 
of a 96-well plate containing macrophages and conditioned 
normal medium (250pl). This procedure was repeated with 
each well of two plates.
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For either cloning method, the plates were fed 
with fresh medium at 5 day intervals. By day 15 it was 
usually possible to see colonies of hybridoma cells 
growing in many wells. The supernatants of wells containing 
colonies were screened for specific antibody by the 
appropriate assay method. Positive colonies were transferred 
to bigger wells and the entire cloning procedure was 
repeated a further two times to ensure the establishment 
of pure clonal cell lines. These could then either be 
suspended in deep frozen storage, or further expanded 
to produce pure antibody in greater quantitity.
2.3.2.7 DIRECT DEMONSTRATION OF IMMUNOGLOBULIN PRODUCTION
BY HYBRIDOMAS
Antibody-producing hybridoma cells were removed 
from culture, concentrated by gentle centrifugation 
and washed once or twice with PBS. They were then 
resuspended in a minimal volume to give a "milky" suspension. 
Small drops (5|j 1) of this suspension were spread over 
the 8mm dia. wells of 10-well multitest slides. They 
were dried at 60°C. The cells were then either fixed 
by immersion of the slides in acetone at -20°C for 10 
min and air-dried, or processed unfixed. Anti-mouse 
Igs (polyvalent or class specific) conjugated to FITC 
(1:100; 50pi 1) were then applied to test wells. Control 
wells were spotted with non-secreting X-63 8Ag myeloma 
cells and/or received no antibody-FITC conjugate.
After 1-2 h at room temperature the antibody- 
conjugate was rinsed carefully away and the slides were
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mounted in PBS/glycerol <1:3). They were examined and 
photographed (sometimes under dual illumination) on 
the Zeiss microscope.
2.3.2.8 FREEZING OF HYBRIDOMAS
If the cells to be frozen were a confluent monolayer 
in a 15/16mm dia. well, then fresh normal medium (lml) 
was exchanged for the existing medium. The culture dishes 
were placed on ice for 15 min and then ice-cold "freezing
mixture" (50% FCS, 30% RPMI 1640, 20% dimethyl sulphoxide;
lml) was added. The cells were suspended in the medium 
by careful trituration, and transferred to a 2ml sterile 
screw-top freezing vial on ice. The sealed containers 
were placed in the "vapour phase" of a liquid nitrogen
storage vessel in such a position that they were cooled
at the rate of approximately 1°C per min. After several 
hours they were fully immersed in the liquid nitrogen.
When required, the cells were rapidly defrosted by placing 
the vials in a 37°C water bath. They were washed with 
two changes of fresh normal medium, with intermediate 
gentle centrifugation, before being returned to normal 
culture conditions.
Larger numbers of cells (up to 15 million) 
could also be frozen in this manner if they were first 
concentrated by gentle centrifugation and re-suspended 
in lml fresh medium.
2. 3. 2. 9 PRODUCTION OF ASCITES FLUID
This procedure was based on that of Brodeur
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et a l . (1984).
Male Balb/c mice approximately 6 weeks old were 
primed for ascites tumour formation by the injection 
of pristane (2,6,10,14 tetramethyl-pentadecane; 0.5ml).
They were left for 14 days and then injected with 3
g
x 10 hybridoma cells (washed and re-suspended in PBS 
(0.5ml)). The mice were observed over the next few days, 
and usually showed abdominal extension by day 10. The 
ascitic fluid was drained over the next few days by 
peritoneal puncture (19g needle) and stored frozen at 
-20 °C.
2.3.2.10 IMMUNOGLOBULIN CLASS AND SUB-CLASS DETERMINATION
These were determined by a dot-immunobinding 
assay as previously described in detail(Section 2.3.2.5 (ii)) . 
The nitrocellulose pieces were spotted with goat anti-mouse 
IgG^, IgG2a / I^G 2b' I^G3 or (lmg/ml; 1 p 1) . After
blocking, each test culture supernatant was incubated 
against the complete series of spotted nitrocellulose 
pieces. Antibody "capture" was detected with peroxidase- 
labelled rabbit anti-mouse Igs and substrate as before.
A brown spot on one of the series of nitrocellulose
pieces indicated tne immunoglobulin class of the monoclonal
antibody.
2.3.2.11 SDS-PAGE AND WESTERN BLOT ANALYSIS
The electrophoresis was performed essentially 
as described by Laemmli (1970). The gels used were
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approximately 15cm2 and 2mm thick of 7.5% acrylamide- 
biacrylamide. An LKB vertical gel tank was used with 
the running buffer of Tris-HCl (5mM), glycine (39mM) 
and SDS (0.1%), pH8.3.
Samples of adult rat spinal cord tissue, foetal 
rat spinal cord cultures, or P3 membrane fragments from 
spinal cord (5mg/ml) were prepared by homogenisation 
in"dissolving buffer" (Tris-HCl 0.1M, 1% SDS, 10% glycerol, 
0.14M 2-mercaptoethanol; pH8.9). A small volume of 
bromophenol blue (0.5%) was added and the samples were 
heated at 100°C in a boiling water bath for 5 min. Aliquots 
(50 — 100|j1) of these samples were loaded into individual 
gel lanes. A mixture of standard proteins (Sigma High 
molecular weight markers; 20|j 1) was also loaded into 
one or two lanes.
Electric current was initially applied at 20mA 
(60V) to allow the samples to enter the gel (30 min).
This was then increased to 30mA (200V). After 30 min 
a small volume of methyl green (0.25%) was added to 
each lane as a marker for subsequent transfer to 
nitrocellulose paper. This was repeated a few minutes 
before the termination of electrophoresis, which was 
usually complete in 5h (ie. when the dye front had 
travelled approximately 11cm).
Gels for direct staining were immersed in Coomassie 
brilliant blue R (lg/1) in fixing solution (methanol: 
acetic acid:water, 5:1:5) for a minimum of lh and then 
destained in methanol:acetic acid:water (1:1.5:17.5).
Gels for electrophoretic protein transferal
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were processed essentially as described by Towbin et 
al. (1979). A Biorad Transblot vertical tank was used,
filled With buffer (25mM Tris, 192mM glycine, 20% methanol).
The transfer was performed overnight at 20V (0.1 A).
Following electrophoretic transfer of the separated 
polypeptides to the nitrocellulose paper, individual 
lanes were cut out to produce many test strips. General 
protein staining was performed using Indian Ink in 
0.01% Tween-20/PBS (lpl/ml). Other test strips were 
first incubated with a blocking solution (eg. 1% casein,
5-10% serum, 0.1% Tween in PBS) and then with the test 
monoclonal antibody containing supernatants (3h at 20°C 
or overnight at 4°C). Antibody binding was detected 
using anti-mouse IgG/M conjugated to peroxidase and 
the substrate solution as detailed for the dot-immunobinding 
assay (Section 2.3.2.5 (ii)).
2.3.2.12 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
The binding of monoclonal antibodies to their 
antigens was also studied using ELISA techniques. These 
were either performed on live or fixed whole spinal 
cell cord cultures in situ, or, alternatively homogenates 
or extracts of cultures or spinal cord was used as a 
potential antigen source.
For antibodies recognising intracellular antigens 
in whole cultures, the method used was identical to 
that decribed previously specifically to give an indication 
of comparative neurofilament protein levels(Section 2 .3 .1.11 (ix) ) .
The binding of antibodies to the cell surfaces
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of live cultures was also investigated by this semi- 
quantitative method. In particular, cultures were directly 
compared for surface antibody binding when they were 
grown under different medium conditions. Cultures were 
set up and grown for the first three days in 20% SSM.
At day 3 some dishes were transferred to SFM while others 
were supplied with a low concentration (2-5%) of serum- 
supplemented SFM. Dishes were saved every three days 
and either tested immediately for surface antibody binding, 
or lightly fixed in glutaraldehyde (0.1% in PBS) and 
stored at 4°C.
Antibody binding to cell culture, spinal cord 
homogenate or P3 "membrane" extract was determined by 
a more traditional ELISA method. The homogenate or extract 
was diluted (to lOpg/ml) in 0.05M carbonate buffer pH9.6 
and was then dispensed into the wells of a 96-well flexible 
microtitre plate (IOOjjI per well) . Control wells received 
only buffer, or another protein solution (eg. BSA).
The protein was left to bind to the wells for 3h at 
37°C. Excess was removed, and the wells were completely 
filled with blocking solution (1% casein, 5% animal 
serum in PBS). This was left in situ for lh at room 
temperature and was then replaced by the test monoclonal 
antibody supernatant or control normal cloning medium 
(or antiserum diluted in blocking solution) for a further 
2/3 h. The wells were then washed several times with 
blocking solution before being filled with anti-mouse 
IgG/M-peroxidase conjugate (1:500 in blocking solution; 
100(j 1). After 2h at room temperature (or overnight at
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4°C), the second antibody was discarded and the wells 
were copiously washed with PBS. The reaction was developed 
with the TMB substrate solution (see p 120) for 15-30 min. 
Sulphuric acid (25m 1) was added to each well to stop 
the reaction, and the O.D. was read at 450nm.
RESULTS
INTRODUCTION TO RESULTS SECTION 3.1 CULTURED SPINAL
CORD CELLS
Several factors have been shown to be beneficial 
to some neuronal tissue culture systems, in addition 
to the essential nutritionally complete medium, serum 
supplements and hormones. Some of these factors were 
therefore tested for their effects in our system, 
with the emphasis on muscle-derived neuronotrophic 
factors. The studies were extended to concentrate 
on previously untested human skeletal muscle extracts - 
a potential source of motor-neuronotrophic factors, 
and of possible relevance in MND.
The cultures were also used in studies to further 
investigate the reported immune system involvement 
in MND. Serum immunoglobulin binding to the cultures 
was assessed by ELISA, and the actual target cells 
for the binding was studied by immunofluorescence. 
Reported serum cytotoxic activity was also examined.
Prior to the commencement of this project, 
successful human foetal spinal cord dissociated cultures 
had not been reported. These were established, and 
used in some comparative experiments with rat spinal 
cord cell cultures.
Two established characterisation experiments 
were tested, and were successful in confirming the 
neuronal identity of the clusters and processes (tetanus 
toxin binding) and their considerable cholinergic 
nature (acetylcholinesterase activity).
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3.1 CULTURED SPINAL CORD CELLS
3.1.1 COMPARISON OF CULTURES GROWN IN THE PRESENCE OR 
ABSENCE OF COLLAGEN
Foetal rat spinal cord cell cultures grown by the 
basic procedure (Section 2.3.1.6) on collagen coated 
glass and plastic ware (Section 2.3.L4)developed as 
previously described by Digby et a l . (1985) . Small clumps
of cells grew into large neuronal clusters with thick 
interconnecting processes, over a monolayer of glial 
and fibroblast-like cells. Protein and ChAT 
levels increased steadily until day 15-21 ( see Fig.l 
P140 ). The neuronal clusters remained viable (ie. phase- 
bright and attached to the substratum) for approximately 
3 weeks.
Collagen-coating of the culture ware was, however, 
recognised to have several disadvantages as listed in 
the Discussion (Section 4.1.1). In view of these factors, 
some cultures, derived from single preparations, were 
grown in the presence or absence of collagen but otherwise 
under identical conditions. The cultures developed and 
appeared totally identical when monitored visually 
throughout their life span. In addition, a time-course 
study of comparative protein levels and choline 
acetyltransferase activity did not show any major 
differences between coated and uncoated dishes (see Fig.l 
P 140) •
The small increase in protein levels (average 
47|jg per 35mm dia. dish) in collagen-coated dishes over
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Fig.l Time course study of the effect of collagen on the 
parameters of rat spinal cord cell cultures
The cultures were grown in 35mm dia. dishes which 
were either pre-coated with collagen (•) or not treated 
(o). All dishes were seeded from the same cell suspension 
at 100,000 per cm2. Each point is the result from cell 
homogenate of three pooled culture dishes.
(a) Protein content per dish (|jg)
(b) Choline acetyltransferase activity
14([ C]-Acetylcholine produced pmoles/min/dish)
(c) Specific choline acetyltransferase activity
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days 12-18 was coincident with the amount of collagen 
used ( 50|jg) to coat each dish. Collagen is detected 
in the protein assay used and the results suggest that 
it is more easily detached by the harvesting procedure 
in older cultures. This confirms the visual observations 
of collagen (plus culture) detachment frequently seen 
in older cultures.
In view of these findings, collagen coating 
was omitted and all subsequent results are based on 
cultures grown on untreated culture ware. Cumulated 
time-course data are presented in Fig.5 (pl54) and Fig.11 
(p 175) .
3.1.2 GROWTH OF CULTURES ON MULTITEST SLIDES
The use of multitest slides was judged to be 
essential in order to screen large numbers of hybridoma 
supernatants by the indirect immunofluorescence technique. 
Preliminary experimentation resulted in the establishment 
of the following successful procedure.
The slides were first washed individually by 
hand in’ warm 3% Decon solution and then rinsed sequentially 
in running tap water, distilled water and double-distilled 
water. The slides were dried at 60°C and then wrapped 
tightly in aluminium foil and autoclave tape prior to 
sterilisation at 121°C, 20psi for 20 min. Five slides 
were then placed face up in each 120mm2 Petri dish and 
the cell suspension in SSM (lOOpl) was dispensed to
5
every well at 2 x 10 cells/cm2. The Petri dish and 
slides were then transferred carefully to the incubator
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and left undisturbed for 24h (at 37°C, 5% CC^)) . When 
examined after this period, the cells could already 
be seen to have formed clusters with a few fine processes 
interconnecting them. They appeared to be quite well 
attached to the surface.
The slides were carefully flooded with SSM (30ml) 
which ensured that the cell clusters remained firmly 
attached to the glass surface. The slides were* replaced 
in the incubator and left for a further 2-3 da;ys before 
transfer to SFM with subsequent changes every 3 days. 
Under these conditions the cultures grew and appeared 
in every respect to be identical to cultures grown in 
plastic ware. They remained viable and firmly attached 
to the glass surface for around 3 weeks, although they 
were usually used in the immunofluorescence screening 
procedure around day 15.
The average foetal rat spinal cord preparation 
provided up to 500 individual cultures by this method.
3.1.3 GROWTH OF CULTURES WITH VARIOUS MEDIUM St!PPT,EMENTS
A number of variables were investigate^ j_n terms 
of their effects on the culture of spinal cord cells.
3.1.3(i) INCREASED POTASSIUM CONCENTRATION
The basic culture medium (Section 2.2 ) contains 
potassium chloride (KC1) at a concentration of 5»4mM.
KC1 solution was prepared at 2g per ml in double distilled 
water, filter sterilised, and then added to the basic 
medium to increase the concentration to 10, 20 or 40mM.
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No adjustment was made to the medium to compensate for 
increased osmolarity (Section 1.1.3).
Foetal rat spinal cord cell cultures were set 
up in 35mm dia. non collagen-coated dishes and grown 
either in normal, or raised KC1 medium. Cultures grown 
in 10 or 20mM KCL showed no visible morphological 
differences from those grown in 5.4mM KC1, and the survival 
time was not affected.
A time-course study was performed for comparison 
of protein content and choline acetyltransferase activity in 
cultures grown either in 5.4mM or 20mM KC1. Cultures 
were washed and stored frozen (-20°C) every 3 days for 
21 days and assays performed simultaneously (see Fig.2 
p 145 ). No differences were seen in protein content 
between the cultures. However choline acetyltransferase 
activity was 41.5% higher (average) between 15 and 21 
days for cultures grown in 20mM KC1.
At 40mM KC1, the neuronal clusters became rapidly 
phase-dark and detached from the culture surface within 
a few days.
3.1.3 (ii) ADDITION OF MITOTIC INHIBITORS
Deoxyfluorouridine (DFU) was made up at 1.5mg/ml 
in H-Eagles medium with uridine (U ) added at 3.5mg/ml.
The solution was filter sterilised and stored in frozen 
aliquots until needed. In an effort to produce cultures 
which were even purer in neurones than those grown from 
day 3 in SFM alone, the inhibitors were added to SFM 
at a final concentration of DFU 15pg/ml and U 35pg/ml.
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Fig.2 Time course study of the effect of elevated
potassium chloride concentration on the parameters 
of rat spinal cord cell cultures
The cultures were grown in untreated 35mm dia. 
dishes in normal, 5.4mM (o) or elevated , 20mM (•) 
potassium chloride containing medium. All dishes were 
seeded from the same cell suspension at 100,000 per 
cm2. Each point is the result from cell homogenate of 
three pooled culture dishes.
(a) Protein content per dish (pg)
(b) Choline acetyltransferase activity
14([ C]-Acetylcholine produced pmoles/min/dish)
(c) Specific choline acetyltransferase activity
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This media was added to cultures at day 3. Thereafter, 
normal SFM was replaced as usual.
The cultures were monitored visually, and a 
time-course study performed with dishes saved at 3 day 
intervals for future assay of protein and choline 
acetyltransferase activity.
When uridine and deoxyfluorouridine were included 
in the SFM between days 3-6, the cultures were erratic 
and unreliable. They were very prone to detach from 
the culture surface, especially during medium changes 
and processing for immunofluorescent staining etc. In 
addition, they did not appear to survive in a healthy 
condition for as long as cultures grown in SFM alone.
Fig.3 (p 148) shows a comparison between cultures 
grown in the presence and absence of mitotic inhibitors. 
Protein levels and choline acetyltransferase activities 
are seen to be lower in the former case, early in the 
time-course. Levels appear to recover by day 15. However, 
the ease of detachment and early death of the cultures 
produces a sharp decline thereafter. Plate 4 shows that 
the presence of mitotic inhibitors, nevertheless, leads 
to very pure neuronal cultures.
3.1.3(iii) ADDITION OF LOW CONCENTRATIONS OF FOETAL 
CALF SERUM (FCS)
This was performed to determine whether long­
term cultures could be maintained in a serum supplemented 
medium without the inclusion of mitotic inhibitors and 
without the excessive proliferation of non neuronal 
cells. It also served as a protein supplement control
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Fig.3 Time course study of the effect of mitotic inhibitors
on the parameters of rat spinal cord cell cultures
The cultures were grown in untreated 35mm dia.
dishes either in normal medium (o) or in medium
supplemented with uridine, 35[jg/ml, and deoxyf luorouridine 
15|jg/ml, between days 3 and 6 (•) . All dishes were 
seeded from the same cell suspension at 100,000 per 
cm2. Each point is the result from cell homogenate of 
three pooled culture dishes.
(a) Protein content per dish (pg)
(b) Choline acetyltransferase activity
14([ C]-Acetylcholine produced pmoles/min/dish)
(c) Specific choline acetyltransferase activity






n mol  / m in /  mg
ro
p mol  / m i n / d i s h  x I O -2 
o  oo ro







for tissue extract experiments.
SFM was supplemented with FCS at 50pg/ml (0,125%),
100|jg/ml (0.25%) and 200pg/ml (0.5%). These media were
!
maintained from day 3 with visual observation until
day 21 when all cultures were terminated and assayed
for total protein, ChAT activity and neurofilament protein.
Other cultures were monitored visually with 
1, 2 or 5% FCS retained in the SFM from day 3. The level 
of non-neuronal cell contamination of the cultures was 
observed to be directly related to the percentage of 
FCS added to the SFM from day 3.
The highest percentage which could be used was 
5% and even then, by day 21, the neuronal clusters were 
practically obscured. 2% and 1% produced correspondingly 
improved cultures.
It was noticed that the serum did not appear 
to have a marked effect on the morphological appearance 
of the neuronal clusters and processes themselves - 
merely on the multiplication of the non-neuronal cells.
The inclusion of serum did, however, appear to increase 
the survival time of the cultures from 21 days average 
to 30 plus.
A dose-response curve (Fig.8 p 164) was followed 
over the range 0-200jjg/ml added FCS (ie. up to approximately 
0.5% serum). It can be seen that there was only a very 
small increase in protein level (15%) at 200|jg/ml. 
Neurofilament protein content was also only slightly 
increased. These two results were linked with a lack 
of significant morphological improvement. Choline
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acetyltransferase activity was, however, increased by 
36% at 200|jg/ml.
3.1.3(iv) ADDITION OF THYROTROPIN RELEASING HORMONE (TRH)
TRH was made up at lOmM in distilled water, 
filter sterilised and stored frozen at -20°C. It was 
added to both SSM and SFM at 0.ImM and compared in culture 
with unsupplemented medium. Cultures were monitored 
visually and dishes saved every 3 days for protein and 
ChAT activity assays.
The inclusion of O.lmM TRH in the medium (every 
3 days from day 0) had no obvious morphological effect. 
Neither was there any discernible difference in the 
protein levels or choline acetyltransferase activity 
levels in the time course study. There was, however, 
a small consistent increase in specific ChAT 
activity (Fig.4 p 152 ) .
3.1.4 GROWTH OF CULTURES IN HUMAN SKELETAL MUSCLE CELL 
CONDITIONED MEDIUM
Human myotube cultures were produced from fragments 
of human skeletal muscle (8-12 weeks), essentially as 
described in the basic procedure for foetal rat spinal 
cord cell cultures (Section 2 . 3X. 6) except that the 
trypsin/DNAse incubation was allowed to proceed for 
45-60 min. The myoblasts produced were seeded at 200,000 
per c m 2 in SSM (30ml) contained in 80cm3 standard culture 
flasks.
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Fig.4 Time course study of the effect of Thyrotropin
releasing hormone (TRH) on the parameters of rat 
spinal cord cell cultures
The cultures were grown in untreated 35mm dia. 
dishes either in normal medium (o) or medium supplemented 
with O.lmM TRH (•), added every 3 days in fresh medium 
from day 0. All dishes were seeded from the same cell 
suspension at 100,000 per cm2. Each point is the result 
from cell homogenate of three pooled culture dishes.
(a) Protein content per dish (pg)
(b) Choline acetyltransferase activity
14([ C]-Acetylcholine produced pmoles/min/dish
(c) Specific choline acetyltransferase activity
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Fig.5 Cumulated time course parameters of rat spinal 
cord cell cultures grown in untreated 35mm dia. 
dishes
The results are accumulated from Figs. 1-4.
Each point (days 3-18) is therefore the mean of four 
results (± S.E.M.). Each point day 21 is the mean of 
two results (± S.E.M.). All cultures were grown in 35mm 
dia. dishes which had not been collagen coated. The 
seeding density was 100,000 per cm2.
(a) Protein content per dish (jjg)
(b) Choline acetyltransferase activity
14([ C]-Acetylcholine produced pmoles/min/dish)
(c) Specific choline acetyltransferase activity
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The myoblasts multiplied for the first 3 days, 
completely covering the culture surface. At this time 
the SSM was decanted from the cells, centrifuged at 
4,000rpm (2600g) for 10 min and the supernatant (conditioned 
SSM) stored at 4°C for up to 1 week, or frozen (-20°C) 
until required. The cultures were rinsed with SFM and 
then replenished with fresh SFM (30ml). The change to 
SFM caused the myoblasts to fuse rapidly into a network 
of myotubes. After a further 3 days the SFM was decanted 
from the cultures and treated as for conditioned SSM 
(see above). Fresh SFM was added for a further 3 days, 
by which time the myotubes had shrunk and withered away.
The conditioned SFM was saved, and the cultures discarded.
Foetal rat spinal cord cells were seeded either 
into conditioned SSM or normal SSM. At day 3 the cultures 
were transferred to conditioned SFM or normal SFM 
respectively, with changes every 3 days as usual. The 
cultures were monitored visually and dishes saved every 
3 days for future assays.
Cultures grown in conditioned medium thrpughout 
showed noticeable morphological improvements over days 
15-24. The neuronal clusters appeared larger and the 
processes thicker and more numerous. The non-neuronal 
cells appeared unaffected.
The increase in culture size and process density 
was confirmed in a time course study which showed an 
average 40% increase in protein levels over days 15-24.
This was paralleled by an average 48% increase in choline 
acetyltransferase activity over the same period. The
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net result was that the specific activity of choline 
acetyltransferase remained fairly constant throughout 
the entire time course (Fig.6 p 158). This is clearly 
different to the factors previously tested which caused 
increases in choline acetyltransferase activity only, 
without parallel increases in protein levels, thus 
resulting in a consistent rise in specific activity.
3.1.5 ADDITION OF FOETAL HUMAN TISSUE EXTRACTS
All tissue extracts were prepared by the same 
method (Section 2.3.1- 7) .Cultures were set up from day 0 
in SSM with or without the extract added. At day 3 the 
media was changed to SFM with or without the extract 
added, as appropriate. The cultures were visually monitored 
with fresh media added, and dishes saved for assay, 
every 3 days as usual. Alternatively, all assays were 
performed on a fixed day (usually day 21). Foetal calf 
muscle was also tested for comparison with human muscle.
Control experiments were performed to study 
the effects of dialysis on the extracts, or pre-incubation 
of the culture dishes with media containing extract.
There was an obvious morphological improvement 
in cultures grown in the presence of foetal human skeletal 
muscle extract (50|jg/ml medium). As with conditioned 
medium, the neuronal clusters appeared larger and the 
processes thicker and more numerous. This was most 
noticeable over days 15-24.
The increase in cluster size and process density 
was confirmed in a time course study which showed an
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Fig.6 Time course study of the effect of human skeletal 
muscle cell conditioned medium on the parameters 
of rat spinal cord cell cultures
The cultures were grown in untreated 4x15mm dia. 
dishes in normal medium (o) or human skeletal muscle 
cell conditioned medium (•). All dishes were seeded 
from the same cell suspension at 150,000 per cm2. Each 
point is the result from one dish ie. cell homogenate 
of four pooled culture wells (expressed per 15mm dia. 
well).
(a) Protein content per well (|jg)
(b) Choline acetyltransferase activity
3
([ H]-Acetylcholine produced pmoles/min/well)
(c) Specific choline acetyltransferase activity
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average 34% increase in protein levels over days 15-24. 
This was paralleled by an average 29% increase in choline 
acetyltransferase activity over the same period. The 
net result was that the specific activity of choline 
acetyltransferase was fairly constant over that period. 
(Fig. 7 p 161 ) .
The newly introduced assay for neurofilament 
protein also indicated an increase in levels (over days 
18-24) for those cultures grown in the presence of the 
extract.
A dose-response curve was performed over the 
range 0-200^jg extract per ml medium with all assays 
performed on day 21. The improvement in morphological 
appearance in the cultures grown in 200pg extract per 
ml medium is particularly striking by days 15-21 (See 
Plate 14). The assays confirmed this by demonstrating 
a linear increase in protein levels with an 118% increase 
at 200jjg/ml. The choline acetyltransferase activity 
rose in parallel with the protein levels, but appeared 
to peak at 100|jg/ml with an increase of near 70%. The 
net effect was a drop in specific activity at 200pg/ml 
(Fig.8 p 174).
The index of neurofilament protein levels showed 
a near linear increase over the range studied and appears 
to confirm the morphological observations of a large 
increase in the neuronal cluster and process density, 
while the non-neuronal cells are unaffected. This suggests 
a direct action of the extract on the neuronal structures.
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Fig.7 Time course study of the effect of foetal human 
skeletal muscle extract on the parameters of rat 
spinal cord cell cultures
The cultures were grown in untreated 4x15mm dia. 
dishes in normal medium (o) or medium supplemented with 
foetal human skeletal muscle extract, 50|jg protein per 
ml (•). All dishes were seeded from the same cell 
suspension at 150,000 per cm2. Each point is the result 
from one dish ie. cell homogenate of four pooled culture 
wells (expressed per 15mm dia. well).
(a) Protein content per well (pg)
(b) Choline acetyltransferase activity
( [^H]-Acetylcholine produced pmoles|min|well)
(c) Specific choline acetyltransferase activity
3
([ H]-Acetylcholine produced nmoles/min/mg protein)
























































Fig.8 Dose response curves of the effect of foetal
human skeletal muscle extract (and foetal calf 
serum) on the parameters of foetal rat spinal 
cord cells in culture
The extract (or FCS) was added to the cultures 
over the range 0-200(jg protein per ml medium from day 0. 
The 4x15mm dia. dishes were all seeded from the same 
cell suspension at 150,000 cells per cm2. The assays 
were all performed on day 21 and each point is the result 
from cell homogenate of four pooled wells (1 dish), 
expressed per well.
■ = Foetal human skeletal muscle extract 
□ = Foetal calf serum (c = no addition)
(a) Protein content per well (|jg)
(b) Choline acetyltransferase activity
3
([ H]-Acetylcholine produced pmoles/min/wel1)
(c) Specific choline acetyltransferase activity
3
([ H]-Acetylcholine produced nmoles/min/mg protein)






































An experiment was performed for comparison with 
these effects (see Table 5 p 167). It was found that:-
(a) Heating the extract to 100°C for 5 min 
destroyed the trophic activities (it became 
toxic in effect),
(b) Heat inactivation of the extract (56°C, 30') 
considerably reduced the "morphologic" trophic 
activity.
(c) Dialysis of the extract did not significantly 
reduce the trophic activities.
(d) Pre-incubation of the culture surface with 
the extract (200|jg/ml SSM) did not itself have 
considerable trophic effects.
(e) Inclusion of human foetal heart extract
(up- to 200jjg/ml) did not have comparable trophic 
activities.
(f) Inclusion of human foetal liver extract 
( 200pg/ml) did, however, have moderate effects 
on the culture morphology, protein levels and 
choline acetyltransferase activity.
(g) The extract could not be used from day 0 
as a substitute for serum.
It was with foetal human and foetal calf skeletal 
muscle extracts that an extension in the survival time 
of the cultures was first noticed. Up until this, time, 
cultures had been studied over 21-24 days with termination 
at this point for assay. In cultures now maintained 
for longer periods it was seen that the neuronal clusters 
in serum-free medium alone were mostly phase-dark (dead)
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Table 5 The extracts were all added to rat spinal cord 
cell cultures at 200ng/ml medium. Assays were 
performed on day 21. Each point is the result 
from four pooled 15mm dia. wells.






























and detaching from the culture surface by day 30. Cultures 
from the same preparation grown in SFM plus foetal human 
or foetal calf skeletal muscle extract (50-200[jg/ml) , 
however, appeared phase-bright, healthy and well attached 
to the culture surface. This was maintained until at 
least day 40.
Extension of culture survival was examined in 
more detail with extracts of adult human skeletal muscle 
(Section 3.1.6).
3.1.6 ADDITION OF ADULT HUMAN SKELETAL MUSCLE EXTRACTS
The extracts were prepared by the same method 
(Section 2.3.1.*^as for foetal tissue. The extracts were 
added to the cultures over the range 0-200|jg extract 
per ml of media. Dishes were saved at 3 day intervals 
for time course studies, or alternatively all assays 
were performed on days 21, 30 or 40.
Time course studies (50(jg/ml; Fig. 9 pl69) and 
200pg/ml; Fig.10 p 172 ) and a dose-response curve (Fig.12 
p 177 ; range 0-200pg/ml) using amputated human leg muscle 
as source, gave results similar to those obtained with 
foetal human skeletal muscle extract (see also Plates 
14 and 15).
Five extracts from different amputated muscle 
samples were then tested (at 200pg/ml) with assays 
performed on days 21, 30 and 40 and compared to those 
cultures grown in SFM alone. The results are collected 
in Table 6 (pl79).
It is clear from these results that the extract
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Fig.9 Time course study of the effect of adult human
skeletal muscle extract (50|jg/ml) on the parameters 
of rat spinal cord cell cultures
The cultures were grown in untreated 4x15mm dia. 
dishes in normal medium (o) or medium supplemented with 
adult human skeletal muscle extract from an amputated 
limb at 50pg protein per ml (•). All dishes were seeded 
from the same cell suspension at 150,000 per cm2. Each 
point is the result from one dish ie. cell homogenate 
of four pooled culture wells (expressed per well).
(a) Protein content per well (pg)
(b) Choline acetyltransferase activity
3([ H]-Acetylcholine produced pmoles|min|well)
(c) Specific choline acetyltransferase activity
( [^H]-Acetylcholine produced nmoles/min/mg protein)
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Fig.10 Time course study of the effect of adult human
skeletal muscle extract (200pg/ml) on the parameters 
of rat spinal cord cell cultures
The cultures were grown in untreated 4x15mm dia. 
dishes in normal medium (o) or medium supplemented with 
adult human skeletal muscle extract from an amputated 
limb at 200pg protein per ml (•). All dishes were seeded 
from the same cell suspension at 150,000 per cm2. Each 
point is the result from one dish ie. cell homogenate 
of four pooled culture wells (expressed per well).
(a) Protein content per well (|jg)
(b) Choline acetyltransferase activity
3
([ H]-Acetylcholine produced pmoles|min|well)
(c) Specific choline acetyltransferase activity
3
([ H]-Acetylcholine produced nmoles/min/mg protein)































































Fig.11 Cumulated time course parameters of rat spinal 
cord cell cultures grown in untreated 4x15mm 
dia. dishes
The results are cumulated from Figs. 6, 7, 9 
and 10. Each point is therefore the mean of four results 
(± S.E.M). All cultures were grown in 4x15mm .dia. dishes 
which had not been collagen coated. The seeding density 
was 150,000 per cm2.
(a) Protein content per well (|jg)
(b) Choline acetyltransferase activity
2
([ H]-Acetylcholine produced pmoles|min|well)
(c) Specific choline acetyltransferase activity
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Fig.12 Dose response curves of the effect of adult human 
skeletal muscle extract (from amputated limb) 
on the parameters of foetal rat spinal cord cells 
in culture
The extract was added to the cultures over the 
range 0-200|jg protein per ml medium from day 0. The 
4x15mm dia. dishes were all seeded from the same cell 
suspension at 150,000 cells per cm2. The assays were 
all performed on day 21 and each point is the result 
from cell homogenate of four pooled wells (1 dish), 
expressed per well.
c = no addition
(a) Protein content per well (pig)
(b) Choline acetyltransferase activity
3
([ H]-Acetylcholine produced pmoles|min|wel1)
(c) Specific choline acetyltransferase activity
3
([ H]-Acetylcholine produced nmoles/min/mg protein
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Table 6 Effect of addition of human adult skeletal muscle extract (from amputated limb muscle) 
on the parameters of rat spinal cord cells in culture (extracts from 5 different 
patients were tested at 200|jg/ml medium) .
Assays DAY 21 DAY 30 DAY 40
Control +Extract %increase Control +Extract %increase Control +Extract %increase
PROTEIN 
jjg/wel 1
83 . 4±2 .1
n=5




























0.24 + 0.04 
n=5




0.39 + 0.06 
n=4
225% dead & 
detached




promotes large inceases in all of the parameters and 
these are sustained until at least day 40. The neuronal 
clusters in the control cultures on the other hand are 
mostly dead and detached by day 30.
A dose-response curve, Fig.13 p 181 (range 0-200|jg/ml) 
performed with extract from a sample of normal biopsied 
abdominal rectus muscle gave similar results to the 
other muscle extracts tested ie. striking morphological 
improvement, a sharp rise in choline acetyltransferase 
activity peaking at 100|jg/ml (110% increase) , and near 
linear rises in protein levels (100% at 200|jg/ml) and 
neurofilament protein levels.
The three extracts from different normal small 
biopsy samples tested at 50|jg/ml with assays at day 
21 (through neccessity) showed consistent increases 
in the parameters. These increases were also reflected 
at day 40 in cultures which had received extract (at 
50pg/ml) from seven different, larger normal biopsy 
samples (Table 7 p 183 ) •
3.1.7 PREPARATION, GROWTH AND DEVELOPMENT OF FOETAL 
HUMAN CELL CULTURES
3.1.7(i) PRODUCTION OF SINGLE CELL SUSPENSIONS FROM 
FOETAL HUMAN SPINAL CORD
Because of the force produced by the suction 
termination equipment and the narrow bore of the tubing 
leading to the 'waste' container, only the very youngest 
foetuses (6-8 weeks) were found reasonably intact. Older 
foetuses (8-14 weeks) were considerably disrupted. In
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Fig. 13 Dose response curves of the effect of adult
human skeletal muscle extract (normal) on the 
parameters of foetal rat spinal cord cells in 
culture
The extract was added to the cultures over the 
range 0-200[jg protein per ml medium from day 0. The 
4x15mm dia. dishes were all seeded from the same cell 
suspension at 150,000 cells per cm2. The assays were 
all performed on day 21 and each point is the result 
from cells pooled from 4 wells (1 dish), expressed per 
well.
c = no addition
(a) Protein content per well (|jg)
(b) Choline acetyltransferase activity
([ H]-Acetylcholine produced pmoles|min|wel1)
(c) Specific choline acetyltransferase activity
3
([ H]-Acetylcholine produced nmoles/min/mg protein)
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Table 7 Effect of addition of adult humah skeletal muscle extract ("normal") on the parameters 
of rat spinal cord cells in culture (extracts from two groups; n=3,day21; n=7,day40/ 
are shown-see text) tested at 50pg/ml medium).
DAY 21 DAY 4 0


































these cases, sections of vertebrae were collected in 
the hope that they might contain some spinal cord tissue.
The foetal parts were rapidly transported in H-Eagles 
medium containing Gentamycin (100^ig/ml) and fungizone 
(2.5pg/ml) .
Identified spinal cord tissue was processed 
in an identical manner to that for foetal rat spinal 
cord (Section 2.3.15). Appropriate adjustments were 
made to volumes of reagents etc. to allow for the difference 
in quantity of tissue obtained.
3.1. 7(ii) MAINTENANCE OF DEVELOPING FOETAL HUMAN SPINAL 
CORD CELL CULTURES
The growth and development of dissociated 
cell suspensions, prepared from the spinal cords of 
7-14 week human foetuses, were studied in a variety 
of different media under-different conditions. The key 
observations which eventually dictated the successful 
protocol for maintenance in serum free medium are listed 
below:
(a) Cultures prepared from spinal cords of older, 
disrupted foetuses (9-14 weeks) never produced 
a neurone-rich culture, whatever the medium 
and conditions tested. The cultures produced 
were almost entirely composed of large, 
flat fibroblast-like cells. The cell count 
performed using trypan blue prior to seeding
g
was between 5-8 x 10 viable cells per whole 
cord. There were, however, many dead cells
present.
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(b) Cultures prepared from the spinal cords of the 
smallest ( 2cm long), most intact foetuses 
(7-8 weeks), initially developed in a similar 
manner to that of rat cultures. Small clusters 
of cells were rapidly formed and a few fine 
processes could be seen to connect them.
(c) The development of the cultures was judged
to be best when the normal SSM was additionally 
supplemented with the components of SFM.
This medium, designated Human Medium-A,
HM-A (see Section 2.2 for composition) was 
therefore routinely employed. Reasonable 
cultures were also seen in SFM supplemented 
with 10% human serum.
(d) The cultures did not survive if they were 
transferred to SFM before a confluent monolayer 
of non-neuronal cells had been formed. The 
multiplication of the non-neuronal cells
was slower than in the rat cultures, and 
confluency was not achieved until day 7-9.
Under these conditions the cultures would 
survive for around three weeks. Cultures 
grown throughout in SSM remain viable for 
longer, although the distinct neuronal clusters 
become largely obscured by non-neuronal 
cells after approximately 3 weeks in culture.
The human cultures never attained the degree of development 
seen in the rat cultures. The neuronal clusters were 
always smaller and more widely spaced, and the processes
186
'thinner' and less numerous.
The protocol finally developed is summarised
below.
(1) Spinal cord tissue from 7-8 week human foetuses
was dissected by the method described for rat spinal 
cord cells (Section 2.3.L5).
5
(2) Cells were seeded at 2.5 x 10 cells per 15mm dia. 
well ( 150,000 per cm2) in HM-A(lml). (Collagen 
coating does not appear to improve the cultures).
(3) The cultures were incubated at 37°C in 10% CC^/air 
and the medium was replaced with fresh, warm HM-A 
(lml) on days 3 and 6. The HM-A could be replaced 
with SFM from day 9 and replenished every 3 days 
thereafter.
3.1.7 (iii) CHARACTERISATION OF FOETAL HUMAN SPINAL CORD 
CELL CULTURES
Comparison of protein and choline acetyl- 
transferase activities of cultures from a single foetus 
transferred to SFM at day 9, or maintained in HM-A 
throughout are shown in Fig.14 p 187.
The cultures have been photographed at different 
developmental stages (see Plates 16, 18, 19), under 
varying media conditions (see Plate 16) and after 
histochemical and/or immunochemical staining procedures 
(for further details see sections 3.1.8, 3.1.9 and Plates 
16, 17, 18 and 19) .
In addition the cultures have been used to a 
limited extent in studies primarily for comparison with
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Fig.14 Time course study of the comparative effects 
on the parameters of foetal human spinal cord 
neurones grown in serum-supplemented or serum 
free medium
A 7-8 week old human foetus with intact spinal 
cord provided 5 million cells on dissociation. Five 
4x15mm dia. dishes were seeded at 150,000 cells per 
cm2 in HM-A with changes at 3 day intervals. At day 9, 
one dish was saved for assay and two of the others 
replenished with SFM (A), the others still receiving 
HM-A (A).
(a) Protein content per well (|jg)
(b) Choline acetyl transferase activity
([ H]-Acetylcholine produced pmoles|min|well)
(c) Specific choline acetyl transferase activity
3











































SFM Days in culture
189
rat cultures (see Sections 3.1.-8, 3.1.9, 3.1.10,3.2.3,3.2.5).
3.1.7 (iv) FOETAL HUMAN SPINAL CORD-SKELETAL MUSCLE 
CO-CULTURE
Some successful co-cultures were produced 
by the deliberate inclusion of a small amount (approx.
2mm3) of autologous skeletal muscle tissue in the spinal 
cord dissociation procedure (Section 2. 3.1.5). in addition, 
a few successful co-cultures were obtained when separately 
dissociated skeletal muscle cells were added to spinal 
cord cells in the ratio 1:10 respectively.
Another critical factor was the stage at which 
the medium was changed from SSM to SFM. If it was changed 
too early, the muscle cells did not survive- too late 
and the neuronal clusters were overwhelmed and destroyed. 
This point could occur anytime between days 3 and 6.
In successful cultures, neuronal clusters could 
be seen in close proximity to well-developed myotubes.
Fine processes could be seen to connect the neuronal 
clusters with the myotubes in apparent innervation (see 
Plate 20). These combined structures remained 'healthy' 
for up to 30 days in SFM and twitching activity was 
seen in the myotubes at around day 15. This was in marked 
contrast to neuronal cultures grown alone in SFM, which 
did not survive beyond day 9 (when transferred to SFM 
on day 3).
A time course study was performed for protein 
and choline acetyltransferase activity levels. The mixed 
spinal cord/muscle cell suspension was seeded at 100,000 
per cm2 in 15mm dia. wells in HM-A. The medium was changed
190
to SFM on day 4 and every 4 days thereafter. Six wells 
were harvested, pooled, and assayed, every 4 days. A 
time course study performed on a pure spinal cord cell 
culture by the identical procedure is included in Fig.15 
(p 191 ) for comparison.
There appears to be a considerable difference 
in protein levels (as would be expected with, dividing 
myoblasts and myotubes present), and choline acetyl­
transf erase activity is 4-fold higher in the co-culture.
3.1.8 LOCALISATION OF ACETYLCHOLINESTERASE ACTIVITY
IN THE CULTURES
Dense brown staining was seen in test cultures, 
concentrated in the neuronal clusters. Control cultures 
which received, in addition, the acetylcholinesterase 
inhibitor neostigmine bromide, did not show any such 
colouration (see Plate 11 (rat) and Plate 16 (human)).
These results demonstrate intense cholinergic 
activity in the cultures and backs up the high levels 
of choline acetyltransferase activity seen in the 
radiometric assays.
3.1.9 LOCALISATION OF TETANUS TOXIN BINDING TO THE CULTURES
The clusters and processes of live cultures (both 
rat and human) were stained overall, thus helping to 
confirm their neuronal identity. All controls were 
negative (see Plate 2 (rat) and Plate 17 (human)).
In fixed cultures there was general intracellular 
staining throughout, indicating cross-reactivity with
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Fig. 15 Time course study of the effect of co-culture 
of foetal human spinal cord cells and skeletal 
muscle cells on the culture parameters
Spinal cord cells were seeded in HM-A alone (a ; , or in 
combination with skeletal muscle cells (A) at 100,000/cm2. 
Each point is the result from pooled homogenate of 
4 x 15mm dia. wells saved frozen every 4 days.
Assays were performed simultaneously on day 28.
(a) Protein content per well (pg).
(b) Choline acetyltransferase activity
([ H]-Acetyylcholine produced pmoles|min|well).
(c) Specific choline acetyltransferase activity
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internal elements (control normal rabbit serum was 
negative in this respect).
The surface staining produced by tetanus toxin 
appeared to increase in intensity in relation to the 
age of the cultures tested, when grown in SFM.
3.1.10 SCREENING OF MNP SERA FOR ANTI-NEURONAL ANTIBODIES
3.1.10(i) IMMUNOFLUORESCENT STAINING PATTERNS OF CULTURED 
CELLS
The cultures were grown on multitest slides 
by the reported procedure (Section 3.1.2) until day 
15-18. They were either used live to demonstrate cell- 
surface antibody binding, or fixed with 5% acetic acid 
in 70% ethanol to reveal intra-cellular antibody-antigen 
recognition. The procedures are identical to those for 
the indirect immunofluorescence assay to screen hybridoma 
supernatants (Section2 . 3 . 2 . 5(D) .The test serum was normally 
applied diluted 1:10, although other dilutions between 
neat and 1:100 were also tested on some occassions.
The second antibody used was anti-human polyvalent 
immunoglobulins-FITC conjugate or a mixture of anti-human 
IgG/IgM-FITC conjugate.
When tested on fixed rat cultures, some staining 
was always seen. It was possible to delineate three 
main staining patterns based on the type of cells which 
were predominantly stained. The most frequent pattern 
seen, TYPE I, was staining of the neuronal clusters 
and processes, with only weak, or absent staining of
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other cells. TYPE II was staining of background, glial- 
like cells, and TYPE III was staining of cell nuclei.
The comparative results obtained with MND and control 
sera are summarised in Table 8 p 195 (see also Plate 12) .
It is interesting to note that the three main 
types of staining seen with sera correspond to the patterns 
seen when supernatants- from hybridoma cells produced 
by fusion of X-63s with spleen cells from mice immunised 
with spinal cord cell cultures are tested (Section 3.2.3).
The results show that there is no obvious difference 
in staining between MND and control sera. Both groups 
of sera produced TYPE I staining at a similar frequency 
and it was impossible to determine any difference in 
strength of staining between them, based on this method.
When tested on live cultures, all sera from 
both groups produced weak-moderate staining. The staining 
was restricted soleley to the neuronal clusters and 
processes. No consistent difference could be discerned 
between the two groups of sera by this method.
Concentration of the immunoglobulin fraction 
(to 20mg protein/ml) by the ammonium sulphate precipitation 
method, produced surface staining strong enough for 
photography (Plate 13) when these samples were tested 
on live rat cultures.
A few comparative MND/control serum samples 
were also tested on live and fixed human cultures when 
available. The results were in line with those seen 
with rat cultures, and was therefore not systematically 
pursued.
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Table 8 All sera were tested at 1:10 dilution on rat
spinal cord cell cultures (fixed in 5%HAc/70%EtOH). 
Examples of the three different staining patterns 
















3.1.10 (ii) DETECTION OF IMMUNOGLOBULIN BINDING TO CULTURED
CELLS BY ELISA
The cultures were grown in 15/16mm dia. culture 
dish wells, or many small cultures were produced in 
96-well flat bottomed trays. The cultures were used 
either live or fixed, although the emphasis was on live 
cultures as the demonstration of cell-surface antibody binding 
was judged to be the most important. The cultures were 
pre-incubated with 5% SSM and then the test human sera 
were introduced to this medium at a final dilution of 
1:40 (5|j 1 serum per 200^1 medium in an 8mm dia. well).
The incubation was for 2/3 h and then the medium was 
carefully changed several times to remove excess human 
serum. The second antibody incubation was performed 
with anti-human polyvalent immunoglobulins-peroxidase 
conjugate (1:500 in 5% SSM) or alternatively an anti­
human IgG and/or IgM specific peroxidase conjugated 
antisera. The ELISA was completed by the standard method 
as previously described (Section 2 . 3 • 2J.2). Results could 
be related day to day by the inclusion of a pooled control 
serum sample as reference.
The cumulated results obtained from these 
experiments are presented in Table 9 (p 197) . The results 
show no difference except under one set of conditions- 
when the sera were tested on live rat spinal cord cell 
cultures, and the second antibody used was an anti-human 
IgM (p-chain specific)-peroxidase conjugate. In this 
case there was an obvious elevation of the mean binding 
index in the MND group.
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Table 9 Comparison of MND and control serum immunoglobulin 
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n=no. of serum samples tested (at 1:40 dilution) 
x=mean O.D. 450nm 
SEM=standard error of the mean
198
3.1.10(iii) INVESTIGATION OF POSSIBLE CYTOTOXIC EFFECT 
TOWARDS CULTURED CELLS
Samples of MND or control serum/plasma were 
removed from deep frozen storage and allowed to defrost. 
They were centrifuged at 4,000rpm (2600 g) and then added 
to 15-18 day cultures in SFM to a final concentration 
of 10%. The cultures were observed closely over the 
next 24h.
The same serum/plasma samples were then heat 
inactivated by standing in a 5 6°C water bath for 45 
min. They were re-tested on fresh cultures in the same 
way as before.
Finally, the same samples were re-tested on 
fresh cultures in the additional presence (or absence) 
of guinea-pig complement (also added at 10%). Three 
different types of guinea-pig complement were tested 
in combination with the serum samples (or alone).
Freshly defrosted control or MND sera did not 
produce any obvious morphological difference on rat 
cultures over the first 3h when added at 10-20%. When 
examined after 24h there was a proliferation of the 
non-neuronal cells and loss of normal "serum-free" 
morphology in all cases. No unique cytotoxic effect 
was noted over this time period in either of the groups.
When the sera were heat inactivated and re-tested 
as above, the results were identical. When the heat 
inactivated sera were tested in the presence of 10% 
guinea-pig complement, the cell clusters became phase-dark 
within three hours, with some detachment. This indicates
vacuolation and cell death. Unfortunately, this was 
observed in all cases and when the three different types 
of complement were added alone. It would thus appear 
that guinea-pig complement (ie. serum) was itself toxic 
to rat spinal neurones in culture. A cytotoxicity assay 
could not be developed under these circumstances.
INTRODUCTION TO RESULTS SECTION 3.2 MONOCLONAL ANTIBODIES
Monoclonal antibodies are powerful tools in 
neurobiology for identification, assay and developmental 
studies of specific cell types of the nervous system.
At the commencement of this project few were commercially
available and the potential for the generation of
interesting and useful novel antibodies directed at
neural antigens was virtually unlimited. Although
the direct goals were the production of an anti-neurofilament,
anti-choline acetyltransferase and anti-neuronal membrane
monoclonal antibody, other interesting antibodies
were also generated by the immunisation procedures
employed. The characteristics of the monoclonal antibodies
generated during the course of this project are reported
in the forthcoming section.
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3.2 MONOCLONAL ANTIBODIES
A list of all the monoclonal antibodies, established 
during this work, together with their properties is 
given in Table 10 (p 2011.
3.2.1 TYPICAL FUSION AND CLONING PROCEDURES
Fusions carried out as described in the Methods 
Section yielded an average of 50% of the wells bearing 
hybridoma colonies. The number of these wells which 
gave positive, or mixed positive results in the relevant 
initial screening assay varied greatly depending on the 
antigen used (see Sections 3 . 2 . 3,3.2.4,3.2.5) .
The first cloning procedure also yielded an 
average of 50% colony-bearing wells in the plates seeded 
at 1 cell per well. The plates seeded at 2 and 5 cells 
per well by limiting dilution were "safety nets" to 
allow for possible poor viability of some cells.
The number of wells which gave positive results 
after the first cloning procedure was usually quite 
small. It did not normally exceed 10% and was usually 
much lower (0-2%). This presumably resulted from the 
presence of multiple hybridoma cell lines in the original 
positive well, and/or positive hybridoma cell reversion 
to a non-secreting type through initial instability 
and chromosome loss.
The number of positives obtained after the second 
cloning was usually 90-100% by micromanipulation and 
50-100% by limiting dilution. As would be expected these 
figures indicate that it is safe to assume that the
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hybridoma cell lines established through micromanipulation 
are now derived from a single cell and are hence producing 
monoclonal antibodies. In practice, however, these cell 
lines were often cloned a third time by either method 
before bulk growth or frozen storage.
The positive cells cloned by limiting dilution, 
however, were always cloned a third (and sometimes fourth) 
time until their positive ratio was greater than 90%.
Cell lines removed from frozen storage were 
usually re-cloned prior to bulk growth.
3.2.2 EXPANSION OF CLONAL HYBRIDOMAS IN TISSUE CULTURE
It proved wise to gradually expand the cells into 
larger scale culture. They were sequentially moved from 
15/16mm dia. wells in 1ml media to 35mm dia. dishes 
in 3ml media, then 50ml "T" flasks in 10ml media etc.
A sudden change to large volume often resulted in cell 
death and complete loss. In addition, some cell lines 
appeared to retain a dependence on macrophages or 
macrophage-conditioned medium for their survival and 
could be lost if this was not provided.
Sub-culturing was performed by resuspending 
a confluent monolayer of cells in a 50ml "T" flask into 
the supernatant (15ml). This suspension (approx. 13ml) 
was then withdrawn and gently centrifuged in a 30ml 
Sterilin container. The antibody-containing supernatant 
was transferred to a second Sterilin tube and stored 
at 40°C. The cells could either be discarded or resuspended 
and stored frozen. The "T" flask was re-filled with
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fresh medium (13ml) and replaced in the incubator. As 
with the myeloma cell line, it was usually necessary 
to carry out this procedure every 2 or 3 days. The 
percentage of cells secreting antibody declined with 
many sub-culturings (as demonstrated by the direct 
immunofluorescence method (23. Z 7) and it was necessary 
to frequently re-clone the cells or remove fresh from 
frozen storage.
3.2.3 HYBRIDOMA CELL LINES ESTABLISHED FOLLOWING IMMUNISATION
WITH FOETAL RAT SPINAL CORD CELL CULTURES
Mice were immunised and their spleen cells fused 
with myeloma cells as described in the Methods Sections 
(2.3.2.1 to 2.2.2.4J.
First batch of cells One fifth of the cells from the 
fusion were initially plated out (the rest were stored 
frozen). In this plate, colonies were seen in 58 (60%) 
of the wells. When tested by the indirect immunofluorescence 
screening procedure, 28 (48%) of these colony supernatants 
produced intra-cellular staining of the foetal rat spinal 
cord cell cultures. Unfortunately, in almost all cases, 
this staining was uniform suggesting multiple hybridoma 
colonies in each well or (less likely) a single hybridoma 
colony producing antibody cross-reactive with many antigens. 
There was only one example of less general staining 
(well C3) and this was further investigated in detail.
The specific staining noted appeared to be directed 
against the nucleus of the large, flat fibroblast-like 
celIs.
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Subsequent cloning by micromanipulation yielded 
48 (from 192) colonies 100% of which were positive by 
the indirect immunofluorescence test.
A further cloning procedure by micromanipulation 
yielded 104 (from 192) colonies 100% of which were positive.
The immunofluorescent staining patterns were 
more fully examined with culture supernatant from these 
cells. It was noted that not only were the large, oval 
nuclei of the flat fibroblast-like background cells 
stained (fibroblasts and Type I astrocytes), but also 
the smaller, rounder nuclei of cells which were closely 
associated with the neuronal clusters and processes 
(presumably Type II astrocytes). It was difficult to 
see through this staining into the three-dimensional 
neuronal clusters, but it did appear that underlying 
cells were not stained (see Plate 4). This may, however, 
have been an artefact of poor penetration of the antibody 
into the cluster.
When tested on human spinal cord cultures the 
monoclonal antibody supernatants produced the same nuclear 
staining pattern thus demonstrating inter-species cross­
reactivity (see Plate 17).
Second batch of cells A second sample (1/5 original) 
of the fusion cells was defrosted and plated out. Colonies 
were produced in 42 (44%) of the wells.
On screening, two examples of immunofluorescent 
staining restricted to the neuronal clusters and processes 
were seen. The staining appeared identical to that observed 
with the donated anti-neurofilament monoclonal antibody 
(John Wood, RT97) (see Plate 1).
206
One of these (2F7) was cloned, producing 11 
(from 92) positives in the first cloning. The fastest 
growing, strongest positive antibody producing hybridomas 
were pursued through a further three clonings before 
bulk growth.
The immunoglobulin class was shown to be IgG2b 
and immunoblot analysis using adult rat spinal cord 
homogenate as antigen showed strong affinity for two 
bands at approximately 200KDa and 160KDa (but not 70KDa).
This corresponds with the Mwts of the two main polypeptides 
of the neurofilament triplet (see also Sections 3.2.8 and plate
The antibody produced a similar staining pattern 
in human spinal cord cell cultures (see Plate 17 ) and 
was therefore used regularly as a marker for neurones 
in both types of culture.
A second example of specific staining was observed 
in one well (2F3) from this fusion plate. In one respect 
it was similar to the 1C3 nuclear staining antibody, 
but on closer examination the staining appeared to be 
localised to the nuclear envelope (see Plate 5). It 
was cloned twice and stored frozen.
3.2.4 HYBRIDOMA CELL LINES ESTABLISHED FOLLOWING BOVINE 
CHOLINE ACETYLTRANSFERASE IMMUNISATION
Mice were immunised with bovine ChAT as described 
in the Methods section 2 . 3 . 2.1. When the pre-fusion sera 
were tested they gave strong positive reactions in the 
dot-immunobinding screening assay using ChAT as antigen, 
at 1:100 dilution. Normal mouse sera produced only a 
faint response at 1:100 dilution.
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When tested on rat spinal cord cell cultures 
(at 1:10 dilution), both sera produced moderate overall 
diffuse staining, predominantly of the neuronal clusters 
and processes. Normal mouse sera did not produce staining 
discernibly stronger than control background levels.
Two successful fusions (Section 2. 3 . 2. 4)were performed 
with spleen cells from the immunised mice. On initial 
testing, a total of ten supernatants from both fusions 
produced strong positive spots in the dot-immunobinding 
screen for anti-bovine ChAT antibodies. When tested 
on fixed rat cultures for immunofluorescent staining(Section 
(Section 2 . 3 .25(i) ,however, only one of the supernatants 
produced staining distinguishable from control background 
levels. The staining produced was not similar to that 
seen with the sera, but appeared to pick out a few cells 
with a "bipolar" morphology. While the rest of the 
hybridomas were stored frozen, the cells from this well 
(3G6) were cloned twice and the supernatants retested.
High power photography under UV illumination (see Plate 6) 
has demonstrated that the antibody decorates an intra­
cellular cytoplasmic antigen. The nucleus is not stained.
The stained cells are "bipolar" and apparently trace
the route of processes emanating from the neuronal clusters.
3.2.5 HYBRIDOMA CELL LINES ESTABLISHED FOLLOWING
IMMUNISATION WITH SYNAPTIC MEMBRANE FRACTION (P3)
Mice were immunised with synaptic membrane fraction 
(Section 23.2.1) and their spleen cells were fused with 
mouse myeloma cells as described in the Methods(section 
2.3.2.4J .
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The immunofluorescence assays performed with 
hybridoma supernatants from these fusion procedures 
were modified so that live cultures could be used. This 
was essential to ensure that the antibodies demonstrated 
were to cell-surface components. The cultures had to 
be handled with extreme care, and were used at no more 
than 15 days old, to minimise detachment from the glass 
surfaces. In addition, all incubations and washing was 
carried out in SSM,as BSS + 5%NRS appeared to greatly 
increase detachment. All tests were made in duplicate.
All other times and conditions were identical to those 
for fixed cultures.(Section 2.3.2.5(i)) .
When the pre-fusion sera were tested by the 
above method on live rat spinal cord cell cultures, 
they produced overall moderate staining of the cell 
surfaces at 1:10 dilution. Normal mouse serum did not 
produce staining discernibly stronger than control 
background levels under these same conditions.
From five fusions, approximately one thousand 
supernatants from hybridoma containing wells were tested 
in total on live rat cultures in a search for cell-surface 
specific antibodies. Many were also tested on fixed 
cultures.
In the first fusion no positives were seen when 
tested on live cultures. Of the few that were also tested 
on fixed cultures, however, there were some examples 
of intracellular staining. One in particular (5A5) strongly 
stained star-like glial cells (Type II astrocytes) and 
other background cells (see Plate 3). It was cloned
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three times. The immunoglobulin class was determined 
as IgM.
The second fusion did not produce any recognisable 
positives when supernatants were tested on live cultures.
The third fusion did, however, give rise to 
one well (IB7) where supernatant gave a definite staining 
pattern when tested on live cultures. It may be useful 
to note that the cultures used in the initial screening 
procedure were younger than usual (4-7 days). The staining 
was not, unfortunately, specific to the surface of the 
neuronal clusters and processes, but appeared to pick 
out a number of very small, round, non-process bearing 
cells which were mainly associated with the clusters 
(see Plate 7). When tested on older cultures, a few 
cells were still weakly stained. They appeared to be 
embedded in the clusters and had now taken on a more 
irregular, fine-process bearing morphology (see Plate 7). 
Their nature is uncertain but it seems likely that they 
are a type of glial cell, or glial cell precursor. The 
hybridoma cells were cloned twice and stored frozen.
The fourth fusion gave a few wells with 
supernatants of similar specificites to those described 
above from fusion three. There was, however, no well 
showing staining of the surfaces of neuronal cluster 
and processes.
One wel1(3C4)from fusion five yielded the first 
example of the latter staining pattern. The staining 
was very weak but clearly distinguishable from controls. 
When tested on fixed cultures it produced a very strong
overall stain of clusters, processes and background
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cells. The first cloning of the cells (by limiting 
dilution) gave ten wells showing the weak surface staining 
described above. All ten supernatants also showed the 
intra-cellular staining pattern. One of the supernatants 
was tested against a four day old human culture and 
produced the strongest example of surface staining seen 
to this point (see Plate 18). The hybridomas from the 
ten positive wells were transferred to 15mm dia. wells 
and allowed to expand. Eight were frozen down and the 
other two re-cloned (again by limiting dilution).
The supernatants from the larger wells were 
tested on a 12 day old human culture. Some of which had been 
transferred to SFM on day 6 and others maintained in 
SSM. The difference in staining strength between the 
two sets of cultures was obvious and consistent. In 
all cases the cultures maintained in SSM stained strongly, 
while those in SFM were only weakly stained.
The surface antigen, recognised by the above 
supernatant, was apparently associated with cells grown 
in serum. The disappearance of this antigen during culture 
in serum free medium was monitored by immunofluorescence, 
using rat cultures transferred to SFM at day 3, compared 
to those maintained throughout in SFM and 5% serum (DHS 
and FCS). The same supernatant was used for comparative 
tests, performed at three day intervals. By day 15, 
the staining of cultures grown in SFM had declined to 
levels that were not easily distinguishable from controls. 
The strength of staining produced in the serum-supplemented 
medium also declined, but to a much lesser degree. It
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was still clearly distinguishable by day 15. By days 
18-21 there was some interfernce from the still-dividing 
non-neuronal cell types.
The phenomenom of serum inducibility was further 
pursued by an ELISA method (Section 3.2.9 ).
The hybridomas tested above were cloned for 
a second time when several wells gave supernatants which 
showed strong surface staining of cultured rat cells.
The best were transferred to 15mm dia. wells.
It was noticed that some of the supernatants 
from the successfully expanded hybridomas did not produce 
a strong background stain when tested on fixed cultures- 
only the clusters and processes were stained. In contrast, 
other supernatants only produced a strong staining of 
background cells and the clusters and processes were 
completely untouched creating a striking "negative" 
type effect. Dark, unstained neuronal processes could 
be clearly seen to run over the surface of the stained 
cells (see Plates 9 and 10). it was suspected from these 
observations that the surface and intra-cellular staining 
were attributable to separate antibodies derived from 
two different hybridoma cell lines. These were named 
3C4a and 3C4b respectively as they had originated from 
the same fusion well.
The striking pattern produced in fixed cultures 
by 3C4b was not similar to that produced by 5A5 (suspected 
anti-GFAP) in that there was no staining of the star-like 
Type II astrocytes which predominantly organise themselves 
in close contact with the neuronal clusters and processes.
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Only large, flat fibroblast-like cells were stained.
With acetone fixation the staining was intensified and 
fine networks of intra-cellular filaments could be clearly 
visualised within these cells (see Plate 10).
The results of experiments designed to investigate 
the nature of the 3C4a surface antigen are reported 
in the relevant forthcoming Sections (3.2.7, 3.2.8,.3.2.9).
3.2.6 DIRECT DEMONSTRATION OF IMMUNOGLOBULIN PRODUCTION 
BY HYBRIDOMAS
Immunoglobulin production of established hybridoma 
cell lines was followed by the procedure outlined in
Section 2.3.2.7.
In tests where the cells were fixed prior to 
incubation with the anti-mouse Ig-FITC conjugate, the 
vast majority of cells were homogeneously stained (see 
Plate 21). This did not appear to diminish greatly after 
several sub-culturings.
When the cells were tested live, however, there 
was a marked decrease in the number of cells which were 
demonstrated to be secreting immunoglobulin as shown 
by irregular surface staining patterns (see Plate 21).
It would, therefore, appear that although the 
cells retain intra-cellular immunoglobulin, their capability 
to secrete it continually declines.
The class of immunoglobulin secreted by the 
different hybridomas could be determined by the method 
described in Section 2 . 3 .2.10 .These determinations are 
shown in Table 10 (p201).
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3.2.7 IMMUNOFLUORESCENT STAINING PATTERNS
The pattern of staining produced by each monoclonal 
antibody was carefully examined, often at different 
stages of culture development and under varying medium 
conditions. The method used to study antibodies recognising 
intra-cellular antigens was identical to the basic 
screening procedure (Section 2. 3.5.1 (i)) Jn addition, 
alternative fixation methods were tested to see if the 
characteristic immunofluorescent staining patterns were 
affected.
When acetone was used, only cultures grown on 
glass coverslips or 10-well multitest slides could be 
used. They were rinsed and then immersed in the acetone 
at -20°C for 10 min. They were air-dried prior to further 
processing by the standard method (Section 2.3.2.5(D).
Cultures could also be fixed by exposure to 
4% paraformaldehyde (w/v) in PBS for 15h at 4°C. They 
were rinsed with PBS alone before further processing 
by the basic method (Section 2.3.2.5(D).
The paraformaldehyde method produced poor, 
indistinct results with all antibodies tested (results 
not shown).
The acetone fixation method affected the staining 
characteristics of three of the monoclonal antibodies.
The 2F7 (anti-neurofilament) monoclonal antibody staining 
appeared to become less specific with greater background 
staining of non-neuronal cells and nuclei. The 5A5 
(possible anti-GFAP) monoclonal antibody staining became 
greatly intensified, with more definite staining of
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large, flat fibroblast-like cells (Type I astrocytes).
The 3C4b (intracellular) monoclonal antibody staining 
was particularly affected by acetone fixation. It became 
far more intense and distinct so that individual intra­
cellular filaments could be distinguished in some large, 
flat fibroblast-like cells (see Plate 10(C)). In addition, 
a second type of staining could be distinguished (in 
cells with similar morphology) where there was more 
diffuse overall staining of the cytoplasm, with fine 
"lace-like" edges visible (see Plate 10(B)).
3.2.8 WESTERN BLOT ANALYSIS OF MONOCLONAL ANTIBODIES
All established monoclonal antibodies were examined 
by Western Blot analysis using spinal cord homogenate, 
culture homogenate or P3 membrane pellet as antigen.
Only the 2F7 anti-neurofilament monoclonal antibody 
produced a consistently positive result (see Plate 22) .
It recognised two bands of approximately 200KDa and 
160KDa, recognising an antigenic determinant common 
to two of the neurofilament polypeptide triplet. No 
band was ever seen in the region of 70KDa, the molecular 
weight of the third polypeptide.
A weak response which was not visible after 
photography was also seen with some of the other monoclonal 
antibodies(1B6,5A5,1C3) . Unfortunately, no band was 
ever seen on the several occasions that the 3C4a surface 
staining antibody was tested. The 3C4b intracellular 
antibody was not tested at this time.
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3.2.9 ENZYME-LINKED IMMUNOSORBENT ASSAY ANALYSIS OF
MONOCLONAL ANTIBODIES
Established monoclonal antibodies (Table 10, p201) were 
examined by ELISA (Section 2.3.2.12) using rat spinal 
cord cell cultures as antigen.
In fixed cultures, the 2F7 anti-neurofilament 
monoclonal antibody gave a strong signal which was 
proportional to the quantity of neurofilament protein 
present. The results obtained have been presented in 
detail in previous Sections (3.1.4, 3.1.5, 3.1.6).
The 5A5 and 3C4b monoclonal antibodies also 
produced strong signals when tested on fixed cultures, but 
were not used in semi-quantitative comparative assays.
The 3C4a surface staining monoclonal antibody 
produced a good signal when tested on live cultures, 
and this method was effective in providing a comparative 
time-course study of the binding of the antibody to 
cultures grown either in serum-supplemented or serum- 
free medium (Fig. 16, p 216). The graph shows the clear 
difference in strength of binding between the two and 
confirms the observed difference seen with the 
immunofluorescence technique (Section 3.2.5).
When homogenates of cultures, adult rat spinal 
cord and P3 membrane preparations were used as antigen 
(Section 2.3.2.12) in the ELISA, the 3C4a antibody again 
produced a good signal. It was also noted that the 5A5 
and 2F7 antibodies gave strong signals, notably, even 
with the P3 synaptic membrane pellet (Table 11, p218).
The sensitivity of the antigen(s) to organic
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Fig. 16 Time course ELISA of 3C4a/b antibody binding 
to live rat spinal cord cell cultures grown 
in SFM or SSM
The ELISAs were performed at three day intervals 
using the same sample of antibody supernatants under 
identical conditions. Each point for the 3C4a/b antibody 
is the average of two wells. Each point for the 5A5 
antibody (intracellular control) and background control 
(second antibody only) is the mean of the average of 
two wells from the SFM and SSM culture.
□ = background control (second antibody alone)
0 =  5A5 antibody binding (intracellular control)
• = 3C4a/b antibody binding (cultures transferred to 
SFM at day 3)
■ = 3C4a/b antibody binding (cultures transferred to 





















Table 11 Reactivity of antibodies with various antigen 
sources as demonstrated by ELISA.
^ ^A n t i b o d y
Antigen\.
O.D. 450nm
3C4a/b 3C4a 1B7 5A5 2F7
Adult rat spinal 
cord homogenate
2.49 1.10 1.78 0.60 2.48
Adult rat spinal 
cord "P3" membrane 
fraction
2.35 1.10 1.84 0.43 2.02
Foetal rat spinal 
cord cell culture 
homogenate
2.5 + 1.42 2.26 0.97 1.19
All antigens were coated at 10|jg/ml. The batch of antibody 
supernatant was the same for each antigen, as were all 
other conditions. The final incubation was 30min at room 
temperature.
Note the high content of intracellular antigens 
still present in the P3 membrane pellet (all but the 
3C4a antibody produce intracellular staining in the 
immunofluorescence test).
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solvent was also tested by the ELISA method. To samples 
of the tissue homogenate were added chloroform, methanol 
or chloroform/methanol (10 vol.). This was shaken 
vigorously for a few minutes and then centrifuged 
(microfuge, high speed). the organic solvent was discarded 
and the pellet resuspended in carbonate buffer and dispensed 
into the wells as usual. When the homogenates were 
extracted as above, there was no difference in response 
to the 3C4a monoclonal antibody when compared to the 
un-extracted homogenate (see Table 1 2 ,p220).
It was also possible to study the trypsin 
sensitivity of the coated antigens by interjecting an 
incubation with 0.05% trypsin solution between coating 
and the primary antibody incubation. When the plates 
coated with homogenate were subjected to trypsinisation 
prior to incubation with 3C4a antibody, the signal was 
considerably reduced (see Table 13 ,p221).
3.2.10 IMMUNOPRECIPITATION
This was used to help clarify whether monoclonal 
antibodies raised to the choline acetyltransferase 
preparation were directed towards the enzyme itself, 
or to some other contaminant present. Alternatively, 
the monoclonal antibody might not be cross-reactive 
with rat choline acetyltransferase.
The crude enzyme preparation (lOOpl) was incubated 
with suspected anti-choline acetyltransferase monoclonal 
antibody (150|jl), or another control monoclonal antibody 
(eg. anti-neurofilament) for several hours at 4°C.Goat
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Table 12 Effect of extraction with organic solvent on
the antigenicity of rat spinal cord homogenate 




3C4a 1B7 5A5 2F7
Adult rat spinal 
cord homogenate




0.51 0.38 1.45 1.46
Both antigen sources were coated at lOpg/ml. Antibody 
supernatant was from the same batch. All other conditions 
were identical. Final incubation 30min, room temperature.
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Table 13 Effect of incubation with trypsin on the 
antigenicity of rat spinal cord fractions 




3C4a No trypsin 3C4a + trypsin
Adult rat spinal 
cord homogenate
0.47 0.06
Adult rat spinal 
cord P3 membrane 
fraction
1.44 <0
Foetal rat spinal 
cord cell culture 
homogenate
1.18 0.11
All antigens were coated at 10|jg/ml. The results are 
those obtained after the subtraction of non-specific 
binding values.
Note the apparent abolition of the antigenicity 
of the fractions for the 3C4a antibody, following trypsin 
treatment.
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anti-mouse Ig antisera (100|j 1) was then added and incubated 
for several hours at 4°C. The samples were then centrifuged 
(MSE microcentaur, high speed) and aliquots of the 
supernatant assayed for residual choline acetyltransferase 
activity by the standard method (Section 2.3.1.10). On 
no occassion was the level of choline acetyltransferase 
activity reduced with comparison with the control thus 
helping to confirm that the monoclonal antibodies raised 
against the crude commercial preparation do not appear 
to be directed at the enzyme itself.
PHOTOGRAPHIC PLATES
1 - 2 2
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PLATE 1
A, B and C are the same rat spinal cord cell culture 
(day 18) grown by the standard method (Section 2.3.1.6) 
from day 3 in SFM. It has been fixed with 5%HAc/70% EtOH 
and processed for indirect immunofluorescence (Section 
2.3.2.5(i)) using the 2F7 monoclonal antibody (see Table
10, p201).
A. Large cell cluster and processes (LP x 100, Tungsten
lamp).
B. Same field of view as in A (above). The 2F7 monoclonal 
antibody has specifically stained the cell cluster 
and processes. Similar results (not shown) are seen 
with the RT97 anti-neurofilament monoclonal antibody 
(Wood & Anderton, 1981).




A, B and C are the same rat spinal cord cell culture 
(day 18) grown by the standard method (Section 2.3.1.6) 
from day 3 in SFM. The culture has been processed for 
indiect immunofluorescence (Section 2.3.2.5(i)), without 
prior fixation, using tetanus toxin and antiserum (Section 
2.3.1.13).
A. Large cell clusters and processes (LP x 100, Tungsten 
lamp).
B. Same field of view as in A (above). The tetanus toxin
has specifically stained the cell clusters and processes, 
thus confirming (in conjunction with anti-neurofilament 
monoclonal antibody binding? Plate 1) their neuronal 
identity (LP x 100, UV lamp).
C. A high power photograph of B (above) showing the 
diffuse nature of tetanus toxin binding to a single 
neuronal process (HP x 400, UV lamp).
The overall staining produced when tetanus toxin 
is tested on fixed cultures is not shown, but it is 






A, B and C are the same rat spinal cord cell culture 
(approximately day 12). The culture was prepared by 
the basic method (Section 2.3.1.6) except it was allowed 
to remain in SSM for longer (day 4/5) thus producing 
an "impure" culture. The culture was fixed in 5% HAc/70% 
EtOH and processed by the indirect immunofluorescence 
technique (Section 2.3.2.5(D) using the 5A5 monoclonal 
antibody (see Table 10 p201) .
A. This shows the impure nature of the culture, with 
the neuronal cluster and processes partially obscured 
by non-neuronal cells (LP x 100, Tungsten lamp).
B. Star-like astrocytes are stained strongly. They appear 
mostly in close association with the neuronal cluster 
and processes (LP x 100, UV lamp).
C. This is an enlargement of a section of photograph B 
(above). A well-defined Type II astrocyte is clearly 





A and B/C are both rat spinal cord cell cultures (15-18 
days) which have been fixed in 5%HAc/70% EtOH and processed 
by the indirect immunofluorescence method (Section 
2.3.2.5(D) using the 1C3 monoclonal antibody (see Table 10 
P 201) •
A. This culture was grown by the basic method (Section 
2.3.1.6) in SFM from day 3 with the additional 
inclusion of the mitotic inhibitors uridine (3.5|jg/ml) 
and deoxyfluorouridine (1.5pg/ml) added to the SFM
at day 3 only. Note the staining of small, roundish 
nuclei surrounding the neuronal clusters. The sparse 
staining of large oval background cell nuclei gives 
an indication of the neuronal purity of the culture 
obtained by this method (LP x 100, UV lamp).
B. This culture was grown by the basic method as in
A (above), without the inclusion of mitotic inhibitors. 
Note the greater density of nuclear staining seen 
in comparison with A (above) (LP x 100, UV lamp).
C. A high power photograph of B (above). Note the total 
absence of cytoplasmic staining (HP x 400, UV lamp).
• 0 •





A/B and C are rat spinal cord cell cultures (15-18 days) 
which have been grown by the basic method (Section 2.3.1.6), 
and fixed in 5% HAc/70% EtOH and processed by the indirect 
immunofluorescence method (Section 2.3.2.5(i)) using 
the 2F3 monoclonal antibody (see TablelO p201).
A. Note how (in comparison to the 1C3 monoclonal antibody, 
Plate 4) the staining appears to be limited to the 
nuclear envelope (LP x 100, UV lamp).
B. A high-power photograph of the central section of 
A (above).
C. This culture was processed as in A/B (above) with 
the sole omission of the 2F3 antibody. Two large 
neuronal clusters are just visible. This photograph 
serves as a universal control for the omission of 
primary antibody, and also in the case of non-fixation 
when an intra-cellular staining monoclonal antibody
is tested (eg. 2F7, anti-neurofilament) (LP x 100,
UV lamp).
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A , B and c are all rat spinal cord cell cultures(15-18 
days) grown by the basic method (Section 2.3.1.6) in 
SFM from day 3, fixed in 5%HAc/70% EtOH and processed 
by the indirect immunofluorescence method (Section 
2.3.2.5(D) using the 3G6 antibody (see TablelO p201).
A. Several cells with a bipolar morphology are strongly 
stained. Their long processes appear, in some cases,
to trace the route between neuronal clusters (unstained) 
(LP x 100, UV lamp).
B. This photograph clearly shows the morphology and 
orientation of these bipolar cells. They appear to 
trace the route of neuronal processes from the cluster 
(just visible, right). Note the unstained nucleus.
It seems most likely that they are Schwann cells 
(HP x 400, UV lamp).
C. This photograph is of a single example of the type 
of cell which stains with the 3G6 antibody (see B, 
above). The long processes transverse the surface 
of background cells whose nuclei (N) are clearly 




A/B is a very young rat spinal cord cell cluster (day 2/3) 
grown from day 0 in SSM (Section 2.3.1.6). It has been 
processed, without prior fixation, by the indirect 
immunofluorescence technique using the 1B7 antibody 
(Table 10 p201) .
A. A number of small, round cells have been indicated 
on the photograph. They occur within the neuronal 
cluster (HP x 400, Tungsten lamp).
B. The strongest surface-staining cells in this photograph 
are the ones numbered in A (above). For the sake
of clarity, only number 6 has been individually 
identified (HP x 400, UV lamp).
C. This is an older rat spinal cord cell culture (day 
15-18) grown and processed as in A/B (above). The 
staining is much weaker, and the small, round cells 
appear to develop an irregular shape and even send 
out fine processes. Their nature is unknown (HP x 400, 
UV lamp) (see Section 4.2.2(vi)).
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A/B and C are both rat spinal cord cell cultures (day 
12-15) which have been maintained in SFM containing 
a low serum concentration (2%) from day 3 (Section 
3.1.3 (iii)). They have been processed without prior 
fixation by the indirect immunofluorescence technique 
(Section 2.3.2.5(i)) using the 3C4a/b antibody (see 
Table 10 p201) .
A. A single, small neuronal cluster (background cells
are not in focus due to the 3-D nature of the cluster).
(HP x 400, Tungsten lamp).
B. The surface staining produced by the antibody is
particulate and appears to trace small individual 
tracts within a neuronal process (bottom centre)- 
(HP x 400, UV lamp).
C. Another example of the staining produced by the 3C4a/b 
antibody. Note the neuronal specificity of the staining. 
Occasional small blobs of staining are active microglial 
cells which have ingested some of the labelled antibody 




A, B and C are examples of the three different types 
of staining which have been seen when the 3C4a/b antibody 
has been tested on rat spinal cord cell cultures, fixed 
in 5%HAc/70% EtOH and processed by the indirect 
immunofluorescence technique (2 .3 . 2.5 (i) ) .
A. Type A staining is more intense, and less particulate 
than seen with live cultures (see Plate 8(C)). the 
staining is still specific to the clusters and processes 
with absent or only weak background staining (LP
x 100, UV lamp).
B. Type B staining is characterised by strong staining 
of neuronal clusters and processes, plus background 
cells (LP x 100, UV lamp).
C. Type C staining is characterised by strong staining 
of background cells only. The neuronal processes
are completely unstained and produce a strange 
"negative-like" effect as they run over the surface 
of the background cells (LP x 100, UV lamp) (see 
Section 4.2.2(vii)).




A. This photograph is a high-power shot of the Type C 
staining previously described with the 3C4a/b antibody 
(Section 3.2.5 and Plate 9(C)) (HP x 400, UV lamp).
B/C. These rat spinal cord cell cultures have been fixed 
by the alternative acetone method (Section 3.2.7) 
and then processed for indirect immunofluorescence 
by the usual technique (Section 2.3.2.5(D), using 
the 3C4a/b antibody. The staining becomes clearer 
and more intense and, where individual background 
cells can be isolated, two different types of staining 
can be identified.
B. The staining is intense around the nucleus and becomes 
more diffuse towards the cell periphery, defining
a "lace-like" morphology (HP x 400, UV lamp).
C. The staining is localised to a fibrous network within
the cell cytoplasm (HP x 400, UV lamp).
It is possible that the cell seen in B is a
fibroblast, while the cell seen in C is a Type I astrocyte.
These cells appear identical under tungsten lamp
illumination.
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A. Foetal rat spinal cord cell culture (day 12-15, grown 
in SFM from day 3). This live culture was processed 
by the localisation of acetylcholinesterase technique 
with the inclusion of the inhibitor neostigmine 
bromide (Sections 2.3.1.12 and 3.1.8). It serves
as a negative control for B and C (below) (LP x 100, 
Tungsten lamp).
B. A culture from the same preparation, and grown and 
processed as in A (above) , but with the exclusion 
of the acetylcholinesterase inhibitor. Dark brown 
staining is seen concentrated in the neuronal clusters 
(LP x 100, Tungsten lamp).
C. Another example of the above staining procedure 
in a different (18 day) rat culture. The intense 
staining is concentrated in the neuronal clusters 




A, B and C are all 15-18 day rat spinal cord cell cultures 
grown by the standard method (Section 2.3.1.6) in SFM 
from day 3. They have all been fixed in 5%HAc/70% EtOH 
and processed by the indirect immunofluorescence method 
(Section 2.3.2.5(D) using human serum (1:10 dilution) 
as the primary antibody source and goat anti-human 
IgG/IgM-FITC conjugate to detect antibody binding (LP 
x 100, UV lamp).
A. TYPE I staining pattern - primarily of neuronal clusters 
and processes (most common).
B. TYPE II staining pattern - astrocytes are primarily 
stained (rare).
C. TYPE III staining pattern - cell nuclei are primarily 
stained (rare).
The staining patterns above were seen in the 
same frequency and at (subjectively) the same intensity, 
whether the serum was from a normal (control) individual, 
or from a patient suffering from Motor Neurone Disease.




A/B and C are both rat spinal cord cell cultures (day 
15-18) grown by the standard method (Section 2.3.1.6) 
in SFM from day 3.
A/B. This culture has been processed live by the indirect 
immunofluorescence method (Section 2.3.2.5(i))'using 
normal human serum (neat) as the primary antibody 
source and goat anti-human IgG/IgM-FITC conjugate 
to detect antibody binding.
(A:LP x 100, Tungsten lamp; B:LP x 100, UV lamp).
C. This culture has been processed as in A/B (above) 
but using serum from a patient with MND (LP x 100,
UV lamp).
The results are typical-surface antibody binding 
was seen in all cases and was (subjectively) of equal 
intensity. The staining was largely specific for the 
neuronal clusters and processes.




A. Rat spinal cord cell culture (day 15-18) grown by 
the basic method (Section 2.3.1.6) in SFM from day
3. Neuronal clusters and processes are the most obvious 
morphological feature at this magnification (LP x 100, 
Tungsten lamp).
B. A separate culture produced from the same cell 
preparation as used for A (above), but grown with 
the additional inclusion of foetal human skeletal 
muscle extract (200|jg/ml) in the medium from day 0.
The culture was photographed on the same day as A 
(above) and at the same magnification (LP x 100, 
Tungsten lamp). The neuronal clusters are typically 
larger, and the processes thicker and more numerous.
C. Example of a dead or dying culture (day 21+) . Cultures 
which have suffered a toxic stimuli also appear thus. 
The neuronal clusters become phase-dark and the 




A. Example of a very large rat spinal neurone cluster 
produced by the inclusion of foetal calf skeletal 
muscle extract (200pg/ml) in the basic SFM. The 
culture (day 21) was stained for neurofilament 
protein using the 2F7 monoclonal antibody (see Table 10 
p201)(LP x 100, UV lamp).
B. Example of a large rat spinal neurone cluster produced
by the inclusion of adult human skeletal muscle extract 
(200pg/ml) in the basic SFM. The culture (day 21)
was stained as in A (above) (LP x 100, UV lamp).
C. Example of rat spinal neurone cluster (from the same
preparation as A and B) grown in SFM alone (from
day 3). The culture (day 21) was stained as in A 
and B (above) (LP x 100, UV lamp). Note the gradual 





A. Human foetal spinal neurone cluster (day 15-18) grown 
throughout in HM-A. Note the large number of background 
cells (nuclei visible) which mainly obscure the neuronal 
processes. The culture was stained with Ehrlichs 
haematoxylin /eosin (HP x 400, Tungsten lamp).
B. Human foetal spinal neurone cluster (day 15-18) grown 
from day 6-9 in SFM. The neuronal cell bodies and 
processes are more distinct than in A (above). Only a 
few background cells are visible. The extent of the 
cytoplasm of a single fibroblast-like cell is indicated 
with arrows. The single, large, oval nucleus is clearly 
visible (N).
It is interesting to note that an area of the 
culture (bottom right) appears totally devoid of any 
background cells. No neuronal processes are seen to 
transverse this area. This is consistent with the 
substrate-mediated theories of growth cone advancement 
(Section 1.1.5) . The culture was stained as in A (above) 
(HP x 400, Tungsten lamp).
C. Human foetal Spinal cord cell culture, processed for 
the localisation of acetylcholinesterase activity 
(Sections 2.3.1.12 and 3.1.8). The dense brown staining 
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A. Human foetal spinal neurone clusters (grown in SFM 
from day 6-9, fixed in 5% HAc/70% EtOH day 18). The
culture was stained for neurofilament protein with j
3
the 2F7 monoclonal antibody (see Table 10 p201). This j
demonstrates cross-reactivity with human neurofilament j
protein. Note weak staining of background cell nuclei j
as mentioned elsewhere (Section 4.2.2(D)(LP x 100, j
UV lamp). )
|
B. Human foetal spinal neurone cluster (grown as in j
A above). The culture was processed live on day 15 ,
for the localisation of tetanus toxin binding
(Section 2.3.1.13 and 3.1.9). Note specificity of 
staining confirming (with A, above) the neuronal 
identity of the clusters and processes (HP x 400,
UV lamp).
C. Human foetal spinal cord cell culture (grown as in
A and B above, fixed in 5% HAc/70% EtOH). This photograph 
demonstrates the cross-reactivity of the 1C3 monoclonal 
antibody (see Table 10 p201) for human cell nuclei (HP 







A. Very young (3/4 days) human foetal spinal neurone 
culture (grown in HM-A; live cells) . The clusters 
are small, and the processes poorly formed (LP x 100, 
Tungsten lamp).
B. The live culture in A (above) had been processed
by the immunofluorescence technique (Section 2.3.2.5(D) 
using the 3C4a/b antibody (see Table 10 p201) . Strong 
surface staining is seen, specific to the neuronal 
clusters and processes demonstrating cross-reactivity 
with human neurones (LP x 100, UV lamp).
C. Another field of view of the same culture as in A 




A. Human foetal spinal cord cell culture (day 21, grown 
in HM-A throughout; live cells). The non-neuronal 
cells have continued to multiply and now practically 
obscure the neuronal clusters and processes (LP x 100, 
Tungsten lamp).
B. The live culture in A (above) had been processed
by the immunofluorescence technique (Section 2.3.2.5(D) 
using the 3C4a/b antibody (see TablelO p201). Neuronal 
specific surface staining is still strong enough 
for photography (this is not the case in cultures 
grown in SFM from day 6-9).
C. Another field of view of the same culture as in A 




A, B , C .
Three different human spinal cord cell/skeletal muscle 
co-cultures (grown from day 6-9 in SFM: A = live cells,
B and C are fixed in 5%HAc/70% EtOH and lightly stained 
with Ehrlichs haematoxylin/eosin). Neuronal, clusters 
are seen in close proximity to well developed myotubes. 
Fine neuronal processes are seen to connect the clusters 
and also in apparent innervation of the myotubes 
(LP x 100, Tungsten lamp).
NC = neuronal cluster 
M = myotube




A. These are immunoglobulin secreting hybridoma cells 
which have been fixed in acetone and processed by 
the indirect immunofluorescence technique (Section 
2.3.2.5(D). Practically every cell is stained (LP 
x 100, UV lamp; Tungsten equivalent not shown).
B/C. These are the same cells as above which have beer 
processed as above without prior fixation. Many cells 
are only weakly stained and a considerable number 
are unstained (indicated with arrows ). Only the 
highly vacuolated, secreting cells appear to be 
strongly stained (See Section 3.2.6).







This plate is of an SDS-PAGE/Western blot analysis 
experiment using adult rat, rabbit (Rb) and human (H)
spinal cord homogenate as polypeptide antigen sources. j
‘i
Part of the gel, including standard proteins (STD) was 
stained with Coomassie brilliant blue R. Other lanes 
were transferred to nitrocellulose paper and incubated 
with the RT97 anti-neurofilament monoclonal antibody, 
or the 2F7 monoclonal antibody (suspected anti-neurofilameni 
Note that the reactivity patterns appear identical with 
a major band at 200KDa and another major (although





79KDa Human IgM p chain
65KDa Bovine serum albumin
50KDa Human IgG J chain
40KDa Egg albumin
30KDa Carbonic anhydrase
KDa STD RAT Rb H RAT Rb H RAT Rb H 




4.1 CULTURED SPINAL CORD CELLS
4.1.1 GENERAL GROWTH OF FOETAL RAT SPINAL CORD CELL CULTURES
The most commonly used neuronal culture systems 
are prepared from embryonic chick (see Table 2 ,p 28 ) .
A few investigators have used embryonic mouse as a source 
of dissociated spinal cord cell cultures (Giller et a l ., 
1973; Giller et a l ., 1977; Brookes et al ., 1980; Godfrey 
et al ., 1980)r and fewer still use foetal rat (Schnaar 
& Schaffner, 1981; Smith & Appel, 1983; Kaufman et a l .,
1985; Smith et al ., 1985). In the mammalian culture system 
the medium has invariably been supplemented with serum 
and mitotic inhibitors and the cel Is plated on coated 
culture surfaces. Kaufman et a l . (1985) are an exception
in growing their dissociated foetal rat spinal cord cells 
in a"CSF-like nutrient medium" supplemented with a "survival 
factor purified from horse serum".
The procedure developed in this department, and 
previously described by Digby et a l . (1985), involves
the initial culture of dissociated foetal rat spinal 
cord cells in a serum supplemented medium on collagen 
coated culture ware to allow for cell attachment and 
the proliferation of a monolayer population of essential 
non-neuronal cells. The cells are transferred, after 
three days, to a chemically-defined serum free medium 
modified from that reported by Bottenstein and Sato (1979) . 
This system has the advantage that mitotic inhibitors 
need not be added to prevent the over-representation 
of non-neuronal cells. In addition, it enables the culture
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system to be used to investigate the effects of additional 
trophic factors on neuronal growth and development (see 
Section4.13) , as the trophic factors and survival factors 
present in the serum are not present to mask or confuse 
the results (see Appel, 1984).
The conditions described by Digby et al (1985) 
have been modified in the present work, in which plates 
are not pre-coated with collagen. Initial experiments 
showed that omission of collagen allowed growth of viable 
cultures and was preferred because the use of collagen 
suffers from the following disadvantages. Collagen:
(a) is time consuming to apply
(b) is a potential source of infection or toxicity
(c) is detected in the protein assay used
(d) frequently detaches ("rolls back") from the culture 
surface after 2-3 weeks, thus destroying the cultures
(e) would be present as a contaminating immunogen when 
cultures were injected into mice for monoclonal 
antibody production (Section 2. 3. 2J.) .
(f) adsorbs reagents used in immunological procedures, 
thus producing high backgrounds in the indirect
immunofluorescence test (Section 2 .3 . 2.5 (i)).
(g) may influence the growth and representation of non­
neuronal cells and hence the neurones themselves.
The initially higher levels of choline acetyl- 
transferase activity seen in uncoated dishes (Fig.l pl40) 
may be the result of an indirect stimulatory effect caused 
by faster initial multiplication and spreading of glial 
cells and fibroblasts. There is evidence that coated
surfaces do reduce glial cell and fibroblast motility 
(see Section 1.1.5).
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Nevertheless, it was advisable to increase the 
usual seeding density of 100,000 cells per cm2 to 
150,000 per cm2 on plastic surfaces and 200,000 per cm2 
on glass surfaces. This ensured the firm attachment of 
the rapidly forming neuronal clusters to the surfaces, 
presumably due to the increased proportion of glial cells 
and fibroblasts which themselves secrete attachment factors 
(laminin, fibronectin, collagen) (see Section 1.1.5).
Neuronal cultures for use in immunofluorescence 
studies of specific antibody binding have invariably 
been grown on glass collagen-coated coverslips (eg. Dickson 
et al ., 1982). This requires large numbers of cells per 
individual culture, and also large quantities of reagents 
during the processing. The ability to grow individual 
cultures on multitest slides (see Section 3.1.2) has 
greatly increased the capacity and ease of screening 
large numbers of hybridoma supernatants for specific 
anti-neural antibodies.
Cumulative time-course graphs of cultures grown 
in 35mm uncoated dishes seeded at 100,000 cells per cm2 
(Fig. 5 p 154) and those grown in 4 x 15mm dia. uncoated 
dishes seeded at 150,000 cells per cm2 (Fig. 11 pl75), 
are very similar. There is a steady rise in all parameters 
and plateaus are achieved between days 15 and 21. This, 
is in contrast to cultures which are grown on collagen 
(in SFM) where there is a sharper rise in the parameters 
with a peak at day 15 followed by a sharp decline (Digby 
et a l ., 1985). The difference may be explained if collagen 
causes an initial reduction in glia and fibroblast motility
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leading to faster growth of neurones. This is consistent 
with previous reports (see Section 1.1.5). The sharp 
decline may be exacerbated by detachment of collagen 
from culture surfaces (maintained in SFM), after day 
15.
Table 14,p 249 compares the mean parameters 
from time-course studies using 35mm and 15mm wells. The 
mean increase in protein content of the 35mm dishes is 
x 3.54 (± 0.18) that of the 15mm wells, which corresponds 
to the ratio of cells seeded into the systems. There 
is, however, less ChAT activity per unit of protein in 
the 15mm dia. wells, which results in the average 66% 
decrease in specific activity. This most probably arises 
from the increased seeding density in the 15mm wells 
which must effect the proportion of non-neuronal and 
neuronal (cholinergic) cells.
4.1.2 EFFECTS OF VARYING MEDIUM COMPOSITION 
4.1.2(i) INCREASED POTASSIUM CONCENTRATION
Some investigators have reported improvements 
in their neuronal culture system when the basic K+ 
concentration in the medium was raised from 5.4mM to 
(usually) 25mM. (Scott, 1971; Bennett & White, 1979;
Kato et al., 1985). Nishi and Berg (1981) reported that 
"Neuronal (chick ciliary ganglion) survival on the fibroblast 
substratum with simple medium containing 25mM K+ was 
extended to several weeks (from 6 days) and was 
indistinguishable from that found with a complex medium...".
Table 14 Comparison of rat spinal cord cell parameters grown in uncoated 15mm dia. and 35mm dia. 
culture wells (extracted from Fig. 5 (pl54) and Fig.11 (pl75) respectively).
Parameters A protein pg/well? B ChAT activity 3ACh produced pm/min/well 
C specific ChAT activity ^ACh produced nm/min/mg protein.
DAY 3 6 9 12 15 18 21
15mm 35mm INC 15mm 35mm INC 15mm 35mm INC 15mm 35mm INC 15mm 35mm INC 15mm 35mm INC 15mm 35mm INC
A 40 144 3.6 64 184 2.9 67 216 3.2 68 236 3.5 75 244 3.3 68 272 4.0 69 298 4.3
B 61 420 6.9 111 620 5.6 155 880 5.7 161 940 5.8 180 1080 6.0 186 1250 6.7 176 1280 7.3
C 1.7 2.9 1.8 2.1 3.5 1.6 2.7 4.0 1.5 2.5 4.1 1. 6 2.5 4.6 1.8 2.9 4.8 1.7 2.7 4.3 1.6
Average protein increase (days 3-21) = x3.54 ± 0.18
Average ChAT activity increase (days 3-21) = x6.29 ± 0.25
Average specific ChAT activity increase (days 3-21) = xl.66 ± 0.04
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Increasing the K+ concentration to 20mM in our 
system produced a small rise in ChAT activity, with 
no "morphologic"effect (Fig. 2 pl45). Survival (past 
day 21) was not investigated. In view of the likelihood 
that increased K+ would mask the effects, on ChAT activity 
and neuronal survival, of the trophic factors to be 
tested, it was not routinely employed (as advocated 
by Kato et a l ., 1985)
4.1.2 (ii) ADDITION OF MITOTIC INHIBITORS
Deoxyfluorouridine, uridine or cytosine 
arabinoside are routinely added to serum-supplemented 
neuronal culture systems (see Table 2 p28 ). They are 
usually added after a few days in culture to prevent 
overgrowth of the non-neuronal cells. In our culture 
system (Digby et a l .,1985), mitotic inhibitors are not 
normally added as culture in SFM suppresses non-neuronal 
cell growth.
Nevertheless, the effects of adding mitotic 
inhibitors at day 3 (concurrent with the switch from 
SSM to SFM) (see Section 3.1.3 (ii) was studied. Whereas 
this undoubtedly produces very pure neuronal cultures 
(see Plate4A), they are also unreliable and very short 
lived (see Fig.3 pl48). Clearly, there is a limit to
just how free of glial cells and fibroblasts a neuronal 
culture can be and still remain viable and useful. There 
is evidence that factors supplied by glial cells are 
essential for the growth and survival of neurones in 
culture (Burnham et a l ., 1972; Monard, 1985). Moreover,
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Kato et al . (1985) have reported undesirable side effects
associated with the use of mitotic inhibitors, and their 
use is thus best avoided.
4.1.2(iii) ADDITION OF LOW CONCENTRATIONS OF FOETAL 
CALF SERUM (FCS)
Most neuronal culture systems are supplemented 
with high concentrations (10-20%) of serum throughout 
their life span (see Table 2 p 28). Only a few reported 
cultures are serum-free throughout (eg. Henderson et 
al,. ,1981; Tanaka & Obata, 1982; Doherty et a l ., 1984c).
When the use of low concentrations of FCS (’0.125-5%) 
in the SFM was investigated (Section 3.1.3 (iii), it 
was found that up to 2% FCS could be employed, without 
the total destruction of normal culture morphology, 
up to 21 days. The increase in survival time and moderate 
stimulation of cholinergic activity demonstrates that 
serum does contain neuronotrophic and "maintenance" 
factors.
Depending on the type of studies which are to 
be performed with the cultures, it may well be that 
the retention of a low concentration of FCS would be 
advantageous. Clearly, this is not the case when other 
neuronotrophic factors are to be assessed (especially 
long term survival) as already pointed out by Appel 
(1984) .
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4.1.2(iv) ADDITION OF THYROTROPIN RELEASING HORMONE (TRH)
In view of the report by Engel et a l .(1983a) 
of a transient improvement in patients with MND when 
infused with TRH, and an apparent 10-16 fold increase 
of ChAT activity in neuronal cultures supplemented with 
TRH (O.lmM) (Schmidt-Achert et a l ., 1984), inclusion 
of TRH was tested in our culture system.
The lack of significant effect with TRH (Section 
3.1.3(iv)) may be indicative of the efficiency of our 
culture system. Most reports of increased ChAT activity 
associated with neuronotrophic factors are in the order 
of a twofold increase (see Table 2, p 28 ). This is consistent 
with the effects of other neuronotrophic factors tested 
in our system (Sections 3.1.4 - 3.1.6). Hence the large 
increase reported by Schmidt-Achert et a l . (19 84) may
be related to an inefficient system with a greater 
capacity for cholinergic improvement.
4.1.3 EFFECTS OF HUMAN MUSCLE-DERIVED FACTORS ON CULTURE 
GROWTH AND DEVELOPMENT
Many investigators have shown potent neuronotrophic 
effects associated with muscle cells or extracts (see 
Table 2 ,p 28 ) . Previous studies have been restricted 
to animal sources, apart from those of Doherty et al . (1986)
who tested conditioned medium from cultured human infant 
muscle cells.
Present results obtained with foetal and adult 
human skeletal muscle extracts (Section 3.1.5 and 3.1.6)
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appear to be consistent with those reported by Smith 
and Appel (19 83) . They demonstrated that the trophic 
activities affecting the cholinergic system, and those 
having an influence on the morphology of foetal rat 
spinal motor neurones in culture are separable. Using 
various tissue extracts from newborn rats, they concluded 
that the "morphological effect appears to be highly 
specific for skeletal muscle extract" whereas the 
cholinergic activity "shows less tissue specificity, 
being increased with extracts of tissues that receive 
dense cholinergic innervation".
In contrast to the findings of Smith and Appel, 
however, foetal human liver extract did .'appear to 
have a noticeable morphological effect on my cultures.
It has been reported (Henderson et a l ., 1984) that media 
conditioned by exposure to conditioned embryonic chick 
liver cells show a neurite-outgrowth promoting trophic 
effect on cultured chick foetal spinal neurones. This 
may suggest an early central source of the "morphologically 
active" trophic factor. Smith and Appel found no trophic 
effects with neonatal rat liver extract. This may be 
because production of the factor by the liver is terminated 
at an early stage.
In the present studies, the highest concentration 
of muscle extract used was 200|jg/ml and there was a linear 
increase in levels of neuronal protein up to this value. 
Smith and Appel (1983) reported that "this increment 
in neurite outgrowth was linear with increasing muscle 
extract concentration up to 600|jg of protein per millilitre 
of medium". Clearly, there may still be room for further
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morphological improvement with larger doses of adult 
human skeletal muscle extract. They also found that
"The morphological enhancement decreased with
developmental age, whereas the cholinergic enhancement.... 
..did not change with age". In the present studies, 
both activities were retained in adult human skeletal 
muscle extract and were of the same order of potency 
as that of foetal human skeletal muscle extract (Sections 
3.1.5 and 3.1.6). There was little difference in the 
trophic activity of extracts from normal biopsied human 
muscle, and amputated limb muscle (Section 3.1.6), despite 
the possible functional denervation of the latter. 
Functional denervation, or simply immobilisation of 
the limb, have been shown to increase the neurite outgrowth 
promoting activity of adult animal skeletal muscle extracts 
(Nurcombe et a l ., 1984; Gurney et al., 1984b).It has 
been shown, however, that this stimulated activity is 
a short term response and may only be produced during 
the first few days/weeks (animals) or months (human) 
following denervation or immobilisation. It is possible 
that the levels of trophic activity had returned to 
control levels in the amputated limb group.
My finding of neuronotrophic activity in normal 
adult human skeletal muscle extracts is in contrast, 
not only to the results of Smith and Appel (1983) but 
also to those obtained in other animal studies by Slack 
and Pockett (1982) and by Nurcombe et a l . (1984).
Differences might be attributed to differences in culture 
systems (especially the use of SFM), human life-span/size
or, the need for continual peripheral re-innervation etc.
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In view of the similarity in potency of 
neuronotrophic activities from "normal" and "amputated" 
adult human skeletal muscle extracts (see Table6,pi79 
and Table 7, p 183) amputated muscle (which is available 
in large quantities) would be suitable as the source 
for separation and purification of neuronotrophic 
factors.
4.1.4 GROWTH AND MAINTENANCE OF FOETAL HUMAN SPINAL 
CORD AND MUSCLE CULTURES
The age in utero of the human foetus appeared 
to be the most crucial factor for the successful growth 
of spinal neurones in culture. While it is difficult 
to judge the exact age of a very young foetus, the optimum 
seemed to lie between six and eight weeks.
Even when cultures are prepared from these young 
foetuses and seeded in SSM at the same density as for 
rat, they never achieve the same degree of morphological 
development as rat cultures, the neuronal clusters are 
smaller and fewer, and the processes are much finer 
and less numerous (See Plates 16 - 20).
It is possible that human spinal neurones have 
a greater requirement for specific neuronotrophic factors. 
In preliminary tests, the human skeletal muscle cell- 
conditioned medium and extract proved to be toxic to 
the neurones. They may be particularly sensitive to 
harmful components in these preparations, and it may 
therefore be essential to at least semi-purify the trophic 
factors before they can be safely tested for growth
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and enhancement of enzyme activity.
A further potential problem with human foetal 
cultures was pointed out by Kennedy et al . (1980) who
observed the "extreme sensitivity of central neurones 
to anoxia". They suggested that it may prove"difficult 
to culture central neurones from aborted foetuses unless 
cultures are prepared soon after the foetal heart has 
stopped". Although, in the present work, foetuses were 
extracted, transported and dissected as soon as possible 
after termination (usually within lh), it is likely 
that time delay had some effect on neuronal survival.
On site culture facilities might meet with greater 
success.
The studies that can be performed with human 
spinal neurone cultures are severely restricted by the 
numbers of correct age foetuses available, and the 
relatively small numbers of cells obtained from each 
spinal cord (4-5 million per whole cord). Infection 
is also a constant danger in this work.
Successful human foetal spinal cord cell cultures 
(which have been demonstrated to contain neurones) were 
reported during the progress of these experiments (Kato 
et a l ., 1985; Kim et a l ., 1986) Both studies employed 
very young foetuses, and the cultures were maintained 
in a serum-supplemented medium throughout.
The age of foetus necessary for satisfactory
skeletal myotube cultures is less restrictive. Good 
cultures were obtained from 8-12 week old foetuses.
The rapid fusion of myoblasts to healthy myotubes induced
by changing to SFM followed by their subsequent decay
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over the next few days is interesting. In other studies 
performed in this department (Lis Childs, personal 
communication), human skeletal myotube cultures, were 
maintained in 10% donor horse serum-supplemented medium 
with the mitotic inhibitor cytosine arabinoside ( 10 pM ) 
added at day 3 to prevent the outgrowth of fibroblasts.
This procedure produces a slower fusion of the myoblasts, 
but longer-lasting cultures are obtained and can be 
used in complement-mediated lysis studies from day 6 
(Childs et a l ., 1985). The serum-free medium is 
nutritionally complete and it would therefore seem that 
other, trophic factors are supplied by the serum to 
enable them to maintain their integrity. This is consistent 
with previous reports (Section 1.1.6).
In combined human neurone-skeletal muscle cultures 
(Section 3.1.7(iv) and Plate 20) it seems that healthy 
myotubes will survive for long periods in SFM provided 
that they are in close proximity to neuronal clusters.
This strengthens the argument for the supply of trophic 
factor(s) to the muscle cells from innervating neurones 
(and vice versa) and is backed up by the measured increase 
in ChAT activity (see Fig.15, pl91). Once again, the 
lack of material and unreliability of the cultures makes 
it unlikely that they can be applied to large, quantitative 
studies.
4.1.5 CHARACTERISATION OF FOETAL RAT AND HUMAN SPINAL
CORD CELL CULTURES
Binding of anti-neurofilament monoclonal antibody
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(RT97 and 2F7), and tetanus toxin showed the major cell 
clusters and interconnecting processes of spinal cord 
cell cultures to be primarily neuronal (see Plates l, 2, 
15, 17 )• In addition, the high levels of ChAT activity
and the localisation of intense acetylcholinesterase 
activity in the neuronal clusters shows the latter to 
be cholinergic. The proportion of these cells which 
are somatic Of-motorneurones has not been ascertained.
In whole spinal cord such cells comprise only 5-10% 
of the total population (Smith et al., 1986) and are 
therefore not likely to be present to a larger extent 
in culture unless the conditions specifically favour 
their survival. Using the combined techniques of 
fluorescent labelled WGA retrograde transport and anti- 
ChAT monoclonal antibody binding, Smith et al. (1986),
have estimated the proportion of motorneurones in their 
foetal rat ventral spinal cord cell cultures to be only 
3.3-11% (or 1.5-5% total spinal cord cells).
Other morphological characteristics of the spinal 
cord cell cultures have been recognised during the process 
of specific monoclonal antibody production and are 
discussed in the forthcoming Section (4.2.2).
4.1.6 CULTURED SPINAL CORD CELLS AS A MODEL FOR THE 
INVESTIGATION OF MOTOR NEURONE DISEASE
4.1.6(i) SERUM IMMUNOGLOBULIN BINDING
Stefansson et al. (1985) point out that"according
to the clonal selection theory of Burnet (1959) the
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presence of autoantibodies signified disease". Since 
1959, however, evidence has been steadily accumulating 
to disprove this assertion. In particular, Guilbert 
et a l . (1982) and Dighiero et al . (1982) demonstrated
that the serum from normal healthy individuals contained 
autoantibodies directed at tubulin, actin, thyroglobulin, 
myoglobin, fetuin, transferrin, albumin, cytochrome c 
and collagen.
Eutz and Wipf (1982) showed that "the IgG fraction 
of sera of healthy human subjects contains natural 
antibodies to cytoskeletal elements of the donors own 
red blood cell membranes".
In their review of 1984, Kurki and Virtanen 
concluded that all normal individuals have lymphocytes 
capable of producing antibody to self-antigens not normally 
exposed to the immune system (eg. cytoskeletal components) 
and concurred with the suggestion of Lutz and Wipf that 
these autoantibodies may have a normal physiological 
role in the clearance of debris from lysed cells. Following 
on from this, it is easy to see that patients with a 
disease which involves the destruction of cells eg.
Systemic Lupus Erythematosus (SLE) are likely to have 
higher levels of these specific anti-cytoskeletal (and 
nucleoskeletal) antibodies to cope with the increased 
liberation of these highly insoluble antigens. It is 
significant that anti-cytoskeletal antibodies in 
pathological conditions are often of the IgG class, 
whereas those in normal sera tend to be of IgM class 
(Kurki & Virtanen, 1984).
Of potential relevance to MND is the report
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by Daar and Fabre (1981) that normal healthy individuals
have organ-soecific autoantibodies to brain homogenates
(as well as to liver and heart). The shape of the titration
125 . .curves in their sensitive I-anti-immunoglobulin 
binding assay resembled those of an antiserum in every 
respect. There was no difference in binding to brain 
homogenates when sera from patients with multiple sclerosis 
were tested. The autoantibodies were found to be IgM 
in nature.
Stefansson et a l . (1985) also reported that
the sera of normal healthy individuals contained 
autoantibodies to the 200KDa protein of the neurofilament 
triplet. They found no increased titre of these antibodies 
in sera from patients with ALS, or other neurological 
diseases. Jehanli et al . (1986), however, using Triton-
insoluble fractions from rat spinal cord (in contrast 
to the homogenates of human neural tissue used by 
Stefansson et a l ., 1985) were able to show a clear 
difference in the binding of serum immunoglobulins from 
patients with MND and normal controls in immunoblot 
studies. MND sera showed binding of IgG to the three 
neurofilament polypeptides in several combinations, 
with binding intensifying as the disease progressed 
in individuals. Serum IgG from normal individuals produced 
much weaker staining patterns, if any.
In summary, it would appear, on the balance 
of evidence, that all normal individuals contain lymphocytes 
capable of producing antibodies to their own cytoskeletal 
filaments (including neurofilaments). The antibodies
261
are predominantly IgM in nature and may serve to aid 
the clearance of debris liberated from lysed cells.
In patients with MND, where there is a large 
increase in the rate of neuronal cell death, the increased 
release of neurofilament protein may therefore stimulate 
the expansion of existing clones of B-lymphocytes, or 
induce the establishment of new clones. The antibodies 
generated may then serve a role in catabolism; they 
would become increasingly IgG in nature. These antibodies 
would probably not be implicated in the pathogenesis 
or exacerbation of MND as they cannot gain access to 
healthy neurones to initiate the destructive process.
Experiments reported in this thesis (Section 
3.1.10(i) demonstrate that serum immunoglobulins from 
both MND and normal individuals bind to fixed spinal 
cord cell cultures, producing three distinguishable 
staining patterns in the indirect immunofluorescence 
test (see Plate 12). No difference in type or strength 
of binding could be discerned using this method (with 
a polyvalent (anti-IgG, A and M) second antibody)(cf.
Watts et a l ■ (1981). This was also the case in the ELISA
with fixed cells and a polyvalent second antibody (Section 
3.1.10(ii) ) .
Of far greater importance to the question of 
the etiology and pathogenesis of MND, however, is whether 
MND serum contains unique, or high titres of, antibodies 
directed against a neural antigen which is normally 
exposed to the immune system. Digby et a l . (1985) reported
a significant increase in serum immunoglobulin binding
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to live rat spinal cord cell cultures from patients
125with MND. They used a I labelled goat anti-human 
light chain second antibody (which would tend to amplify 
IgM binding).
In this thesis (Section 3.1.10(ii)) no difference 
could be demonstrated between MND and normal serum Ig 
binding to live cultures using the immunofluorescence 
and ELISA techniques and a polyvalent second antibody.
When the ELISA technique for live cells was used in 
conjunction with class specific second antibodies, however, 
a difference was seen with specific anti-human IgM- 
peroxidase conjugate (not with IgG specific)(see Table 
9, pl97 ). This would tend to confirm the earlier report 
by Digby et a l . (1985).
These observations raise several interesting 
questions. Does the increased IgM binding reflect a 
novel antibody recognising an antigen not usually 
challenged by the immune system, or is it just an increased 
titre of an existing antibody? Why do the antibodies 
present in normal sera not have a destructive effect 
on neurones - are they perhaps related to the so-called 
harmless "blocking" serum factors for protection against 
autoimmunity? (Hellstrdm & Hellstrdm, 1972).
Conradi and Ronnevi (19 87) have shown that 
antibodies can distinguish between surface components 
of healthy and effete red blood cells. Could it be that 
a change occurs in the surface membranes of dying neurones 
which allows them to be recognised and destroyed by 
existing autoantibodies?
Whether the increased?ssrum immunoglobulins of
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patients with MND are involved in the disease process, 
or not, it is nevertheless possible that a well-defined 
assay system (eg. ELISA) could be developed as an early 
diagnostic tool for the disease. Particular attention 
would have to be paid to other neurodegenerative disease 
(OND) sera, which may also contain raised titres of 
specific anti-neuronal antibodies.
4 .1. 6(ii) SERUM CYTOTOXIC ACTIVITY
There are conflicting reports as to whether 
or not MND sera contain a factor which is toxic to 
neurones in vitro, (see Section 1.3.5(iv). This subject 
was therefore explored in the present thesis. No difference 
was seen in the effects of MND or control sera on rat 
spinal cord cells in culture (Section 3.1.10 (iii)).
In the experiments where guinea-pig serum was 
employed as a complement source, it was itself toxic 
to the cultures. This might be explained by the observations 
of Shichij o et a l . (19 85), who noted that guinea pig
sera contained naturally-occurring antibodies to 
gangliosides. In particular, some individual sera contained 
high titres of antibodies to Gml and GDlb. As gangliosides 
are a major component of neuronal tissue membranes 
(Leeden, 1985), it is possible that the toxicity represented 
a complemented-mediated lysis of the cultures through 
this route. Natural antibodies against gangliosides 
have also been found in normal human serum (see Shichijo 
et al., 1985 ). This is additional evidence that normal 
healthy individuals can tolerate natural autoantibodies 
to neuronal surface components (Section 4.1.6(i)).
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4.2 MONOCLONAL ANTIBODIES
4.2.1 ESTABLISHMENT OF HYBRIDOMA CELL LINES
(i) IMMUNISATION
It is frequently stated that antigen purity 
is "not critical" in immunisation with a view to monoclonal 
antibody production (eg. Levey et a l ., 1981). This is 
misleading and may only apply in very limited instances. 
Time spent in improving the purity of the antigen source 
may well be minimal when compared to screening vast 
numbers of hybridomas for the desired antibody specificity.
In the example of mice immunised with a "membrane" 
fraction (Section 3.2.5) prepared by the method of Young 
and Snyder (1973) , it was subsequently shown that 
neurofilament (and other) cytoskeletal proteins were 
present as a major contaminant (Section 3.2.9). These 
highly immunogenic polypeptides produce a strong reaction 
when injected. It is, therefore, hardly suprising that 
only one in a thousand resulting hybridoma supernatants 
(from five fusion procedures) was positive for a surface 
antigen (Section 3.2.5).
A preferable procedure may involve the initial 
detergent solubilisation of membrane proteins. In 
particular the phase-separation procedure utilising 
Triton X-114 (Bordier, 1981; N^rendran & Hoffmann, 
unpublished) appears promising for the isolation of 
pure integral membrane proteins.
(ii) FUSION AND CLONING PROCEDURES
The fusion procedure itself proved satisfactory
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in establishing a good proportion of hybridoma containing 
wells (average 50%).
The advantages of cloning by micromanipulation 
are that it is certain that each well received an individual 
cell, and only "healthy"-looking cells need to be selected 
and seeded. It was, however, exceedingly time-consuming 
and could only be used on limited accasions.
Sometimes,because of the sheer numbers of similar 
positives obtained, it was necessary to select only 
the fastest growing, strongest positive wells for further 
processing. In addition, it was advisable to clone the 
cells as soon as possible after transfer. The antibody- 
secreting hybridoma may have been just one of several 
hybridomas, some non-secreting; or secreting undesirable 
antibody. There was therefore a real danger that the 
positive antibody producing cells would be rapidly 
"overgrown".
It was often not possible to clone all of the 
positives at the same time. Some of them were "frozen" 
for future processing, once they had achieved confluency 
in the wells (ie. approximately 10^/ml).
(iii) GENERAL
When whole spinal cord cell cultures were 
used as the antigen source, the hybridomas produced 
by the fusion procedure appeared to secrete antibodies 
which were directed at the insoluble, fibrous, protein 
filaments of the cytoskeleton or nucleoskeleton. These 
structures are obviously highly immunogenic (Cooper,
1986) .
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It is impossible to say whether hybridomas 
secreting antibody to cell membrane components were 
produced, as the supernatants were only tested on fixed 
cultures and hence any surface staining would not have 
been easily distinguishable from intra-cellular staining. 
Alternatively, it may have been lost against a background 
of intra-cellular staining produced by other antibody- 
secreting hybridomas present in the same fusion well.
The main disadvantage of antibodies to intra­
cellular antigens is that the cells have to be fixed 
and permeabilised (ie. killed) before study.
Antibodies to cell membrane components have 
considerably greater potential than those to intra-cellular 
structures. They are likely to be less "general" and 
may prove to be capable of distinguishing between small 
subsets of a particular cell type. Anti-neurofilament 
monoclonal antibody will, for example, recognise 
neurofilament protein in all neurones, whereas the 
38/B7 and A4 monoclonal antibodies which recognise surface 
components have already been shown to distinguish between 
central and peripheral neurones (see Table 4, p 70 ) . The 
CHOL-1 antibody apparently selects neurones which 
use acetylcholine as their transmitter molecule (Jones 
et a l ., 1981) . It is likely that the future will bring 
a battery of such highly specific neuronal surface 
antibodies. An antibody specific to a surface component 
of somatic Of-motor neurones, for example, would prove 
invaluable.
Apart from the highly specific identification
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promised by these antibodies, they could also be used 
in immunoaffinity columns or fluorescence activated 
cell-sorting to achieve near 100% purification of the 
cell type under study (see Section 1.1.4). This would 
enable many aspects of the cells to be studied (eg. growth 
and development) without the interference of other cell 
types.
The best hope in this direction at the moment 
lies with the family of gangliosides. It has been shown 
that the CHOL-1 antigen is in fact ganglioside GTlb 
+ Gq (Ferretti & Borroni, 1986) and there is accumulating 
evidence that gangliosides have specific limited 
distributions on neuronal membranes (Kim et a l ■, 1986).
Another possibility is receptor molecules - if 
it could be shown that a specific type of receptor molecule 
was only present on one set of neurones, then antibody 
to this receptor could be produced and tested. A candidate 
here could be the glycine receptor, a form of which 
might be restricted to motor neurones. In this context, 
there are already many monoclonal antibodies in existence 
directed at the nicotinic acetylcholine receptor 
(Lindstrom et a l ., 1981).
4.2.2 MONOCLONAL ANTIBODIES PRODUCED
4.2.2 (i) 2F7 (Anti-neurofilament)
This monoclonal antibody was produced through 
immunisation with foetal rat spinal cord cell cultures 
(Day 21, grown in SFM). It was recognised as a potential 
anti-neurofilament monoclonal antibody because of the
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identical staining pattern it produced in the indirect 
immunofluorescence test (see Plate 1 ) when compared 
with an established anti-neurofilament monoclonal antibody 
(RT97; Wood & Anderton, 1981). In Western Blotting 
experiments (Section 3.2.8) 2F7 had strong affinity 
for an approximate 200KDa polypeptide in rat, rabbit 
and human spinal cord homogenate. It also reacted weakly 
with an approximate 160KDa polypeptide. The results 
were identical when the RT9 7 monoclonal antibody was 
used in the same system (see Plate 22) and hence the 
reactivity was established as anti-neurofilament. No 
reactivity was seen with the 70KDa neurofilament poly­
peptide.
The different intensity of reactivity in the 
western blots may be due to a different proportional 
representation of the 200 and 160KDa neurofilament 
polypeptides in adult spinal cord, rather than different 
affinities.
When mature (21 days in SFM) foetal rat spinal 
cord cell culture homogenate was used as antigen source, 
the 2F7 reactivity in western blots was similar to that 
seen with spinal cord homogenates (not shown).
The hybridoma cell line is very stable and large 
quantities of supernatant were produced. 2F7 monoclonal 
antibody has been used in ELISAs (Doherty et a l ., 1984b) 
to produce an arbitrary comparative index of neurofilament 
protein present in divided cultures grown under different 
medium conditions (eg. in the presence or absence of 
additional potential neuronotrophic factor-containing 
extracts).
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The occasional additional nuclear staining seen 
in the indirect immunofluorescence test (eg. Plate 17) 
is probably associated with over-long fixation (with 
acid-alcohol). It is also seen with acetone fixation 
(Section 3.2.7). This phenomenom has also been reported 
with the RT97 antibody (wood & Anderton, 1981), and 
is consistent with the demonstration that some antigens 
of the cytoplasmic cytoskeleton are found in the nucleus 
(see Kurki & Virtanen, 1984) .
Other workers (eg. Lee et al., 1982) have produced 
monoclonal antibodies specific to each of the neurofilament 
polypeptides, and these are now commercially available 
(BCL Ltd., Lewes, Sussex, U.K.).
(ii) 1C3 (Anti-nuclear)
This monoclonal antibody was produced as a 
by-product in the attempt to raise anti-neurofilament 
monoclonal antibodies. It is possible that the antigen 
recognised is a nucleo-skeletal protein. Antibodies 
to these proteins (with similar immunofluorescent staining 
characteristics) have already been described (Kurki 
& Virtanen, 1984).
When tested in Western Blot studies, the antibody 
did not produce a clear, repeatable banding pattern 
under the conditions used. There was, on one occasion, 
a faint band at approximately lOOKDa.
The antibody was, however, useful as a striking 
visual indicator of culture purity (see Plate 4 ). with 
cultures grown in SFM supplemented with mitotic inhibitors
(Section3*L3 (i-)) the density of nuclear staining is greatly
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reduced thus indicating the sparcity of glial and 
fibroblast cells present. The effect could probably 
be quantitated by counting the number of nuclei stained 
in a given area.
(iii) 2F3 (Anti-nuclear Membrane)
This was also a by-product antibody. It appears 
to be specific for a component of the nuclear membrane 
(see Plate 5 ), it does not produce the overall nuclear 
staining seen with the 1C3 antibody. The nature of the 
antibody and its antigen was not pursued further.
(iv) 3G6 (Anti-Schwann Cell-intracellular Antigen.
This antibody is, perhaps, the best example 
of unexpected antibody generation. Several antibody- 
secreting hybridoma cell lines were established following 
immunisation with bovine ChAT (commercial preparation). 
They all produced strong positive reactions in the 
dot-immunobinding assay.with bovine ChAT as the antigen 
(Section 3.2.4). When tested on acid-alcohol fixed foetal 
rat spinal cord cell cultures, only one (3G6) produced 
any staining in the immunofluorescence procedure. If 
3G6 was directed at (and cross-reacting with) rat ChAT 
then one would have expected staining to be localised 
to the neuronal clusters and processes, or even to 
individual cholinergic neurones. Instead, a sparse 
population of bipolar cells was specifically stained.
The photographic evidence strongly suggests that they 
are Schwann cells (cf. Burroni et al., 1988). They appear
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to trace the path of neuronal processes between the 
clusters.
This is the first demonstration of Schwann cells 
in our cultures; they may well derive from neuronal 
structures associated with the spinal cord (eg. DRG) 
which are not meticulously removed prior to dissociation. 
Other Schwann-cell specific marker antibodies have been 
described (Ran-1, S-100, mAb 224-58,see Table 4, p70).
The antigen is probably present in the commercial 
ChAT preparation as a minor (albeit immunogenic) impurity. 
SDS-PAGE of this preparation has demonstrated four major 
bands (one at 66-68KDa) and other minor bands (A. Jehanli, 
personal communication).
The difficulty in producing monoclonal antibodies 
directed at ChAT itself has been pointed out by others 
(reviewed by Kasa, 1986). It is apparently not a very 
immunogenic molecule. A well characterised, cross-reactive 
anti-ChAT monoclonal antibody has, however, recently 
become commercially available (BCL, Ltd., Lewes, Sussex, 
U.K.).
The other antibodies produced through the present 
immunisation protocol are likely to be:-
(a) directed to impurities in the commercial ChAT 
preparation which do not cross-react with, or are not 
present in foetal rat spinal cord cell cultures
(b) directed at the enzyme itself, but not cross-reactive 
with the rat enzyme.
These possibilities have not been investigated 
(by Western Blotting etc.) The 3G6 antibody did not
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itself produce a banding pattern when tested against 
foetal rat spinal cord cell culture homogenate as antigen 
(under the conditions used).
(v) 5A5 (Anti-Astrocyte/Fibroblast).
This was produced as a by-product of immunisation 
with adult rat spinal cord "P3" membrane pellet (produced 
by the method of Young & Snyder, 1973). Some of the 
resulting hybridomas were tested on fixed cultures (in 
addition to live). Many examples were seen of mixed 
intracellular staining - this underlines the impurity 
of the "P3" preparation and hence its unsuitability 
as an immunogenic source for surface-reactive antibody 
generation (See also Section 3.2.9). The 5A5 hybridoma 
line was retained as a potential anti-GFAP monoclonal 
antibody producer. Type II fibrous astrocytes are clearly 
stained (see Plate 3 ). In other tests, large, flat 
type I protoplasmic astrocytes (or fibroblasts) were 
also seen to be stained. This may be related to the 
developmental age of the culture used, or fixation 
inconsistencies. The antibody was reactive in ELISA 
tests, but a definite banding pattern could not be 
established in Western Blot studies under the conditions 
used.
(vi) 1B7 (Anti-"small round cell").
This was the first surface reactive antibody 
to be recognised by using live cultures in the 
immunofluorescence assay. 1B7 stains small round cells
associated with young neuronal clusters (see Plate 7) .
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As the culture matures (in SFM) the cells diminish in 
number, they become larger, more irregular and may extend 
a few fine processes. The strength of staining is 
considerably reduced. The nature of the cells and their 
antigen is unknown. The staining pattern produced does, 
however, appear identical to that described by Walker 
et al . (1984/85) for A2B5+ (ganglioside GQ) cells in
their cultures of rat cerebral tissue. They too refer 
to these cells as small and round, and they also develop 
processes. Their cells are galactocerebroside negative 
(GC ) and hence not oligodendrocytes. They suggest that 
these cell may be progenitor glial cells (as described 
by Raff et a l ., 1983). These cells develop into Type 
II (A2B5+ , GFAP+) astrocytes in the presence of foetal 
calf serum or into GC+ , A2B5 oligodendrocytes in serum- 
free medium.
No banding pattern was produced on Western Blot 
analysis and, in fixed cultures, considerable intracellular 
background staining is seen in the immunofluorescence 
test. This is consistent with the antigen being a 
ganglioside, as they are reported to be associated with 
intracellular filaments (Kim et al ., 1986).
(vi) 3C4 (Anti-neuronal Cluster and Processes and 
intracellular)
This antibody was first recognised by its weak 
surface staining of live neuronal clusters and processes, 
barely distinguishable from control levels. Subsequent 
experiments determined that this was probably due to 
the fact that the assay cultures were usually 15-18
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days old, grown in SFM from day 3. The surface antigen 
does not appear to be retained for long periods in SFM.
This could partly explain the fact that only one surface- 
reactive antibody was detected out of a thousand 
hybridomas (see also Section 4.2.1(iii). A strong 
representation of the antigen was first seen in a young 
human spinal cord cell culture (Plate 18) which was 
still growing in a serum-supplemented medium (HM-A).
When tested on fixed rat and human cultures 
the 3C4 antibody produced strong intracellular staining 
(Plate 9B ). The antibody was cloned three times and 
yet still this intracellular staining persisted. It 
was concluded at that time that the antibody was monoclonal 
and that it was cross-reactive with surface and intra­
cellular structures. There was a precedent for this 
in the TllA9e antibody which appears to recognise both 
Thy-1 and a component of intermediate filaments, probably 
vimentin (Dulbecco et a l ., 1981).
On subsequent cloning, however, aliquots of 
supernatant were produced from different wells which 
appeared to stain just the neuronal clusters and processes 
in live and fixed cultures or just the background cells 
in fixed cultures (see Plate 9 ). This appeared to be 
consistent with the final separation of two independent 
hybridoma cell lines and they were accordingly labelled 
3C4a and 3C4b respectively. No banding pattern could 
be established with the 3C4a "neuronal surface specific" 
monoclonal antibody.
Further characterisation experiments have indicated
that the 3C4a antigen is probably a glycoprotein (Section
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3.2.9). Its apparent loss in SFM (see Fig.16, p216) 
suggests that it is serum inducible. There is a similarity 
in this to the NGF-indicible large external (NILE) 
glycoprotein (McGuire et al., 1978).
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